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GENERAL INTRODUCTION 
Objectives of Dissertation Research 
A new and severe swine disease, porcine reproductive and respiratory 
syndrome (PRRS), emerged in the late 1980s (Hill, 1990; Paton et al., 1991; 
Wensvoort et al., 1991). The disease, characterized by reproductive failure and 
respiratory disease in swine herds, was often referred to as mystery swine disease 
because of its unknown etiology (Keffaber, 1989; Dial et al., 1990; Hill, 1990; Loula, 
1991). PRRS is an economically important swine disease because of the severe 
adverse effects on swine production. In 1991, a previously unrecognized virus, 
porcine reproductive and respiratory syndrome virus (PRRSV), was isolated using 
primary swine alveolar macrophage (SAM) cultures and was shown to be the 
causative agent of PRRS (Pol et al., 1991; Terpstra et al., 1991; Wensvoort et al., 
1991). The hypotheses of my dissertation research were: (1) The respiratory 
disease in nursery and growing pigs was caused by a vims which could be 
cultivated and characterized in an established cell line (s); (2) The vims evolved 
from a known virus and could be classified into an existing virus family; and (3) 
There is a genetic basis for the observed difference in virulence among different 
virus isolates (Halbur et al., 1995c, 1995d). 
The initial objective of my dissertation research in 1991 was to isolate and 
characterize PRRSV in a continuous cell line because there was no established 
cell line which could support the replication of PRRSV at that time. As this initial 
objective was achieved, my colleagues and I wished to clone and sequence part of 
the PRRSV genome which was the second objective of my dissertation research. 
The third objective was to study the possible evolution and phylogenetic 
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relationship of PRRSV with other related viruses as well as between different 
PRRSV isolates in the U. S. A. and Europe. From the results obtained in the 
second objective, my colleagues and I found that PRRSV replication required the 
formation of a 3'-terminal nested set of subgenomic mRNAs, thus the fourth 
objective was to characterize the subgenomic mRNAs in PRRSV-infected cells in 
more detail. Because marked variation in virulence among PRRSV isolates has 
been demonstrated (Halbur et al., 1995c, 1995d), the fifth objective of my 
dissertation research was to compare the genetic differences between low and 
high virulence isolates of PRRSV, which would provide some useful information 
about the virulence determinant (s) of PRRSV. 
Dissertation Organization 
This dissertation contains five separate manuscripts. Each individual 
manuscript was written according to the guidelines for authors of the appropriate 
journal to which the manuscript is published or submitted. The Ph.D. candidate, 
Xiang-Jin Meng, was the senior author for each manuscript. Each manuscript 
typically includes an Abstract, Introduction, Materials and Methods, Results, 
Discussion and Acknowledgment sections. References cited in manuscripts were 
included at the end of each manuscript followed by any tables or figures in the text. 
A General Literature review section relevant to this dissertation precedes the first 
manuscript, and a General Conclusion section follows the last manuscript. 
References cited in the General Introduction, Literature Review, and Appendix are 
listed in the Literature Cited section which follows the General Conclusion section. 
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The first manuscript describes the isolation and preliminary characterization 
of PRRSV in a continuous cell line designated as ATCC CRL11171. This 
manuscript has been submitted for publication in the Journal of Veterinary 
Diagnostic Investigation. The second manuscript, which has been published in the 
Journal of General Virology, describes the molecular cloning and nucleotide 
sequencing of the 3'-terminal genomic RNA of PRRSV. The third manuscript, 
which has been published in the Archives of Virology, describes the possible 
evolution and phylogenetic relationship of PRRSV with other related viruses. The 
fourth manuscript describes the molecular characterization of the subgenomic 
mRNAs of PRRSV in virus-infected cells; it has been submitted to the Journal of 
Virology ior publication. The fifth manuscript, which has been submitted to the 
Journal of General Virology ior publication, describes sequence analyses of open 
reading frames 2 to 7 of six U. S. isolates of PRRSV with differing virulence. The 
appendix contains a manuscript which has been published in the Journal of 
Veterinary Diagnostic Investigation. This manuscript describes a nucleic acid 
probe for the detection of swine encephalomyocarditis virus which was once 
incriminated as the possible cause of PRRS. 
4 
LITERATURE REVIEW 
History of PRRS 
A mysterious and devastating swine disease, characterized by severe 
reproductive failure in sows, respiratory diseases in young pigs and influenza-like 
syndrome in grower-finisher pigs, was first noticed in 1987 in the United States 
(Hill, 1990). The disease was often referred to as "Mystery Swine Disease" (MSD) 
because of its unknown etiology (Keffaber, 1989; Dial et al., 1990; Hill, 1990; Loula, 
1991). By 1990, MSD had been reported in eleven states of the United States and 
two provinces of Canada (Hill, 1990). In late 1990, a similar disease was reported 
in Germany, and then rapidly recognized in most Western European countries 
(Raton et al., 1991; Wensvoort et al., 1991; Wensvoort, 1993). As MSD spread 
through the world, more and more names were used to describe this syndrome, 
such as porcine reproductive and respiratory syndrome (PRRS), swine infertility 
and respiratory syndrome (SIRS), porcine epidemic abortion and respiratory 
syndrome (PEARS), blue ear disease, Heko-Heko disease and so on (reviewed by 
Paul et al., 1993). At the first international symposium on this disease at St. Paul, 
Minnesota, scientists agreed to use PRRS as the official name for this disease 
(Collins, 1993). 
Etiology of PRRS 
The search for the cause of PRRS took about four years. Initially, many 
different pathogens were incriminated as the causative agents of PRRS, including 
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swine encephalomyocarditis virus (EMCV), hemagglutinating encephalomyelitis 
virus (HEV), porcine parvovirus (PPV), atypical swine influenza virus (aSIV), 
porcine enterovirus (REV), pseudorabies virus (PRV), and porcine cytomegalovirus 
(PCMV), etc. (Keffaber, 1989; Joo et al., 1990; Mengeling and Lager, 1990; Woolen 
et al., 1990; Deaet al., 1991,1992; Benfield et al., 1992; Meng et al., 1993). 
However, none of these suspected agents were proven to be the causative agent 
of PRRS. 
In 1991, a previously unrecognized virus, designated as the Lelystad virus 
(LV), was first Isolated in the Netherlands from cases of PRRS by using swine 
alveolar macrophage (SAM) cultures (Wensvoort et al., 1991). The LV caused 
PRRS in experimentally infected pigs and was demonstrated to be the causative 
agent of European PRRS (Pol et al., 1991; Terpestra et al., 1991). In the United 
States, the PRRS virus (PRRSV) was first isolated in a continuous cell line 
(Benfield et al., 1992; Collins et al., 1992), and subsequently demonstrated to be 
the causative agent of PRRS In the U. S. (Christianson et al., 1992). Other 
laboratories in the U. S. and Canada have also isolated PRRSV using SAM and 
two different continuous cell lines (Dea et al., 1992; Yoon et al., 1992; Kim et al., 
1993; Meng et al., 1995). The PRRSV was also isolated in many Western 
European countries (reviewed by Wensvoort, 1993). The LV and PRRSV have 
been shown to be antigenically and structurally related (Wensvoort et al., 1992). 
Biochemical and Physical Characteristics of PRRSV 
PRRSV is a small, enveloped, single positive-stranded RNA virus. Virus is 
inactivated after chloroform treatment, suggesting the presence of a lipid-
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containing envelope (Wensvoort et al., 1991; Benfield et al., 1992; Plana et al., 
1992; Meng et al., 1995d). Electronmicrograph studies showed that PRRSV is 
pleomorphic, but mostly spherical, enveloped particles ranging from 50 to 80 nm In 
size (Wensvoort et al., 1991; Benfield et al., 1992; Meng et al., 1995d). Its buoyant 
density is about 1.18 g/ml in a gradient of cesium chloride (Wensvoort et al., 1991; 
Benfield et al., 1992; Meng et al., 1995d). The virus was heat labile in that it was 
inactivated at 370C in 24 hrs and at 560C in 20 min. (Benfield et al., 1992; Yoon et 
al., 1992). However, the virus is stable at 4^0 for one month and at -70OC for 4 
months (Benfield et al., 1992; Yoon et al., 1992). The virus infectivity titers are 
reduced over 90% at pH levels less than 5 or greater than 7 (Benfield et al., 1992). 
PRRSV does not hemagglutinate erythrocytes from many different species 
(Wensvoort et al., 1991; Benfield et al., 1992; Yoon et al., 1992; Meng et al., 
1995d). Three to four virus specific proteins have been detected in virus-infected 
cells by radioimmunoprecipitation (RIP), the molecular mass of these proteins 
varied slightly among different PRRSV isolates reported (Benfield et al., 1992; 
Nelson et al., 1993; Meng et al., 1995d; Meulenberg et al., 1995). The predominant 
protein is about 15 kDa which is the nucleocapsid protein (Meulenberg et al., 1993; 
Nelson et al., 1993; Meng et al., 1995d; Meulenberg et al., 1995). 
PRRSV replicates in SAM (Wensvoort et al., 1991) and at least three 
continuous cell lines, CL2621 (Benfield et al., 1992; Collins et al., 1992), MA-104 
(Kim et al., 1993) and CRL11171 (Meng et al., 1994,1995d). The European 
PRRSV preferentially replicates in SAM cultures (reviewed by Wensvoort, 1993). 
Cytopathic effects (CPE) in SAM cultures began at about 24 to 36 hrs postinfection, 
and were characterized by clumping of the macrophages and cell lysis (Wensvoort 
et al., 1991; Meng et al., 1995d). The virus can replicate to a titer of 10^ to 10^ 
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TCIDso/ml in SAM cultures (Wensvoort et al., 1991; Meng et al., 1995cl). The CPEs 
in the three continuous cell lines, CL2621, MARC-145 and CRL11171, were slower 
to develop, appearing at about 2 to 3 days postinfection (Benfield et al., 1992; Kim 
et al., 1993; Meng et al., 1995d). The type of the CPEs in these cell lines was 
similar which is characterized by rounding and clumping of degenerating cells on 
top of the monolayers (Benfield et al., 1992; Kim et al., 1993; Meng et al., 1995d). 
Eventually, the degenerating cells will detach from the monolayers which lead to 
the disintegration of the monolayers (Meng et al., 1995d). Immunofluorescence 
assay showed that PRRSV replicates in the cytoplasm of these continuous cell 
lines (Benfield et al., 1992; Kim et al., 1993; Meng et al., 1995d). Typical PRRSV 
particles can be found in the cytoplasm vesicles of PRRSV-infected CRL11171 
cells (Meng et al., 1995d). 
More than thirty other different cell lines or primary cell cultures from various 
species of animals and different tissues of origin were tested, and no evidence for 
virus replication was found (Wensvoort et al., 1991; Yoon et al., 1992; Meng et al., 
1995). The swine testis (ST) cells were reported to support viral replication (Plana 
et al., 1992). However, the ST cells can not propagate a high virulence PRRSV 
isolate VR2385 (Meng et al., 1995d), and no other duplicating studies regarding 
the susceptibility of ST cells to PRRSV infection have been reported. 
Genome Organization and Gene Expression of PRRSV 
The genome of PRRSV is a single plus-stranded RNA molecule of about 15 
kb in length (Conzelmann et al., 1993; Meulenberg et al., 1993; Meng et al., 1994). 
Eight open reading frames (ORFs) which potentially encode virus-specific proteins 
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have been identified and organized in a similar way to those of coronaviruses (Lai, 
1990; Meulenberg et al., 1993). These ORFs overlapped each other from 1 bp 
between ORFs 4 and 5 of LV to up to 253 bp between ORFs 3 and 4 of LV 
(Conzelmann et a!., 1993; Meulenberg et al., 1993; Meng et al., 1994). However, 
there is a 10 bp noncoding region separating ORFs 4 and 5 of U. S. isolates of 
PRRSV (Meng et al., 1995c; Morozov et al., 1995). ORFs la and 1b comprised 
80% of the viral genome and are predicted to encode the viral RNA polymerase 
(Meulenberg et al., 1993). The C-terminus of ORF 1 a overlaps the N-terminus of 
ORF lb by 16 nucleotides (Meulenberg et al., 1993). A RNA sequence element 
which contains a so-called "slippery" sequence and a pseudoknot structure in ORF 
1a and ORF 1b overlap region was shown to be essential for the expression of ORF 
lb of coronavirus via a mechanism of ribosomal frameshifting (Brierley et al., 1987, 
1989). The heptanucleotide slippery sequence UUUAAAC is located just upstream 
of the UAG stop codon of LV ORF 1 a, and a stem-loop structure which may 
participate in forming a pseudoknot structure was also identified downstream of the 
slippery sequence (Meulenberg et al., 1993). Therefore, as with Coronaviridae, 
ORF lb of the PRRSV is also likely expressed by the mechanism of frameshifting 
(Meulenberg et al., 1993). 
ORFs 2,3 and 4 of PRRSV all contain putative N-linked glycosylation sites 
(Meulenberg et al., 1993; Meng et al., 1995c; Morozov et al., 1995). The N-termini 
of ORFs 2, 3 and 4 each contain a hydrophobic region which is likely the signal 
sequence, and there is at least one additional hydrophobic domain toward the C-
termini of each of ORFs 2, 3 and 4 which may function as membrane anchors 
(Meulenberg et al., 1993; Meng et al., 1995c; Morozov et al., 1995). Based on 
these characteristics, the products encoded by ORFs 2, 3 and 4 are predicted to be 
9 
membrane-associated proteins (Conzelmann et al., 1993; Meulenberg et a!., 1993; 
Meng et al., 1995c; Morozov et al., 1995). However, the translation products of 
ORFs 2 to 4 were not detected in virus-infected cell lysates or virions (Meulenberg 
et al., 1995). Like ORFs 2,3 and 4, ORF 5 of PRRSV also contains the N- and C-
terminal hydrophobic sequences that may function as a signal sequence and a 
membrane anchor (Meulenberg et al., 1993; Meng et al., 1994). Recently, ORF 5 of 
LV was found to encode a glycosylated envelope protein (E) of 25 kDa 
(Meulenberg et al., 1995). The E protein is N-glycosylated at two different sites, 
and it is likely that during virus maturation the E protein is transported through Golgi 
apparatus and its N-linked oligosaccharides undergo Golgi-specific modifications 
(Meulenberg et al., 1995). ORF 6 product lacks the N-terminal signal sequence 
and contains three hydrophobic domains which may represent the putative 
membrane-spanning fragments (Conzelmann et al., 1993; Meulenberg et al., 1993; 
Meng et al., 1994). The gene product of ORF 6 was found to be a nonglycosylated 
membrane protein (M) of 18 kDa (Meulenberg et al., 1995) which has the same 
hydrophobiclty profile as the M proteins of EAV (de Vries et al., 1992) and LDV 
(Chen et al., 1993; Godeny et al., 1993). ORF 7 encodes a very basic and 
hydrophiiic protein (Conzelmann et al., 1993; Meulenberg et al., 1993; Meng et al., 
1994). The gene product of ORF 7 was shown to be the nucleocapsid protein (N) 
of 15 kDa (Meulenberg et al., 1995). The N protein is not N-glycosylated 
(Meulenberg et al., 1995) although it contains one or two potential N-glycosylation 
sites (Conzelmann et al., 1993; Meulenberg et al., 1993; Meng et al., 1994). 
Therefore, PRRSV genes are arranged in the following order; 5'-RNA polymerase 
(ORFs 1 a/1 b)-membrane-associated proteins (ORFs 2, 3 and 4)-E (ORF 5)-M (ORF 
6)-N (ORF 7)-3' (Conzelmann et al., 1993; Meulenberg et al., 1993; Meng et al.. 
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1994), which is the same as EAV (den Boon et al., 1991) and LDV (Plagemann and 
Moenning, 1992). 
Subgenomic mRNAs of PRRSV 
Expression and replication of the genome of PRRSV requires the production 
of at least six subgenomic mRNAs (sg mRNAs) (Conzelmann et al., 1993; 
Meuienberg et al., 1993; Meng et al., 1994,1995b). These sg mRNAs, together 
with the genomic virion RNA, form a 3'-coterminai nested set (Conzelmann et al., 
1993; Meuienberg et al., 1993; Meng et al., 1994,1995b). All the sg mRNAs have 
the same 3' terminal sequence including a poly (A) tail. So the sequence of each 
sg mRNA is contained within the 3'-portion of the next larger sg mRNA, and the 5'-
end of each sg mRNA does not overlap with the sequences of the smaller sg 
mRNAs. Each of these sg mRNAs also contains a 5' common leader sequence of 
about 200 bp in size (Meuienberg et al., 1993; Morozov et al., unpublished data). 
The leader-mRNA junction sequence of PRRSV in which the leader joins to the 
body of the sg mRNAs has been determined to be a conserved sequence motif of 
six nucleotides UCAACC or a highly similar sequence (Meuienberg et al., 1993; 
Meng et al., 1995b, 1995c; Morozov et al., unpublished data). It has been shown 
that the sg mRNAs of PRRSV are packaged into the virions, suggesting that the 
encapsidation signal of PRRSV is likely localized within ORF 1 region that is 
unique to the viral genome, but not present in the sg mRNAs (Meng et al., 1995b). 
Northern blot analysis with ORF-specific probes indicated that the structure of the 
sg mRNAs is polycistronic, and each of the sg mRNAs except for the smallest sg 
mRNA 7 contains multiple ORFs (Meng et al., 1995b). It is also believed that only 
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the ORF at the 5' end of each sg mRNA is translationally active (Meng et a!., 
1995b). Therefore, each of the sg mRNAs is functionally monocistronic. In some 
isolates of PRRSV, however, an additional sg mRNA designated as sg mRNA 4-1 is 
formed in vinjs-infected cells (Meng et al., 1995b). The sg mRNA 4-1 was found to 
be generated from the sequence upstream of ORF 4 (Meng et al., 1995b). 
Interestingly, in addition to ORF 4, a small ORF (ORF 4-1) with a coding capacity of 
45 amino acid residues at the 5'-end of the sg mRNA 4-1 was identified (Meng et 
al., 1995b). Thus the sg mRNA 4-1 in some isolates is potentially bicistronic. 
However, whether this small ORF 4-1 is actually translated or has any biological 
functions remains to be studied. 
Phenotypic, Pathogenic and Antigenic Variations in PRRSV 
There is increasing evidence to suggest that there is heterogeneity among 
PRRSV isolates. The European PRRSV isolates were exclusively propagated in 
SAM cultures (Wensvoort et al., 1991; reviewed by Wensvoort, 1993), whereas the 
North American isolates were grown in SAM cultures as well as three continuous 
cell lines, CL2621, MARC-145 and CRL11171 (Benfield et al., 1992; Collins et al., 
1992; Dea et al., 1992; Yoon et al., 1992; Kim et al., 1993; Meng et al., 1994, 
1995d). Variations in the susceptibilities of CL2621 cells and SAM to PRRSV were 
also reported. Not all PRRSV isolates growing in CL2621 cells replicated in SAM, 
and vice versa (Bautista et al., 1993a). Also, some PRRSV isolates showed 
delayed onset of CPE in infected cells (Bautista et al., 1993a; Meng et al., 
unpublished data). 
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Marked differences in virulence between U. S. and the European PRRSV 
isolates as well as among the U. S. isolates have been observed in experimentally-
infected pigs (Halbur et al., 1995c, 1995d). Infection with U.S. isolate VR 2385 
resulted in consolidation in 54.2% of lung in experimentally-infected 4-week-old 
cesarean-derived colostrum-deprived (CDCD) pigs at 10 days postinoculation; 
whereas only 6.8% of lung was consolidated in pigs infected with European LV in 
the same experiment (Halbur et al., 1995c). Significant differences in severity of 
clinical respiratory disease, rectal temperatures, gross lung lesions and 
microscopic lung lesions were also found in pigs infected with nine different U. S. 
isolates of PRRSV (Halbur et al., 1995d). The existence of nonpathogenic isolates 
has also been suggested (Ohiinger et al., 1992; Van Alstine, 1992). 
Considerable antigenic variation among PRRSV isolates has been reported. 
Among seven U. S. and European PRRSV isolates studied (Wensvoort et al., 
1993), the four European isolates resembled each other closely, but differed from 
the U. S. isolates, and the three U. S. isolates differed antigenically from each other 
(Wensvoort et al., 1993). A serologic survey of field samples by IFA indicated that 
about 20% of the sera were positive for European LV but negative for U. S. isolate 
VR2332, and about 44% were positive for VR2332 but negative for LV (Bautista et 
al., 1993b). In another study, North American isolates were more closely related to 
each other serologically than to the European isolates (Frey et al., 1992). Out of 
214 Canadian sera tested, 154 were positive for VR2332 antibody and only 22 
were positive for LV. In contrast, 44 of 50 sera from the Netherlands were positive 
for LV antibody, but only 11 of the 50 sera samples were positive for VR2332 (Frey 
et al., 1992). Western blot analysis indicated that ORF 4 protein of isolate MN-1 
reacted with only 65% of PRRSV-infected pig sera tested (Kwang et al., 1994). The 
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observed antigenic variation has complicated use of diagnostic tests. Currently, we 
can only differentiate North American and European PRRSV isolates serologically 
(Nelson et al., 1993) or by PGR (Mardassi et al., 1994b). However, there is no 
serologic test which can detect infection with ail strains of PRRSV. 
Genetic Variation in PRRSV 
Genetic variations exist not only between U. S. and European PRRSV 
isolates but among U. S. isolates as well (Murtaugh, 1993; Mardassi et al., 1994a; 
Meng et al., 1994,1995a; Morozov et al., 1995; Murtaugh et al., 1995). The amino 
acid sequence identity of ORFs 2 to 7 of U. S. isolate VR2385 with the 
corresponding ORFs of the European LV are 55%, 55%, 66%, 54%, 78% and 58%, 
respectively (Meulenberg et al., 1993; Meng et al., 1994; Morozov et al., 1995). 
Sequence variation was also found in the 3'-noncoding region (NCR) between 
VR2385 and LV (Meng et al., 1994). In comparison with LV, a 38 nucleotide 
insertion was identified in the 3' NCR of VR2385 isolate following the stop codon of 
ORF 7 (Meng et al., 1994). The 3' NCRs were 151 nucleotides in VR2385 which 
was the longest 3' NCR among those identified in the proposed family of 
Arteriviridae, and only 114 nucleotides in LV (Meng et al., 1994). The nucleotide 
sequence identity in the 3' NCR between VR2385 and LV is only 58% when the 
insertion was included (Meng et al., 1994). ORFs 6 and 7 of the North American 
PRRSV isolates are highly conserved, and they shared 96 to 100% amino acid 
sequence identity (Meng et al., 1995a, 1995c). However, considerable sequence 
variations were found in ORFs 2 to 5 of U. S. isolates with differing pathogenicity 
(Murtaugh, 1993; Kwang et al., 1994; Murtaugh et al., 1995; Meng et al., 1995c; 
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Morozov et al., 1995). The amino acid sequence identity between seven U. S. 
isolates with differing pathogenicity was 91-99% in ORF 2, 86-98% in ORF 3, 92-
98% in ORF 4, and 88-97% in ORF 5 (Meng et al., 1995c). The least virulence U. 
S. isolate ISU3927 has the most sequence variations compared to other U. S. 
isolates in ORFs 2 to 4, but not in ORFs 5 to 7 (Meng et al., 1995a, 1995c). 
However, the variations in the least virulence isolate ISU3927 as compared to 
other U. S. isolates are not limited to a particular ORF or region and they are 
present throughout ORFs 2 to 4. Thus, it is difficult to speculate regarding any 
correlation between sequence variation and virulence. An infectious clone would 
be useful to determine the virulence determinant (s) of PRRSV. 
ORFs 1 to 7 of PRRSV overlapped each other except that there is a 10 
nucleotide noncoding sequence between ORF 4 and ORF 5 of all U. S. isolates 
(Meng et al., 1995c: Morozov et al., 1995). However, ORFs 4 and 5 of the 
European isolates, LV and PRRSV-10, overlapped by one nucleotide, and the 
junction region between ORFs 4 and 5 in the European isolates is ATATGA 
(Conzelman et al., 1993; Meulenberg et al., 1993). The single nucleotide 
substitution from A in the start codon of ORF 5 of the two European isolates (LV and 
PRRSV-10) to T in all U. S. isolates makes the start codon of ORF 5 of U. S. isolates 
10 nucleotides downstream of ORF 4 stop codon. This is unusual since all 
members of the proposed Arteriviridae family have overlapping ORFs (Plagemann 
and Moennig, 1992). However, in a related family, the Coronaviridae, ORFs of 
coronavirus were separated by intergenic noncoding region (Lai, 1990). So ORFs 
4 and 5 of the U. S. PRRSV are similar to that of coronaviruses in terms of genomic 
organization. 
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The sizes of ORFs 2 to 7 of all the North American isolates are identical 
except that there is one amino acid deletion in the N-terminai hypervariable region 
of ORF 5 of low virulence isolate ISU3927 and in the C-terminus of ORF 2 of ISU79 
(Meng et al., 1995b, 1995c). All North American isolates varied extensively from 
the European PRRSV isolates, and share only about 60% amino acid sequence 
identity in ORFs 2 to 7 (Meulenberg et al., 1993; Conzelmann et al., 1993; Mardassi 
et al., 1994; Meng et al., 1994,1995a, 1995c: Morozov et al., 1995). Deletions or 
insertions were found throughout ORFs 2 to 7 between European and U. S. 
isolates (Mardassi et al., 1994; Meng et al., 1994,1995a, 1995c; Morozov et al., 
1995). Two insertions, KKSTAPM and TSASO, were found in ORF 7 of European 
isolates as compared to North American isolates (Meng et al., 1994,1995c; 
Mardassi et al., 1994). ORFs 2 to 7 of the two European isolates, LV and PRRSV-
10, are almost identical (Conzelmann et al., 1993; Meulenberg et al., 1993). Also, 
ORF 7 of seven Spanish isolates were also highly conserved (Suarez et al., 1994). 
A hypervariable region which contained non-conserved amino acid substitutions 
was identified in the N-terminus of the major glycosylated envelope protein 
encoded by ORF 5 (Meng et al., 1995c). This hypervariable region contained 
seven hydrophilic amino acid residues, and is antigenic as predicted by computer 
analysis (Meng et al., 1995c). It is likely that this hypervariable region has evolved 
because of selection pressure by host immune system; thus providing a possible 
explanation for the observed antigenic diversity among PRRSV isolates 
(Wensvoort et al., 1992). 
Variation in the number and size of the subgenomic mRNAs among PRRSV 
isolates was also observed (Meng et al., 1995b). A nested set of six or seven sg 
mRNAs is formed in cells infected with U. S. PRRSV isolates with differing virulence 
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(Meng et al., 1995b). There is no apparent correlation, however, between the 
numbers of sg mRNAs and the viral pneumovirulence. The two European isolates 
both produced six sg mRNAs in virus-infected macrophages (Conzelmann et al., 
1993; Meulenberg et al., 1993). The leader-mRNA junction sequence of LV 
(Meulenberg et al., 1993b) and U. S. PRRSV isolates (Meng et al., 1995b, 1995c: 
Morozov et al., unpublished data) have been determined to be a conserved six 
nucleotide sequence motif, UCAACC or a highly similar sequence. However, the 
numbers, locations and sequences of the leader-mRNA junction motif varied 
between the U. S. isolates and the European isolate LV as well as among the U. S. 
isolates (Meng et al., 1995b, 1995c; Morozov et al., 1995; Morozov et al., 
unpublished data). Variations are located in the first three nucleotides of the 
leader-mRNA junction motif. In contrast, the last three nucleotides, ACC, are 
basically invariable (Meulenberg et a!., 1993; Meng et al., 1995b, 1995c; Morozov 
et al., unpublished data). The last nucleotide in the leader-mRNA junction motif 
may be critical for leader binding and for the initiation of transcription (Meng et al., 
1995b). A single nucleotide substitution in the last nucleotide of the leader-mRNA 
junction motif led to the acquisition of a new leader-mRNA junction sequence, and 
therefore an additional species of sg mRNA 4-1 in some of the U. S. PRRSV 
isolates (Meng et al., 1995b, 1995c). 
It has been reported that two major genotypes of PRRSV exist in the U. S. 
and Europe (Meng et al., 1994,1995a). Within the major genotype of U. S. 
PRRSV, three minor genotypes (or group of variants) were also identified (Meng et 
al., 1995c). So, it is highly likely that a number of additional major or minor 
genotypes will be identified as more virus isolates from different geographic 
regions are examined. 
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Classification and Evolution of PRRSV 
The PRRSV is provisionally classified in the newly proposed family of 
Arteriviridae which includes equine arteritis virus (EAV), lactate dehydrogenase-
elevating virus (LDV) and simian hemorrhagic fever virus (SHFV) (Plagemann and 
Moennig, 1992; Conzelmann et al., 1993; Godeny et al., 1993; Meulenberg et al., 
1993; Meng et al., 1994; Godeny et al., 1995; Meng et al., 1995a). This is a group 
of single plus-stranded RNA viruses which share many properties such as 
morphology, macrophage cell tropism, genome organization, subclinical infections 
and persistent viremia with concurrent antibody production (reviewed by 
Plagemann and Moennig, 1992; Goyal, 1993). The genome organization of 
PRRSV resembles coronaviruses and toroviruses in that their replication involves 
the formation of a 3'-coterminal nested set of sg mRNAs (De Vries et al., 1990; Lai, 
1990; Snijder et al., 1990; Den Boon et al., 1991; Plagemann and Moennig, 1992). 
However, there was no cross-reaction with sera directed against many enveloped 
RNA viruses including members of the proposed family of Arteriviridae, LDV, EAV 
and SHFV (Benfield et al., 1992; Ohiinger et al., 1992). 
Phylogenetic analyses showed that both European and U. S. PRRSVs are 
closely related to LDV, and distantly related to EAV (Meng et al., 1995a). Thus, it is 
likely that ail members of the proposed Arteriviridae family evolved from a common 
ancestor, and they may have undergone divergent evolution at different time 
periods (Meng et al., 1995a). Given the fact that only about 60% amino acid 
sequence identity exists between U. S. and European PRRSV isolates (Meng et al., 
1994,1995a, 1995c; Morozov et al., 1995), it is possible that the European PRRSV 
and the U. S. PRRSV may have evolved from a common ancestor independently 
(Meng et al., 1995a). Also, both the U. S. and the European PRRSVs share 
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relatively high sequence homology with the mouse LDV (Conzelmann et al., 1993; 
Meulenberg et al., 1993; Meng et al., 1994; Morozov et al., 1995). Thus, it is also 
possible that the U. S. PRRSV and the European PRRSV may have evolved from 
different LDV variants existing in the U. S. and in Europe. A striking feature of RNA 
viruses is their rapid evolution resulting in extensive sequence variation (Koonin 
and Doija, 1993). Direct evidence for recombination between different positive-
strand RNA viruses has been documented (Hahn et al., 1988; Lai, 1992). Thus, the 
emergence of PRRSV and its close relatedness to LDV and EAV is not surprising. 
From the evolutionary point of view, it is possible that new viruses within the 
proposed Arteriviridae family may appear in the future which may infect other 
species of animals including human. 
Epidemiology of PRRSV 
Retrospective serological studies by IFA suggested that PRRS occurred in 
Iowa as early as in 1985 (Owen et al., 1992), Minnesota in 1986 (Joo et al., 1992) 
and Germany in 1988 and 1989 (Ohiinger et al., 1992; reviewed by Christiansen 
and Joo, 1994). PRRSV antibody was not detected in any of the 1425 sera 
samples from Iowa collected in 1980 (Hill et al., 1992). However, the earliest 
documented outbreaks of PRRS were in 1987 (Hill, 1990; Loula, 1991; Benfield et 
al., 1992b). The incidence of clinical PRRS and seroprevalence has increased 
rapidly since 1988 (Keffaber, 1989; Dial et al., 1990; Benfield et al., 1992b; Hill et 
al., 1992). By 1990, clinical signs of PRRS were found in 19 states in the U.S. 
(Zimmerman et al., 1991) and about 36% (141/396) of the herds in 17 states were 
seropositive to PRRSV (Morrison et al., 1990). However, the serological surveys 
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may yield false-negative results since virus strain differences in serological tests 
have been reported (Morrison et al., 1990; Bautista et al., 1993b). With the 
prevalence of seropositive herds in the U.S. now greater than 50%, however the 
incidence of clinical cases is decreasing (Annelli, 1992; Sanford, 1992). It is not 
known whether this decrease is due to the changes in virus virulence or due to the 
decrease in susceptible herds (Annelli, 1992; Frankena et al., 1992; Sanford, 
1992). 
Pig movement and aerosols are both important in the transmission of PRRS 
(Dee, 1992; Edwards et al., 1992; Gordon, 1992; Robertson, 1992). Airborne 
transmission is important in the local spread of PRRSV. High humidity, low 
temperature and low wind speed are ideal weather conditions for the airborne 
spread of PRRSV (Komijn, 1991; Mortensen and Madsen, 1992). Virus 
transmission by contact and intranasal route has been demonstrated (Terpstra et 
al., 1991; Christiansen et al., 1992; Collins et al., 1992; Halbur et al., 1995b, 1995c, 
1995d). Besides pig movement and airborne spread, the role of semen in 
transmission of PRRSV has been suggested (Edwards et al., 1992; Robertson, 
1992; Yeager et al., 1993; Swenson et al., 1993). It has been shown that semen 
from viremic boars caused inseminated gilts to seroconvert to PRRSV (Yeager et 
al., 1993). Also, when semen from infected boars was inoculated into pigs 
intraperitoneally, the inoculated pigs seroconverted (Swenson et al., 1993). 
However, attempts to isolate PRRSV from semen failed (Swenson et al., 1993; 
Yeager et al., 1993). There are no reports of human infection or diseases caused 
by PRRSV. It has also been shown that rodents are not susceptible to infection 
with PRRSV and are probably not a reservoir for PRRS (Hooper et al., 1994). 
Since PRRSV infection also appears to be maintained in some all-in/all-out 
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operations (Loula, 1992), it is possible that a non-porcine reservoir for PRRSV 
exists. Zimmerman et al. (1993) has demonstrated the susceptibility of four avian 
species (Mallard ducks, Muscovey ducks, Guinea fowl and Cornish-cross chickens) 
to PRRSV. PRRSV can be reisolated from these experimentally-infected birds, but 
clinical signs were not detected and these birds did not seroconveri to PRRSV 
(Zimmerman et al., 1993). More studies are needed to understand the role of other 
possible vectors, if any, in the long-distance spread of PRRSV. 
Immune Response to PRRSV 
Antibodies to PRRSV can be detected in sera of pigs at six to seven days 
postinfection by various assays such as indirect-fluorescent antibody assay (IFA), 
immunoperoxidase monolayer assay (IPMA), and enzyme-linked immunosorbent 
assay (ELISA) (Wensvoort et a!., 1991; Albina et al., 1992; Yoon et al., 1992; 
reviewed by Wensvoort, 1993). However, pigs are commonly viremic for more than 
four weeks (Edwards et al., 1992; Yoon et al., 1993). The development of 
neutralizing antibodies requires about six to seven weeks in growing pigs 
(Christopher-Hennings et al., 1992; Frey et al., 1992). However, neutralization to 
PRRSV was only demonstrated in nonhost CL2621 cells, but not in the SAM. In 
SAM, antibody-dependent enhancement (ADE) of PRRSV replication has been 
demonstrated (Choi et al., 1992). The Fc receptor on macrophages may bind to the 
PRRSV antibody and form immune complex; this immune complex can then 
enhance PRRSV infection. The PRRSV infectivity was shown to increase 10 to 100 
times in the presence of anti-PRRSV antibody in vitro, and ADE is likely to occur in 
vivo as well (Christiansen et al., 1993). 
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PRRSV infection is believed to cause immunosuppression and can therefore 
predispose pigs to secondary viral or bacterial infections (Galina et al., 1992; 
Molitor et al., 1992). Under field conditions, secondary infections such as bacterial 
pneumonia, arthritis, diarrhea, meningitis, and infections with pseudorabies virus 
(PRV), porcine parvovirus (PPV), and swine influenza virus (SIV) are common 
following PRRSV infection (reviewed by Goyal, 1993 and Christianson and Joe, 
1994). Under experimental conditions, PRRSV infection was found to predispose 
pigs to Streptococcus suis meningitis (Galina et al., 1992). However, other 
bacterial and viral pathogens such as Escherichia coli and PRV were found to 
actually enhance humoral and cell-mediated immunity following PRRSV infection 
under experimental conditions, although the concentration and function of alveolar 
macrophages did decrease (Molitor et al., 1992). Besides alveolar macrophages, 
PRRSV infection also affects the dendritic cells in the lymphoid system, and most of 
the dendritic cells are antigen-presenting cells (APC) (Halbur et al., 1994,1995a, 
1995b). Therefore, it is likely that PRRSV infection alters the host immune 
response. The local impairment of lung function due to alveolar macrophage 
destruction may not be responsible for the general immunosuppression 
(Wensvoort et al., 1992; reviewed by Goyal, 1993). However, damages to the 
dendritic APC in the lymphoid system would result in general immunosuppression 
(Molitor et al., 1992; Halbur et al., 1994,1995a, 1995b). 
Diagnosis of PRRSV Infection 
The diagnosis of PRRS was primarily based on clinical signs and 
histopathology before the successful isolation of PRRSV. Once the virus was 
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isolated, a more definitive diagnosis of PRRSV infection could be made on the 
basis of serology and virus isolation (reviewed by Van Alstine et al., 1993). 
Clinical signs of PRRSV infection vary from pig to pig and from farm to farm. 
Therefore, diagnosis of PRRSV infection on the basis of clinical signs is difficult, 
especially when the infection has been complicated by secondary bacterial 
infections. However, PRRSV infection should be suspected if during a 14-day 
period the abnormal number of stillbirths exceeds 20%, abortion and/or premature 
farrowing exceeds 8% or mortality exceeds 25% of piglets in the first week of life 
(reviewed by Goyal, 1993 and Christiansen and Joo, 1994). The acute PRRS is 
transient and often predisposes pigs to secondary infections. Moreover, many 
PRRSV infections are mild and inapparent, so it is not always possible to use 
clinical parameters to diagnose PRRSV infection, but clinical signs are helpful 
indicators of PRRSV infection. 
Since no major gross lesions are observed on necropsy of field cases 
(Loula, 1990) except under experimental conditions (Halbur et al., 1995c, 1995d), 
histopathological examination is important in detecting lesions caused by PRRSV. 
Interstitial pneumonia is the primary lesion of PRRS and is characterized by 
alveolar septa thickening with mononuclear cell infiltrations (Pol et al., 1991; 
Terpstra et al., 1991; Benfield et al., 1992b; Collins et al., 1992), marked type II 
pneumocyte proliferation, moderate alveolar exudate accumulation and occasional 
syncytial cell formation (Halbur et al., 1995b, 1995c, 1995d). Unlike swine 
influenza virus, PRRSV did not affect the airways in the lung (Collins et al., 1991). 
Suppurative bronchopneumonia may be seen in some cases of PRRSV because 
field cases are often complicated with secondary bacterial infections. The severity 
of the interstitial pneumonia varies between different PRRSV isolates (Done et al.. 
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1992; Halbur et al., 1995c, 1995ci). Differential diagnosis should be used because 
other viruses such as swine influenza virus, atypical swine influenza virus, porcine 
respiratory coronavirus etc. can also cause similar lesions. 
Various serological tests have been developed to detect PRRSV antibodies 
in swine sera. These tests include immunoperoxidase monolayer assay (IPMA) 
(Wensvoort et al., 1991; Frey et al., 1992; Wensvoort et al., 1992), indirect 
fluorescent antibody test (IFA) (Hill et al., 1992; Yoon et al., 1992b), serum virus 
neutralization test (SVN) (Christopher-Hennings et al., 1992; Frey et al., 1992; 
Morrison et al., 1992; Hill et al., 1993) and enzyme-linked immunosorbent assay 
(ELISA) (Albina et al., 1992; Edwards et al., 1992). The IPMA antibodies could be 
demonstrated as early as 6 days postinfection (Wensvoort et al., 1991; Frey et a!., 
1992; Wensvoort et al., 1992). The IPMA test appears to be highly specific, but 
lacks sensitivity. Only 123 of 165 (75%) sows with clinical PRRS were positive for 
PRRSV antibody by IPMA (Wensvoort et al., 1991). The IFA test is similar to the 
IPMA and is extensively used in the U. S. (Hill et al., 1992; Yoon et al., 1992b; Van 
Alstine et al., 1993). However, both IFA and IPMA tests must rely on a subjective 
endpoint and can not be automated. The virus neutralizing antibodies are slower 
to develop than IFA antibodies and therefore the SVN test is less sensitive after 
acute infection (Christopher-Hennings et al., 1992; Frey et al., 1992; Minehart et al., 
1992). The SVN test can only be performed in non-porcine host cells because 
antibody-dependent enhancement (ADE) was reported in swine alveolar 
macrophages (Choi et al., 1992). A modified SVN test using MARC-145 cells has 
increased the sensitivity of the SVN test; virus neutralizing antibodies can be 
detected as early as 11 days postinfection using this assay (Yoon et al., 1993). The 
current ELISA test, which uses virus-infected cell lysates as antigens, is 
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unacceptable because of the high background levels In negative herds (Albina et 
al., 1992; Edwards et al., 1992). A reliable ELISA test is needed and could be 
developed using purified recombinant PRRSV proteins as antigens, availability of 
such a test would be very useful in PRRSV diagnosis since ELISA can be 
automated and performed economically on a large scale. 
Serology has been widely used for diagnosis of PRRSV infection (reviewed 
by Van Alstine et al., 1993). Seroconversion, with sera samples taken pre and 
post-outbreak, is an especially good indicator for diagnosis of PRRSV infection. 
However, presence of serum antibodies in swine herds is no longer implicative of 
clinical disease since the virus is now widespread in the world. The prevalence of 
seropositive herds in the U. S. is now greater than 50% (Annelli, 1992; Sanford, 
1992). The recent use of a modified-live vaccine for PRRSV could make it more 
difficult to interpret the results of these serological tests. Moreover, strain variation 
among PRRSV has been reported (Beilage et al., 1992; Frey et al., 1992; 
Wensvoort et al., 1992; Bautista et al., 1993b; Meng et al„ 1994,1995a). Most of 
the current serological tests are based on only one strain of PRRSV and therefore 
false-negative results may be obtained. A common antigen to all strains of PRRSV 
must be identified so that a reliable diagnostic test can be developed. Vinjs 
isolation is the definitive diagnosis for PRRSV infection. Lung, spleen and lymph 
node tissues are all appropriate for vims isolation; however serum and plasma are 
the best for virus isolation (Pol et al., 1991; Frey et al., 1992; Rossow et al., 1992; 
Stevenson et al., 1992). PRRSV was isolated from sera of experimentally-infected 
pigs for up to 41 days postinfection despite the presence of a high antibody titer 
(Rossow et al., 1992; Stevenson et al., 1992). PRRSV can not be isolated from 
autolyzed and mummified fetuses (Christiansen et al., 1992). 
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Conclusion 
The so-called "Mystery Swine Disease" is no longer a mystery. Since the 
initial reports of PRRS, we have learned a great deal about this disease and its 
causative agent. The causative agent of PRRS, PRRSV, has been isolated and 
characterized. The syndrome has been experimentally reproduced. PRRSV was 
shown to be a previously unrecognized virus which is provisionally classified in the 
proposed family of Arteriviridae. The genome of PRRSV has been cloned and 
sequenced. The genome organization and gene expression of PRRSV are also 
being studied. Several diagnostic tests have been developed and are now in use 
in many countries. A modified-live PRRSV vaccine is now on the market, although 
no reported results about the efficacy of this vaccine are available. We now know 
that the virus is widespread in the pig population, that most of the infections are 
subclinical, and that the disease and the virus causing the disease are extremely 
variable. We are beginning to understand the epidemiology of PRRSV; therefore 
progress on the prevention and control of PRRSV should be more rapid. 
Acute outbreaks of PRRS have now decreased in number and the virus may 
already be decreasing in virulence, but we should not be complacent about this 
disease. In the history of infectious diseases of both human and other animals, 
new diseases (often more severe) have periodically appeared. PRRSV is no 
different from other new diseases. The nature of PRRSV, its infectiousness, 
persistent infection, likely airborne spread and strain variation, suggests that it is 
unlikely that we will eliminate the virus completely in the near future. Given that we 
will have to live with this virus for the foreseeable future, there is urgent need for 
fundamental research about this virus. There are more questions than answers 
about PRRSV at this stage since PRRSV was isolated just about 4 years ago. The 
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pathogenesis of PRRSV in reproductive and respiratory disease is poorly 
understood. The mechanisms by which PRRSV produces abortions, premature 
farrowings, secondary infections and pneumonia need to be studied. The 
observed strain variation and its effect on vaccine development also requires 
further study. Since PRRSV has been shown to infect alveolar macrophages and 
other dendritic cells in the lymphoid system, the role of PRRSV in 
immunosuppression and immunomodulation is one of the major future research 
focus. There are many other unanswered questions about PRRSV such as the 
length of virus persistence in pigs and on farms; the mode of virus spread within 
herds and between farms; the development of rapid and accurate diagnostic tests; 
and the virulence determinant (s) of PRRSV etc. We also don't know where 
PRRSV originated from or if PRRSV can infect and cause disease in humans and 
other animals. Intensive research is required to answer these questions and 
effectively control this disease. 
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PROPAGATION OF PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME 
VIRUS (PRRSV) IN A CONTINUOUS CELL LINE AND PRELIMINARY 
CHARACTERIZATION OF A HIGH VIRULENCE U. S. ISOLATE OF PRRSV 
A paper submitted to the Journal of Veterinary Diagnostic Investigation 
Xiang-Jin Meng, Prem S. Paul, Patrick G. Halbur and Melissa A. Lum 
Abstract 
Of twenty-four different cell lines or prinnary cells that were tested, a 
continuous cell line, ATCC CRL11171, and the primary swine alveolar 
macrophage (SAM) cultures were found to support the replication of porcine 
reproductive and respiratory syndrome virus (PRRSV). A PRRSV, ATCC VR2385, 
was isolated from the lung homogenate of a four-week-old pig with severe 
interstitial pneumonia, myocarditis, and encephalitis, and subsequently 
characterized in CRL11171 cells. The VR2385 virus produced cytopathic effects in 
SAM cultures and in CRL11171 cells. Evidence for virus replication was not 
observed in other twenty-two different cell lines or primary cell cultures that were 
tested. The high virulence VR2385 virus was shown to be a PRRSV by 
immunofluorescence assay (IFA) and radioimmunoprecipitation (RIP) using 
polyclonal and monoclonal antibodies against PRRSV. The VR2385 virus is an 
enveloped, nonhemagglutinating, spherical RNA virus with a size of 50-70 nm in 
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diameter. The VR2385 virus can replicate to a high titer (10^ to 108 TClDso/ml) in 
CRL11171 cells and had a buoyant density of 1.15-1.18 g/ml in cesium chloride 
gradient. Fifteen additional U. S. PRRSV isolates were isolated using CRL11171 
cells. This study showed that the ATCC CRL11171 cell line supports the growth of 
PRRSV isolates with differing virulence. 
Introduction 
A mystery swine disease characterized by reproductive failure and respiratory 
disease was first reported in the United States in 1987.12 a similar disease 
appeared in Europe in 1990.21.26 This disease has been referred to as swine 
infertility and respiratory syndrome (SIRS), porcine epidemic abortion and 
respiratory syndrome (PEARS), blue ear disease and porcine reproductive and 
respiratory syndrome (PRRS), etc.2.4.6.12,14,21,26 jhe causative agent of the 
disease, the porcine reproductive and respiratory syndrome virus (PRRSV), was 
first isolated in Europe, designated Lelystad virus (LV), using primary swine 
alveolar macrophage (SAM) cultures.26 The first U.S. PRRSV, ATCC VR2332, was 
isolated using a proprietary continuous cell line ATCC CL2621.2.4 Both LV and 
VR2332 were shown to produce reproductive failure and interstitial pneumonia in 
experimentally-infected pigs.3.24.25 
The PRRSV has been shown to be an enveloped, nonhemagglutinating RNA 
virus of approximately 62 nm in diameter with a buoyant density for VR2332 of 
1.18-1.19 g/ml in cesium chloride gradient.2.26,28 jhe viral genome is a plus-
stranded RNA of about 15 Kb in size and contains eight open reading frames.5.i5.i7 
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The genome organization of both U. S. and European PRRSV is similar to that of 
lactate dehydrogenase-elevating virus (LDV), equine arteritis virus (EAV), and 
simian hemorrhagic fever virus (SHFV), members of the recently proposed family 
>Arfer/V/r/afae 5.7.15.17.22 However, antigenic, genetic and pathogenic variation was 
reported between U. S. and European isolates, and among U. S. isolates as 
WelLlO.11.15.19,27 
Both the U. S. and European PRRSV isolates replicate well in SAM 
cultures."'.26.28 However, the difficulties in obtaining SAM and the high cost of pigs 
used for pulmonary lavage have limited the use of SAM. A proprietary cell line, 
ATCC CL2621,3 was reported to support virus replication.^.^ However, differences 
in the susceptibility of CL2621 to different isolates of PRRSV were reported as not 
all virus growing on SAM replicated on CL2621.'' More recently, a subpopulation 
of MA-104 cells, designated MARC-145, was shown to support the replication of 
eleven different PRRSV isolates that were tested.^^ However, only limited 
information is available for the application of MARC-145 in research and diagnosis. 
In this study we report another continuous cell line which supports the replication of 
PRRSV, and the preliminary characterization of a high virulence U. S. PRRSV 
isolate, ATCC VR2385, in this continuous cell line. 
Materials and Methods 
Source of inoculum. A four-week-old pig exhibiting respiratory distress was 
obtained from a herd which experienced reproductive failure and persistent, severe 
pneumonia in nursery pigs. Microscopic examinations revealed that this pig had 
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proliferative interstitial pneumonia, encephalitis and myocarditis. The pig, 
designated ISU-12, was necropsied and the lung, heart and brain were collected 
under sterile conditions. The lung, heart, and brain homogenates (10% w/v) were 
separately prepared in Eagle's minimal essential medium (MEM) and filtered 
through 0.22 |j.m membrane and used as inoculum. Fifteen other inocula from 
different herds were prepared in the same way and used for virus isolation. 
Cells. Primary swine alveolar macrophage (SAM) cultures prepared from 3 to 
5 week-old specific-pathogen-free (SPF) pigs, a continuous cell line, ATCC 
CRL11171, and twenty-two other cell lines or primary cell cultures from various 
species of animals and different tissues of origin (Table 1) were used for virus 
isolation. The ATCC CRL11171 cells and SAM cells were grown in Dulbecco's 
minimal essential medium (DMEM) supplemented with 10% fetal bovine serum 
(FBS) and 1 X antibiotics (10,000 unit/ml penicillin G, 10,000 mg/ml streptomycin 
and 25 mg/ml amphotericin B). Other primary and continuous cells were 
maintained in appropriate media (Table 1) with 10% FBS and 1 X antibiotics. 
Virus isolation. The ISU-12 pig lung, heart and brain tissues were separately 
homogenized (10% w/v) in DMEM, and then clarified at 2,000 X g at 40C for 15 
min. The supernatant was filtered through a series of filters with final filtration 
through 0.22 |i,m membrane. The filtrates were inoculated onto confluent 
monolayers of twenty-four different primary and continuous cells including 
CRL11171 and SAM, respectively. The cultures were then maintained in 
appropriate media with 2% FBS and 1 X antibiotics (Table 1). The inoculated cells 
were monitored daily for cytopathic effect (CPE). If CPE was not observed within 7 
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days, the cultures were frozen and thawed and blindly passed three times. If 
suspicious CPE was observed, cultures were examined by an indirect 
immunofluorescence assay (IFA) using convalescent antiserum to ISU-12 pig. A 
virus, ATCC VR2385, was isolated in CRL11171 cells and SAM cultures from the 
lung homogenate of ISU-12 pig. The VR2385 virus was then biologically cloned by 
three rounds of plaque purification in CRL11171 cells before further virus 
characterization. Virus isolation from fifteen other inocula was also attempted 
using CRL11171 cells. 
Virus titration. Serial 10-fold dilutions of the VR2385 virus propagated in 
CRL11171 and SAM cells were prepared in DMEM with 2% FBS and 1 X 
antibiotics as described for culture medium. One tenth ml of each dilution was 
inoculated in quadruplicate onto each well of CRL11171 and SAM cell cultures 
seeded into Lab-Tek chambers.'^ After 2 to 3 days postinfection the chambers were 
fixed with cold 80% acetone and 20% methanol solution at 4^0 for 15 minutes and 
an IFA was performed on fixed cells using VR2385 virus convalescent serum and 
anti-VR2332 serum <^to determine the tissue culture infective dose 50 (TCIDso/ml). 
Indirect immunofluorescence assay (IFA). The CRL11171 cells were infected 
with the VR2385 virus at a m. o. i of 0.1. At 4, 6, 8,10,12,14,16, 24, 48 hrs 
postinfection the cultures were fixed with cold 80% acetone and 20% methanol 
solution at 4^0 for 15 minutes, respectively. An IFA was carried out using VR2385 
virus convalescent serum, anti-\/R2332 serum and monoclonal antibody (SDOW-
17 d) to determine the earliest evidence of virus replication in CRL11171 cells. 
Uninfected CRL11171 cells were used as controls. 
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Growth curve of PRRSV VR2385. Confluent monolayers of CRL11171 cells 
growing in 25 cm2 flasks were infected with the third passage of VR2385 virus at a 
m. 0. i. of 1. After 1 hr. absorption, the unabsorbed virus was washed out with 1 X 
phosphate buffered saline (PBS) and the cells were supplied with fresh DMEM 
medium containing 2% FBS and 1 X antibiotics. The infected cells were frozen at 
12,18,24, 36, 48, 60,72, 84, 96, and 120 hrs. postinfection, respectively. Virus 
infectivity titers at different times were determined by I FA as described above. 
Radioimmunoprecipitation assay (RIP). The CRL11171 cells infected with 
VR2385 virus, and mock-infected CRL11171 cells were labeled with 35s-
methionine/cysteine.® Three day-old CRL11171 cells growing in 25 cm2 flasks 
were infected with VR2385 virus at a m. o. i. of 0.1. At 24 hrs postinfection, the 
medium was replaced with methionine/cysteine-deficient DMEM and the cultures 
were incubated at 37^0 for 1 hr. The medium was then replaced with fresh 
methionine/cysteine deficient DMEM with 100 ^Ci/ml of the 35s-
methionine/cysteine. Five hours after addition of 35s-methionine/cysteine, the 
cells were washed three times with cold PBS, pH 7.2, then scraped from the flasks 
and pelleted by centrifugation at 1,000 X g for 10 min. The cell pellets containing 
labeled viral proteins, and mock-infected cell pellets were then disrupted with lysis 
buffer consisting of 50 mM Tris.HCI, pH 7.4, 50 mM NaCI, 5 mM EDTA, 1% Triton X-
100, and 1 mM phenylmethylsulfonyl fluoride (PMSF). The cellular residues were 
clarified by centrifugation at 3,000 X g for 20 minutes. The lysates were then 
incubated with VR2385 convalescent serum and anti-VR2332 serum preabsorbed 
with uninfected CRL11171 cell lysates at 4^0 overnight. Immune complexes were 
collected by the addition of the sepharose-protein A beads ^ for 2 hours at room 
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temperature. The sepharose-protein A beads and immune complexes mixture 
were then washed three times with lysis buffer, and three times with distilled water, 
resuspended in 50 |il sample buffer consisting 0.125 M Tris.HCI (pH 6.8), 4% 
sodium dodecyl sulfate (SDS), 20% glycerol, 10% 2-mercaptoethanol, and run on 
a SDS-PAGE gel. 
Hemagglutination test Blood from a human with type O, guinea pig, mouse, 
rat, sheep, horse, cattle, pig and chicken were collected in Alsever's solution and 
erythrocytes were washed in PBS and resuspended to 50% (v/v) concentration. 
Hemagglutinating activity was tested in a microtitration assay by mixing equal 
amount of 0.5% erythrocyte suspension and two-fold dilutions of VR2385 virus 
propagated in CRL11171 cells. Erythrocytes mixed with PBS or culture lysates 
from uninfected CRL11171 cells were used as controls. 
Electron microscopy (EM). The CRL11171 cells were infected with VR2385 
virus at a m. o. i. of 0.1. At 24 hrs postinfection, the infected cells were fixed with 
3% glutaraldehyde (pH 7.2) at 4^0 for 2 hrs. The cells were then scraped from the 
flask and pelleted by centrifugation at 1,000 X g for 10 minutes. The cell pellets 
were embedded in plastic, thin sectioned, stained and visualized under 
transmission electron microscopy. 
For immunogold EM, the CRL11171 cells were infected with the VR2385 virus 
at a m. o. i. of 0.1. At 48 hrs postinfection, the culture supernatant was collected 
and incubated with VR2385 convalescent serum at a final dilution of 1:100. The 
incubation was carried out at 4^0 overnight with slow rotating. The antibody 
captured virus particles in the supernatant were pelleted by centrifugation at 
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30,000 rpm (SW41 rotor) for 2 hrs at 40C. The virus pellets were resuspended in 
0.5 ml of 1 X cold PBS and incubated with gold particles (5 nm)-labeled protein G 
at 40c overnight with slow rotating. The gold-labeled virus particles were pelleted 
by centrifugation, then washed 4 times with 1 X cold PBS and sprayed on EM grids 
Determination of physical characteristics of VR2385 virus. The type of nucleic 
acid of VR2385 virus was determined by using DNA inhibitor 5-bromo-2-
deoxyuridine (5-BUDR). The PRRSV VR2385 was propagated in the CRL11171 
ceils with or without 5-BUDR ^ at a concentration of 50,100 and 200 |j.g/ml, 
respectively. Three days after infection cells were frozen and thawed three times 
and titrated for virus infectivity. Transmissible gastroenteritis viais (TGEV, Miller 
strain), an enveloped RNA virus, and porcine parvovirus (PPV, NADL-2 strain), a 
nonenveloped DNA virus, were used as controls. Both TGEV and PPV were 
propagated in swine testis (ST) cells. A 1000-fold reduction in virus infectivity titer 
compared to untreated control was considered significant. 
Chloroform treatment of virus was used to determine whether the VR2385 
virus possessed an envelope. The VR2385 virus was mixed with equal volume of 
chloroform at room temperature for 30 minutes. The mixture was then 
microcentrifuged at 40C for 5 min. and the supernatant was harvested. The titer of 
virus before and after treatment was determined. Again, TGEV (an enveloped 
virus) and PPV (a nonenveloped virus) were used as controls. 
The buoyant density of VR2385 virus was determined by centrifugation of the 
virus on cesium chloride gradient.""s The VR2385 virus-infected CRL11171 cells 
were frozen and thawed three times, clarified at 5,000 X g for 15 min. at 40C. The 
clarified virus was resuspended in 2 ml of TE buffer consisting of 50 mM Tris.HCI, 
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pH 7.4, 0.1 M NaCI and 0.01 M ethylene diaminoacetic acid. The resuspended 
pellet was layered over cesium chloride gradient with density ranging from 1.1245 
to 1.2858 g/ml. The gradients were centrifuged at 28,000 RPM (Beckman SW41 
rotor) for 10 hours at 20^0. Two tenth ml fractions were taken from the bottom of 
the tube and titrated for virus infectivity by I FA. Refractive indices of fractions were 
also taken. The density of VR2385 virus was determined as the density of the 
fraction containing the highest amount of virus. 
Results 
Cultivation of PRRSV in SAM cultures and CRL11171 cells. Of twenty-four 
cell lines or primary cells tested (Table 1), possible evidence of virus replication 
was initially noted in four cells. Upon further confirmation, evidence for virus 
replication was only found in SAM cultures and CRL11171 cell line. 
Cytopathic effect (CPE) was first observed in SAM cultures infected with the 
lung filtrate of the naturally-affected ISU-12 pig. The CPE began at 24 to 36 hrs 
postinfection, and was characterized by clumping of the macrophages and cell 
lysis (Fig. 1D). No CPE was observed in uninfected macrophage cultures (Fig. 1C). 
The titer of VR2385 virus in SAM cultures at third passage was 10^ to 10^ 
TClDso/ml. Viral antigens were detected in the cytoplasm of VR2385 virus-infected 
SAM cultures using VR2385 convalescent serum from gnotobiotic pigs by an IFA 
(data not shown). No fluorescence was detected in uninfected SAM cultures. 
The CPE in CRL11171 cells started at about 2 days postinfection and was 
characterized by degeneration, cell rounding and clumping of cells (Fig. 1B). At 3 
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days postinfection, tlie number of the rounded cell clumps increased, and some of 
the clumps fused. Many rounded cells detached from the cell monolayer, and led 
to the disintegration of the monolayer. After 4 to 5 days postinfection, the CPE 
became very extensive, and usually involved over 90% of the monolayer. No CPE 
was observed in mock-infected CRL11171 cells (Fig. 1 A). The VR2385 virus 
replicated to a high titer in CRL11171 cells, about 10® TClDso/ml at the third 
passage and 10^ TCIDso/ml at the 11th cell culture passage. Viral antigens were 
also detected in the cytoplasm of infected cells with convalescent serum from 
gnotobiotic pigs experimentally-inoculated with lung filtrate of the naturally-affected 
ISU-12 pig (Fig. 2A). No fluorescence was observed in uninfected CRL11171 cells 
stained with convalescent serum (Fig. 2D). 
PRRS virus was also isolated in CRL11171 cells from fifteen different inocula 
obtained from different farms in Iowa. These PRRSV isolates have been shown to 
differ in virulence.""®-"''' Attempts to isolate swine influenza virus, swine 
encephalomyocarditis virus, swine transmissible gastroenteritis virus, porcine 
adenovirus, hemagglutinating encephalitis virus, pseudorabies virus, and porcine 
parvovirus failed (data not shown). 
Virus morphology. Electron microscopy revealed typical virus particles in 
cytoplasmic vesicles of the VR2385 virus-infected CRL11171 cells (Fig. 5A). The 
virus envelope structure could be visualized under higher magnification. The virus 
particles were pleomorphic but mostly spherical, ranging from 50-70 nm in 
diameter (Fig. 5). These particles were not detected in uninfected-CRL11171 cells. 
Also, numerous virus particles were visualized in the supernatant of VR2385 virus-
infected CRL11171 cells by the immunogold labeling technique (Fig. 5B). The 
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virus particles were surrounded by gold particles. No virus particles were detected 
in the supernatant of mock-infected CRL11171 cells (data not shown). 
Growth curve. Viral antigens could be detected by IFA as early as 8 hrs 
postinfection (data not shown). Virus infectivity titer increased from 12 to 48 hrs 
and reached the peak titer of 10® TCIDso/ml at 48 hrs. postinfection at the third 
passage. The peak infectivity titer was maintained until 60 hrs postinfection, and 
then decreased dramatically (Fig. 3). The infectivity titer was only 10^ TCIDso/ml 
after 72 hrs postinfection. 
Antigenic relatedness of \/R2385 virus to PRRSV. Monoclonal antibody 
SDOW-17 to PRRSV isolate VR2332 and anti-VR2332 serum reacted with VR2385 
vinjs-infected CRL11171 cells as evidenced by bright cytoplasmic fluorescence 
(Fig. 2B, 2C), but did not react with uninfected CRL11171 cells. Convalescent sera 
from other eight different PRRSV isolates were also cross-reacted with the VR2385 
virus (data not shown). 
Viral proteins. Anti-VR2385 convalescent serum and anti-VR2332 serum 
were used to analyze the viral polypeptides by RIP. Both sera recognized at least 4 
polypeptides with a molecular mass of approximately 15, 19, 31-33 (32), and 42-44 
(43) kDa, respectively (Fig. 4). The predominant protein was 15 kDa. These 
polypeptides were not evident in the mock-infected CRL11171 cells (Fig. 4). 
Biological and biophysical characteristics. The VR2385 virus was sensitive to 
chloroform. The virus infectivity completely disappeared after chloroform treatment. 
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indicating tfie existence of an envelope. Replication of VR2385 virus was not 
affected by 5-BUDR treatment (Table 2), suggesting that its genome was not DNA. 
In contrast, 5-BUDR reduced PPV replication by 10^ TCIDso/ml and had no effect 
on the replication of TGEV. Hemagglutinating activity for erythrocytes from a 
human with blood type O, chicken, guinea pig, rat, sheep, horse, cattle and pig was 
not detected. The buoyant density of VR2385 virus in cesium chloride gradient was 
1.15-1.18 g/ml. The infectivity titer of this fraction was 10® TCID5o/ml as 
determined by IFA. Numerous PRRSV particles were also observed in this fraction 
by negative staining EM (data not shown). 
Discussion 
We report here a continuous cell line, ATCC CRL11171, which supports 
PRRSV replication and the preliminary characterization of a high virulence PRRSV 
isolate, ATCC VR2385, isolated from a naturally-affected pig with interstitial 
pneumonia, myocarditis and encephalitis. The VR2385 virus is unique in that it 
produced much more severe interstitial pneumonia than other reported PRRSV 
isolates, and also produced mild myocarditis in experimentally infected pigs-'^o-"''' 
VR2385 virus-induced pneumonia is characterized by marked type II pneumocyte 
proliferation, moderate interstitial thickening with mononuclear cells, moderate 
alveolar exudate accumulation and occasional syncytial cell formation.io-"''' The 
VR2385 virus was found to be an enveloped, spherical RNA virus with a size of 50-
70 nm in diameter as observed by electron microscopy. The genome of VR2385 
was RNA based on inhibition of its replication by a DNA inhibitor BUDR and the 
39 
presence of viral antigens in the cytoplasm of infected cells. These properties are 
similar to that reported for PRRSV isolates. The VR2385 virus was also similar to 
PRRSV isolates in that it lacked hemagglutinating activity and had a buoyant 
density of about 1.15-1.18 g/ml in cesium chloride gradient. At least four viral 
proteins were detected in VR2385 virus-infected CRL11171 cells. The estimated 
molecular mass of these proteins are slightly different from that of other isolates of 
PRRSV.''®'2o The antigenic relatedness of VR2385 to PRRSV was shown by IFA 
using polyclonal and monoclonal antibodies to the U.S. PRRSV isolate VR2332. 
Its antigenic relatedness to LV was not directly tested. However, the VR2332 
isolate has been shown to be antigenically related to LV using polyclonal and 
monoclonal antibodies.20.27 
The viral genome of PRRSV is a plus stranded RNA of about 15 Kb in 
size.5.15,17 The genome organization of PRRSV is similar to the members of the 
recently proposed family Arterivihdae which includes LDV, EAV, and 
SHFV.5.7.15,17,22 The results of our preliminary characterization indicated that the 
highly pneumovirulence VR2385 virus has biological properties similar to the 
members of arteriviruses, and is a PRRSV which can be easily propagated to high 
titer in CRL11171 cells. Our recent genetic studies have confirmed that VR2385 is 
a PRRSV.15,19 However, extensive sequence variation was found between 
VR23B5 and European LV; only about 60% sequence homology in ORFs 2 to 7 
was found between VR2385 and European LV.''5.i9 Considerable sequence 
variation was also found between VR2385 and other U. S. PRRSV isolates 
(unpublished data). It is likely that the observed differences in the ability to 
replicate in various cell cultures and the differences in virulence among PRRSV 
isolates are caused by genetic variations. 
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PRRSV has been previously reported to replicate in SAM cultures and two 
continuous cell lines, CL 2621 and MARC-145.2Ai3,26 ip t^js study, we have 
propagated PRRSV in SAM cultures and another continuous cell line, ATCC 
CRL11171. The CRL11171 cells supports growth of PRRSV isolates that did not 
replicate in CL2621 cell line at the National Veterinary Services Laboratory 
(unpublished data). PRRS viruses were isolated in CRL11171 cells from all fifteen 
different field cases that were tested. Also, the CRL11171 cell line has been used 
for a number of PRRSV studies-^-^-'iO'"'•''•'5.16.19 jhe swine testis (ST) cells were 
also reported to support PRRSV replication.23 However, in this study we did not 
find any evidence for viral replication in ST cells inoculated with the high virulence 
VR2385 virus. No other duplicating studies about ST cells were reported. Taken 
together, the results from this study indicate that the CRL11171 cells will be a 
useful cell line in PRRSV research and diagnosis. More work needs to be done to 
compare the three available cell lines, CL2621, MARC-145 and CRL11171. 
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Table 1. Cell lines and primary cells used for PRRSV isolation 
ATCC No. Name Species Tissue Origin Medium 
CRL1621 ARH-77 (F-9381) Human Plasma cell Eagle's MEM 
Hep-2 Human Bronchus Eagle's MEM 
CCL26 BS-C-1 African green monkey Kidney Eagle's MEM 
CCL81 Vero African green monkey Kidney DMEM 
CCL70 CV-1 African green monkey Kidney Eagle's MEM 
CCL75 Wl-38 Human Lung Earle's basal 
CCL88 Tb1 Lu (NBL-12) Bat Lung Earle's basal 
CCL160 DBS-FRhL-2 Rhesus monkey Lung Eagle's MEM 
CCL161 DBS-FCL-1 African green monkey Lung Eagle's MEM 
CCL166 MPK Minipig Kidney ATCC-CRCM30 
CCL171 MRC-5 Human Lung Eagle's MEM 
CCL203 CCD-14Br Human Bronchiole Eagle's MEM 
CCL208 4MBr-5 Rhesus monkey Bronchus Ham's F12K 
CRL1576 12MBr6 African green monkey Bronchus Ham's F12K 
CCL78 SP1K(NBL-10) Dolphin Kidney ATCC-CRCM30 
ST Pig Testis DMEM 
MVPK Pig Kidney Eagle's MEM 
Primary Lung cells Pig (4-week-old) Lung Eagle's MEM 
Primary Spleen cells Pig (4-week-old) Spleen Eagle's MEM 
Primary Synovial cells Pig (4-week-old) Joint Eagle's MEM 
Primary Heart cells Pig (4-week-old) Heart Eagle's MEM 
Primary Endoepittielial cells Pig (4-week-old) Vein Eagle's MEM 
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Table 2. Effects of BUDR with different concentrations on the infectivity titers 
(TCID50/ml) of porcine reproductive and respiratory syndrome virus (PRRSV), 
transmissible gastroenteritis virus (TGEV), and porcine parvovirus (PPV) 
Untreated BUDR-treated 
Virus 50 mg/ml 100 mg/ml 200 mg/ml 
TGEV 5X 106 5 X 1 0 6  5 X 106 5 x 1 0 6  
PPV 107 104 104 104 
PRRSV 105 105 105 105 
Figure 1. Cytopattiic effect (CPE) of PRRSV VR2385 in CRL11171 ceils (B) and swine alveolar macrophage 
cultures (D). Mock-infected CRL11171 cells (A) and swine alveolar macrophage cultures (C) were 
used as controls. 

Figure 2. Indirect immunofluorescence staining of PRRSV VR 2385-infected CRL11171 cells with 
convalescent serum to VR2385 (A), monoclonal antibody against VR 2332 strain (B), and 
polyclonal antiserum to VR2332 (C). Mock-infected CRL11171 cells stained with convalescent 
serum (D) was used as control. 
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Figure 3. Growth curve of PRRSV VR2385 in CRL11171 cells. Peak virus 
infectivity titer occurs between 48 to 60 hrs postinfection. 
Figure 4. Radioimmunoprecipitation of viral polypeptides in VR2385 virus-
infected CRL11171 cells. Mock-infected CRL11171 cell lysates 
were immunoprecipitated with VR2385 convalescent serum (lane 
1) and anti-VR2332 serum (lane 2). VR2385-infected CRL11171 
cell lysates were immunoprecipitated with VR2385 convalescent 
serum (lane 3) and anti-VR2332 serum (lane 4). At least four 
polypeptides were recognized in VR2385-infected CRL11171 cells 
(arrows). Protein molecular marker is indicated. 

Figure 5. Electron micrograph of virus particles in the cytoplasmic vesicle of 
the VR2385 virus-infected CRL11171 cells (A) and immunogold 
labeling of virus particles in the supernatant of VR2385 virus-
infected CRL11171 cells (B). Enveloped, and mostly spherical 
virus particles, ranging from 50 to 70 nm in diameter, were 
observed. Bar=100nm. 
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MOLECULAR CLONING AND NUCLEOTIDE SEQUENCING OF THE 3'-TERMINAL 
GENOMIC RNAOF THE PORCINE REPRODUCTIVE AND RESPIRATORY 
SYNDROME VIRUS 
A paper published In the Journal of General Virology, 1994, 75:1795-1801 
Xiang-JIn Meng, Prem S. Paul and Patrick G. Halbur 
Abstract 
The genomic RNA of a porcine reproductive and respiratory syndrome virus 
(PRRSV) isolate from the U. S. A., ATCC VR 2385, was copied into cDNA after 
priming with oligo (dT) and cloned into lambda phage. The cDNA clones 
representing the 3' terminal genomic RNA of VR 2385 were isolated and 
sequenced. The VR 2385 genome is a positive-stranded, polyadenylated RNA with 
an estimated size of 15 Kb. Analysis of the resulting sequence identified three 
complete open reading frames (ORFs) with the potential to encode polypeptides 
with predicted molecular mass of 22.2 (ORF 5), 19.1 (ORF 6) and 13.6 (ORF 7) kDa. 
ORF 7, which is closest to the 3' end, is predicted to encode a highly basic 
nucleocapsid protein, displaying 58% amino acid identity to the corresponding 
protein of the Leiystad virus (LV), a European PRRSV isolate. ORFs 6 and 5, 
preceding the ORF 7, are each predicted to encode proteins containing several 
hydrophobic domains that are thought to be membrane-associated. The VR 2385 
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ORF 6 protein is the most conserved structural protein, it shares 78% amino acid 
identity to the equivalent LV protein, and ORF 5 shares only 54% of its amino acid 
sequence. Northern blot analysis revealed a 3'-coterminal nested set of 6 
subgenomic RNAs in VR 2385 virus-infected ATCC CRL 11171 cells. Our results 
indicate that the U.S. isolate VR 2385, like LV, is a member of the newly proposed 
arterivirus group. However, the striking genetic variation and the difference in 
pathogenicity between LV and VR 2385 suggest that the viruses causing PRRS in 
the U.S. and Europe are highly variable and they may represent different 
genotypes. 
Short Communication 
Porcine reproductive and respiratory syndrome (PRRS) appeared in the 
United States in 1987 (Hill, 1990) and was rapidly recognized around the world 
(Keffaber, 1989; Paton etai, 1991; Wensvoort eta!., 1991; Dea etaL, 1992). The 
disease is characterized by severe reproductive failure in sows, respiratory disease 
in young pigs and a flu-like syndrome in grower-finisher pigs (Loula, 1991; Terpstra 
etai, 1991; Wensvoort etai, 1991; Benfield etai, 1992; Christianson etai, 1992). 
Many other names have been used to describe this syndrome, such as mystery 
swine disease (MSD), swine infertility and respiratory syndrome (SIRS), porcine 
epidemic abortion and respiratory syndrome (PEARS), blue ear disease, "Heko-
Heko" disease, etc. (reviewed by Paul etai, 1993). An apparently new virus, 
porcine reproductive and respiratory syndrome vinjs (PRRSV), was demonstrated to 
be the causative agent of PRRS. 
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In Europe, the Leiystad virus (LV) was isolated (Wensvoort etal., 1991) and 
demonstrated to be the causative agent of the European PRRS (Terpstra etal., 
1991). The LV is a small, enveloped, single-stranded RNA virus. Its genome is 
polyadenylated and about 15 kb in length. Eight open reading frames (ORFs) have 
been identified and are organized in a similar way to those of the coronaviruses 
(Meulenberg etal., 1993a). ORF 1a and ORF lb in the 5' half of the genome are 
predicted to encode the viral RNA polymerase. ORFs 2 to 6 in the 3' half of the 
genome are likely to encode viral membrane-associated proteins. ORF 7 encodes 
for the nucleocapsid protein (Meulenberg etal., 1993a). An approximately 5 kb 
nucleotide sequence of the 3' terminal genomic RNA from another European 
PRRSV isolate has also been determined (Conzelmann etal., 1993) and it has a 
nucleotide sequence almost identical to the corresponding region of LV. In the 
United States, PRRSV has been isolated and antigenically characterized in primary 
porcine alveolar macrophages (PAM) as well as in two continuous cell lines, ATCC 
CL 2621 and ATCC CRL 11171 cells (Benfield etal., 1992; Collins etal., 1992; 
Meng etal., unpublished results). The U.S. isolates can be grown to a titer of 10® to 
10^ TCIDso/ml in both PAM and the two continuous cell lines. Up to the present, 
however, little is known about the genetic and biochemical nature of U.S. PRRSV 
isolates or their genetic relatedness to European PRRSV isolates. 
Both the U.S. PRRSV and the European LV are tentatively classified in a 
newly proposed group of plus-stranded RNA viruses, which includes equine arteritis 
virus (EAV), lactate dehydrogenase-elevating virus (LDV) and probably simian 
hemorrhagic fever vims (SHFV) (Plagemann and Moennig, 1992). Viruses in this 
group form a 3'-coterminal nested set of five to seven subgenomic mRNAs and 
contain a common 5'-terminal leader sequence (den Boon etal., 1991; Kuo etal.. 
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1991, 1992; Chen etal., 1993; Conzelmann et ai, 1993; Godney et ai, 1993; 
Meulenberg etai, 1993a, 1993b). Recent serological and biophysical data suggest 
that the U.S. PRRSV and European LV are the same virus, although a complete 
comparative study of these 2 viruses has not yet been completed. Antigenic 
variation, however, does occur, not only between the U.S. PRRSV and the 
European LV, but also among different U.S. PRRSV isolates (Wensvoort etal., 
1992). The European PRRSV isolates are antigenically and genetically related 
(Wensvoort etal., 1992; Conzelmann etal., 1993; Meulenberg etal., 1993a). 
European LV apparently replicates preferentially in PAM and replicates to a low titer 
in other cell cultures (Wensvoort et al. 1991,1992; Wensvoort, 1993), whereas the 
U.S. PRRSV can grow to a relatively high titer (10^ to 10^ TCIDsQ/ml) in both PAM 
and two continuous cell lines, CL 2621 and CRL 11171. Molecular characterization 
of the U.S. PRRSV isolates is necessary to better understand the relevance of these 
differences. 
We have isolated and antigenically characterized a U.S. PRRSV isolate, 
ATCC VR 2385, in a continuous cell line, ATCC CRL 11171 (Meng et al., 
unpublished results). Experimental reproduction of the disease with the VR 2385 
virus isolate and comparison of the pathogenicity of several other U.S. PRRSV 
isolates have also been performed. The VR 2385 virus experimentally-infected 
specific-pathogen-free (SPF) pigs and caesarean-derived colostrum deprived 
(CDCD) pigs had severe interstitial pneumonia, mild myocarditis and encephalitis. 
The gross and microscopic lesions were more severe and had some unique 
features compared to those caused by several other U.S. PRRSV isolates and the 
European LV (Halbur et al., unpublished results). It is believed that VR 2385 virus is 
one of the most virulence PRRSV isolates. In the present paper we describe the 
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molecular cloning and sequence analysis of the 3'-terminal portion of the genome 
of VR 2385. We also analyzed the VR 2385 virus genomic and subgenomic RNAs 
in VR 2385 virus-infected CRL 11171 cells by Northern blot analysis. 
The PRRSV isolate ATCC VR 2385 was isolated from the lung of a pig in a 
herd which had experienced PRRS with persistent severe nursery-pig pneumonia. 
A continuous cell line, ATCC CRL 11171, was used to isolate and propagate the VR 
2385 virus. The virus was then biologically cloned by three rounds of plaque 
purification and grown on the CRL 11171 cell line. The VR 2385 was demonstrated 
to fulfill Koch's postulates by the experimental reproduction of the disease and re-
isolation of the virus from experimentally-infected pigs. For isolation of PRRS viral 
RNA, the CRL 11171 cells were infected with the VR 2385 virus at a m. o. i. of 0.1. 
When more than 70% of the infected cells showed cytopathic changes, the cultures 
were frozen and thawed 3 times, and the culture medium was clarified by low-speed 
centrifugation at 1,000 X g for 15 min. at 4° C. The virus was then precipitated with 
7% polyethylene glycol {PEG-8000) and 2.3% NaCl at 4° C overnight with stirring 
and subsequently pelleted by centrifugation. The virus pellets were resuspended in 
2 ml of TE (10 mM Tris-HCI pH 8.0,1 mM EDTA) buffer and layered over a cesium 
chloride gradient (1.1245-1.2858 g/ml). After ultracentrifugation at 28,000 rpm 
(Beckman SW 41 rotor) for 10 hrs at 20° C, a clear band with a density of 1.15-1.18 
g/ml was observed and collected. The infectivity titer of this band was determined to 
be 10® TCIDso/ml by indirect immunofluorescence assay with both convalescent 
sera against VR2385 virus and a monoclonal antibody (SDOW-17) against VR2332 
(Nelson etal., 1993). PRRSV particles were also observed in this band by negative 
staining electron microscopy (data not shown). Viral RNA was isolated from the 
banded virus using the guanidine isothiocyanate method (Sambrook etal., 1989). 
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Poly(A)+ RNA was then enriched by oligo (dT)-cellulose column chromatography 
(Invitrogen). A cDNA I library was subsequently constructed. Briefly, first strand 
cDNA was synthesized from polyadenylated RNA, using oligo (dT) primer with a 
Xho I restriction site by reverse transcription. The nucleotide mixture in the first-
strand cDNA synthesis contained normal dATP, dGTP, dTTP and the analog 5-
methyl dCTP which protected the cDNA from the restriction enzyme used in 
subsequent cloning steps. Second-strand cDNA was then prepared with RNase H 
and DNA polymerase I in the presence of normal dNTPs. The cDNA termini were 
blunted with T4 DNA polymerase, ligated to EcoR I adaptors with T4 DNA ligase 
and subsequently phosphorylated by T4 polynucleotide kinase. The cDNA 
fragments were digested with Xho I restriction enzyme and selected for size on 1 % 
agarose gels. The cDNA fragments larger than 1 kb in size were selected and 
purified with a GENECLEAN Kit (Bio 101). The purified cDNA fragments were then 
ligated into lambda phage ZAP vector arm.s engineered with Xho I and EcoR I 
cohesive ends (Stratagene). The ligated vector was packaged into infectious 
phages with lambda extracts. The Escherichia co//SURE strain cells were used for 
transfection and the lambda library was subsequently amplified and titrated in 
Escherichia coliXL-^ blue strain cells (Stratagene). The lambda library had a titer 
of 10^ p.f.u./ml. 
To identify the VR 2385 virus-specific clones in the cDNA lambda library, 
three sets of primers based on the available nucleotide sequence of the European 
LV (Meulenberg etal., 1993a) were initially designed and synthesized. One set of 
the primers, PP105 (5' CTCGTCAAGTATGGCCGGT 3') and PP106 (5' GCCATTC 
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ACCTGACTGTCA 3'), is located in the nucleocapsid gene region. A second set, 
PP106 and PP107 (5' TTGACGAGGACTTCGGCTG 3"), is flanking the ORFs 6 and 7 
and the third set, PM541 (5' GCTCTACCTGCAATTCTGTG 3') and PM542 (5' GTG 
TATAGGACCGGCAACAG 3'), is located in the ORFIb region of the LV sequence. 
Attempts to generate probes to screen the lambda library by PGR using the VR 2385 
virus with these three sets of primers failed, indicating that there was extensive 
sequence variation between the U.S. PRRSV isolate VR 2385 and the European 
LV. However, we were able to identify the authentic plaques representing VR 2385 
virus-specific cDNA by differential hybridization technique (Sambrook etal., 1989). 
Briefly, the lambda library was plated on XL-1 blue cells and plaques were lifted 
onto nylon membranes in duplicates. The membranes were then denatured with 
0.5 N NaOH /1.5 M NaCI for 5 min. and neutralized with 0.5 M Tris HCI (pH 7.0) / 
1.5 M NaCI for 5 min. as described elsewhere (Sambrook etal., 1989). Two cDNA 
probes were synthesized from mRNAs isolated from VR 2385 virus-infected and 
mock-infected GRL 11171 cells using random primers in the presence of 32p-ciQTp 
(Amersham). The two probes were then purified with Sephadex G-50 columns 
(Boehringer Mannheim) and hybridized with duplicate nylon membranes, 
respectively, at 42° C with 50% formamide. Plaques that hybridized with the probe 
prepared from virus-infected cells, but not with the probe prepared from mock-
infected cells were isolated. The specificity of the cDNA clones was further 
confirmed by hybridization with RNAs from VR 2385 virus-infected CRL 11171 cells, 
but not with RNAs from mock-infected CRL 11171 cells. The phagemids containing 
viral cDNA inserts were rescued from the positive plaques by in vitro excision with 
the help of the G408 helper phage. The rescued phagemids were then amplified on 
XL-1 blue cells. Identification of the clones containing larger PRRSV cDNA inserts 
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was accomplished by plaque hybridization (Sambrook etai, 1989) with probes 
generated by PGR. The primers used for PGR [PP286 (5' GCCGGGGAAGGATGAA 
GGAG 3'), PP287 (5' GAAGTTGAGGGTATGTGAGG 3'), DP585 (5' GCTTTGGTGT 
GGTGGAAG 3') and DP586 (5' GATGCCTGACAGATTGGG 3')] were designed on 
the basis of the available nucleotide sequence of the initial and subsequent positive 
cDNA clones. PGR was performed according to the procedures described 
previously (Meng etaL, 1993). 
Plasmids containing viral cDNA inserts were purified as described elsewhere 
(Sambrook etaL, 1989) using QIAGEN columns (QIAGEN Inc.) and subsequently 
sequenced by Sanger's dideoxynucleotide chain termination method (Sambrook et 
al., 1989) with an automated DNA Sequencer (Applied Biosystems). Both universal 
and reverse primers as well as five internal oligonucleotide primers, PP286, PP287, 
PP288 (5' GGGGTGTGGATTGAGGAGAG 3'), PP289 (5' GAGTGGTAGGGGTTGT 
GGAG 3') and PP386 (5' GGGATTGAGGTGAGATAGGG 3'), were used to determine 
the sequence. Sequences were obtained from at least 3 separate clones for any 
given regions of the 3'-terminal part of the genome. Additional clones or regions 
were sequenced when any sequence data were ambiguous. The nucleotide 
sequence data reported in this paper have been deposited with GenBank database 
and assigned the accession number U03040. The nucleotide sequence data were 
assembled and analyzed with the GeneWorks (IntelliGenetics, Inc.) and MacVector 
(International Biotechnologies, Inc.) computer programs. Very few nucleotide 
differences were found among sequences of independent cDNA clones. The 
number of A residues in the poly(A) tail varied between different cDNA clones, 
indicating that they represented independent cDNA molecules. However, the 
length of the poly (A) tail was at least 13 nucleotides. The cDNA sequences in the 
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extreme 3' end of different cDNA clones were found to be identical, indicating that 
these oligo(dT)-primed clones contained the complete 3' end of the VR 2385 RNA 
genome. 
Three large ORFs, ORF 5, ORF 6 and ORF 7, were identified in the resulting 2 
kb 3'-terminal sequences. Another ORF, ORF 4, at the 5' end of the resulting 
sequence was incomplete. All three complete ORFs had a coding capacity of more 
than 100 amino acids. They overlapped each other by 13 bp between ORFs 5 and 
6 and by 8 bp between ORFs 6 and 7. These ORFs each encoded a polypeptide 
with predicted sizes of 22.2,19.1 and 13.6 kDa, respectively (Table 1). ORF 7 
encoded a very basic and hydrophilic protein, 123 amino acids in length, which was 
five amino acids shorter than the corresponding protein of LV. Basic amino acids 
(lysine, arginine or histidine) constituted 20.4% of the residues in this sequence, 
and only 6.5% of the residues were acidic (aspartic acid or glutamic acid). This 
gene product showed a 58% amino acid identity with the ORF 7 protein of LV, which 
was predicted to be the nucleocapsid protein (Fig.1). There was a stretch of 22 
amino acids in the ORF 7 protein of LV and VR 2385 (Fig. 1 c, positions 46 to 66) 
which was extremely conserved, with nineteen out of twenty-two amino acids in this 
region being identical. One of the differences was the presence of isoleucine in LV 
and a structurally similar amino acid, valine, in VR 2385. This conserved amino 
acid region was much more basic than the overall nucleocapsid protein. 
Approximately 40% of the amino acids in this region were arginine, histidine and 
lysine. This short stretch of conserved amino acid region may function as the site of 
interaction with the viral genomic RNA, similar to the region found in the 
nucleocapsid proteins of coronaviruses (Kapke and Brian, 1986). ORF 7 of VR 
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2385 was predicted to encode the viral nucleocapsid protein because of its highly 
basic amino acid composition, and its similarities with the LV nucleocapsid protein. 
In contrast to the ORF 7, ORFs 5 and 6 were very hydrophobic. Several 
hydrophobic domains, which likely represented the putative membrane-spanning 
fragments, were identified in both ORFs (data not shown). The characteristics of VR 
2385 ORFs 5 and 6 resembled those of LDV, EAV and LV (Den Boon et al., 1991; 
Plagemann and Moennig, 1992; Conzelmann etal., 1993; Godeny etai, 1993; 
Meulenberg ei al., 1993a). Therefore, they probably encode viral membrane-
associated proteins. The ORF 6 gene product was found to be the most conserved 
structural protein between European PRRSV and EAV and this may be the case 
with all the members of the arterivirus group (Conzelmann etal., 1993). VR 2385 
also displayed higher homology in ORF 6 than in ORFs 5 and 7 when compared to 
the ORFs of LV (Fig. 1). The ORF 6 gene product of VR 2385 shared 78% amino 
acid sequence identity with that of LV, the highest conservation among the three 
ORFs. The ORF 5-encoded protein of VR 2385 shared only 54% amino acid 
sequence identity with that of LV. Differences were also found between VR 2385 
and LV in the number of the glycosylation sites of these putative proteins. There 
were two, one and two potential A/-glycosylation sites in the ORFs 5, 6 and 7 of VR 
2385, respectively, compared to two, two and one coded for by the same ORFs of 
LV (Table 1). 
Sequence alignment between the 3' non-coding regions (NCR) of VR 2385 
and LV revealed a 38 nucleotide sequence insertion in the VR 2385 isolate 
following the stop codon of the ORF 7 (Fig. 2). The 151 nucleotide 3'-terminal NCR 
of VR 2385, exclusive of the poly (A) tail, was the longest NCR among those 
identified in the proposed arterivirus group. The NCRs were 114 nucleotides long 
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in European LV (Fig. 2), 80 nucleotides in LDV and 59 nucleotides in EAV, 
respectively (Conzelmann etal., 1993). The nucleotide sequence homology in this 
region between LV and VR 2385 was only 58%. However, when the 10 nucleotides 
immediately preceding the poly (A) tail of the LV, LDV, EAV and VR 2385 were 
analyzed, high sequence homology was found. Eight out of ten nucleotides were 
found to be identical in VR 2385, LV and LDV but only four nucleotides were 
identical in VR 2385 and EAV. Higher sequence homology in the region 
immediately preceding the poly A tail was also reported in the NCRs of many other 
positive-strand RNA viruses (Strauss and Strauss, 1988; Conzelman etal., 1993). 
The conserved 3' NCR may function as an attachment region for the polymerase to 
initiate synthesis of the negative-strand RNA in the virus replication process, in a 
similar way to replication in coronaviruses (Kapke and Brian, 1986; Spaan etal., 
1988). 
The short sequence motif AACC is likely the leader-mRNA junction site of VR 
2385, the sequence in the subgenomic mRNAs where the common leader 
sequence derived from the 5' end of the genome is joined to the mRNAs during the 
transcription process (Spaan etal., 1988; Chen etal., 1993; Conzelmann etal., 
1993; Meulenberg etal., 1993a and 1993b). The junction sequences have been 
reported for other members of the proposed arterivirus group to be UCAAC for EAV 
subgenomic mRNAs 6 and 7, UAACC for LDV subgenomic mRNAs 3, 4, 5 and 7, 
AAACC for LDV subgenomic mRNA 6 and AUACC for LDV subgenomic mRNA 2 
(De Vries etal., 1990; Den boon etal., 1991; Plagemann and Moennig, 1991; Kuo 
etal., 1992; Chen etal., 1993; Meulenberg etal., 1993b). More recently the 
identification of the junction sequences of LV (UCAACC or a highly similar 
sequence) was also reported (Meulenberg etal., 1993b). The AACC sites in ORFs 
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6 and 7 of VR 2385 were 21 and 13 nucleotides upstream of the AUG start codon, 
compared to 28 and 13 nucleotides upstream in the same ORFs of LV. However, no 
AACC consensus sequence was found in the region upstream of VR 2385 ORF 5. 
Northern blot analysis was used to determine the subgenomic mRNA species 
in VR2385 virus-infected CRL11171 cells. Monolayers of CRL 11171 cells were 
infected with VR 2385 virus with a m. o. i. of 0.1. At 24 hr. postinfection, the infected 
cells were washed three times with cold PBS buffer. The total intracellular RNAs 
were then isolated by guanidinium isothiocyanate and phenol-chloroform extraction 
(Stratagene). A specific cDNA fragment from the extreme 3' end of VR 2385 
genome was amplified by PGR with a set of primers, PP284 (5' CGGCGGTGTGGT 
TGTGGGGAAT 3') and PP285 (5' CGGGATTTGGGTGTAGCGACTG 3'), 
complementary to the nucleotides in this region. The cDNA fragment was purified 
from an agarose gel using a GENEGLEAN Kit (Bio 101) and labeled with ^^p-dCTP 
(Amersham) by random primer extension method as described elsewhere 
(Sambrook etal., 1989). Ten microgram of total intracellular RNAs from VR 2385 
virus-infected and mock-infected GRL 11171 cells were denatured with 6 M glyoxal-
DMSO and separated on 1% agarose gel along with a RNA standard (GIBGO-BRL). 
The separated intracellular RNAs were then transferred onto nylon membranes by a 
PosiBlot™ Pressure Blotter (Stratagene) with 10 X SSG. Northern blot 
hybridization was carried out in a hybridization oven with roller bottles at 42° G with 
50% formamide (Sambrook etal., 1989). The results showed that the pattern of 
subgenomic mRNA species from VR 2385 virus-infected GRL 11171 cells was very 
similar to that of European PRRSV, EAV, LDV, and coronaviruses in that virus 
replication required the formation of subgenomic mRNAs (Spaan etal., 1988; De 
Vries etal., 1990; Den boon etal., 1991; Plagemann and Moennig, 1991; 
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Conzelmann eta!., 1993; Meulenberg eta!., 1993a). The results also indicated that 
VR 2385 virus-specific subgenomic mRNAs represented a 3'-nested set because 
the probe used in the Northern blot analysis represented only the extreme 3'-
terminal sequence. The size of VR 2385 viral genomic RNA (14.7 kb) and six 
subgenomic mRNAs, RNA 2 (3.3 kb), RNA 3 (2.8 kb), RNA 4 (2.3 kb), RNA 5 (1.9 kb), 
RNA 6 (1.4 kb) and RNA 7 (0.9 kb) were similar to those of LV (Fig. 3, Conzelmann 
eta!., 1993; Meulenberg etai, 1993a). However, variations in the migration 
patterns of the subgenomic mRNAs among several other U.S. PRRSV isolates have 
been observed (Meng etal, unpublished results), suggesting that considerable 
genetic variation among U.S. isolates may also occur. Differences were also 
observed in the relative amounts of the subgenomic mRNAs of VR 2385, 
subgenomic mRNA 7 of the VR 2385 was the most abundant (Fig. 3). Low levels of 
the subgenomic mRNAs of VR 2385 were detected as late as 48 to 60 hrs 
postinfection (data not shown). 
The differences in the three ORFs of LV and VR 2385 were striking, 
considering that the U.S. PRRSV and the European LV were thought to be the same 
virus, it is likely that the observed differences in the ability to replicate in various cell 
cultures between U.S. and European isolates, and among U.S. isolates, are caused 
by genetic and antigenic variation. The VR 2385 isolate used in this study was 
isolated on a continuous cell line, ATCC CRL 11171, and had been growing in the 
cell line for several passages before cloning. The other U.S. PRRSV isolates were 
grown on CL 2621 cells and PAM (Benfield etal., 1992; Collins etal., 1992; Bautista 
etal., 1993). The European PRRSV isolates were exclusively propagated in PAM 
(Wensvoort etal., 1991,1992; Wensvoort, 1993). Differences in the susceptibility of 
CL 2621 cells and PAM to the virus were also reported. Not all virus isolates 
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growing on CL 2621 cells replicated on PAM, and vice versa (Bautista eta!., 1993). 
Genetic and antigenic variation among PRRSV isolates may also be associated 
witfi the observed difference in pathogenicity, as VR 2385 virus is highly pathogenic 
compared to other U.S. isolates and European LV (Halbur etal., unpublished 
results). Genetic comparisons of several U.S. PRRSV isolates that differ in 
pathogenicity are under way. 
In conclusion, the U.S. PRRSV isolate ATCC VR 2385, like the European 
PRRSV, is a member of the newly proposed arterivirus group including LDV, EAV 
and probably SHFV. However, striking genetic variation exists between the U.S. 
PRRSV VR 2385 and the European PRRSV, indicating that the viruses causing 
PRRS, PEARS or SIRS are, if they are the same virus, highly variable. VR 2385 
may represent a different PRRSV genotype. Further antigenic and genetic 
characterization of additional PRRSV isolates, both from the U.S. and Europe, is 
necessary to determine the extent of variation and the differences in pathogenicity 
among PRRSV isolates. 
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Table 1. Characteristics of the U.S. PRRSV ATCC VR 2385 ORFs 5, 6 and 7 
and their related subgenomic RNAs 
RNA Estimated 
RNA size 
(in Kb) 
ORFs No. of 
Amino Acids 
Potential 
N-
glycosylation 
sites 
Calculated 
size of the 
product (kDa) 
5 1.9 5 200 2 22.2 
6 1.4 6 174 1 19.1 
7 0.9 7 123 2 13.6 
A (0RF5) 
LV HP.CSHKl/;RFLTPHSCP.-MLFLL/:TGLSWSFAr>31K5DSSTi'0VlVIJLTICEUJ3m'ILSSHFG'.'JAVETF;LYPVATOlLSLGFLTrSHFFDALGI;3AVSTAGF^'GGRYVLCS^.'VGACAFA 12C 
VP.238S .L-GKC.TAGCCSQLL.L.CIVPSCr/ALVS.!I. .SG.ll-L.L L AIIK.D C. .IF. .L.. .V.Y.A L.T/. .VT H S.M.AV. .L. 118 
LV AFVCF'.'IPJ^KilCMACRVARTRFT!IFIVDDRaRVHRWKSPIV^/EK.ty3KAE*.'D3MLVTIKHWLEGVKAQPLTRTSAE*i'.*Oi- 201 
VR2385 .LI L SW. .SC. .Y. . .LL.TK. .LY. .R. .VII. .R. .V. .E.H.IDL.R.. .D.SA.T.V. .V SRP 200 
B (0RF6) 
LV M-GGLDDFOlIDPIAA0KLVLAFSiriTPIHIYALKVSP.GRLL<3LLHILIFL!frSFTFGYMrA^HF<?ST!JRVALTLGAWALLW3WSFTES'.-.'KFITSRCRLCCLGRRYILAPAHH^.'ESAA 115 
VR2385 .ESS H.ST.P. .VL V L.V A F K M AI .T L. . .K 120 
LV GLHSISASGrJPAYAVRKPGLTS^.aiGTLVPGLRSLVL/^KRAVKRGWnLVK.iGRR 174 
VR2385 .F.P.A.riD.HAr/. .R. .S T K RK. . .Q AK- 174 
C (0RF7) 
LV H---AGKI>2SyKKKKSTAPM31^3';-P^/IJ-5I>:QLLGAMIKS<2RQ---vPRG3vAKKKKPEKPHFPLAAEDDIRHHL'IVTERSLCLv3rvTAFrJ;<;AGTASLSSSGIO,'£iFQVEFMLPVAH'I\'R U4 
VR2385 .PMllT. .Q.KR. --.D M. .KI .AH.».SRGKG. .KKII. . .11 T. . .V. . ,F. PS. .Q. .. S CT. .D. .RI .<i'T. . .S . .TO 113 
LV LIP.^/T3TSA&;-GASS 129 
VR2385 A SP.A 123 
Figure 1. Alignment of the deduced amino acid sequences of ORF 5 (A), ORF 6 (B) and ORF 7 (0) 
of LV and PRRSV VR 2385. LV sequence was shown on top, and only differences were indicated in 
VR 2385. Deletions were indicated by (-). The LV sequences used in this alignment are based on 
the sequence data presented by Meulenberg et al. (1993a). 
78 
VR2385 TGGGCTGGCATTCTTGAGGCATCCCAGTGTTTGAATTGGA 40 
LV TT 2 
VR2385 AGAATGCGTGGTGAATGGCACTGATTGACATTGTGCCTCT 80 
LV T..CA.TCA CGC G.G.GTG 42 
VR2 385 AAGTCACCTATTCAATTAGGGCGACCGTGTGGGGGTAAGA 120 
LV G T.ACA C.T. 82 
VR2 385 TTTAATT-GGCGAGAACCACACGGCCGAAATT 151 
LV C CA...AG TGT.A 114 
Figure 2. Nucleotide sequence alignment of the 3' non-coding region 
(NCR) of PRRSV VR 2385 and LV. The VR2385 sequence was shown on 
top, and only differences in LV was indicated. Nucleotide deletions were 
indicated by (-). The 3' NCR of LV was reported by Meulenberg et ai, 
(1993a). 
Figure 3. Northern blot analysis of the total intracellular RNAs from PRRSV 
VR 2385 virus-infected CRL 11171 cells. The RNAs were isolated 
at 24 hrs postinfection and separated on a 1 % glyoxal-DMSO 
agarose gel. The blot was hybridized with a 32p-iabeled cDNA 
probe generated by PGR from the extreme 3' end of the VR 2385 
genome. The RNA numbered 1 represents the viral genome and 
the other six subgenomic mRNAs are numbered from 2 to 7 
according to their sizes. PRRSV subgenomic mRNAs from mock-
infected CRL 11171 cells were not detected (data not shown). 
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Abstract 
The putative membrane (M) protein (ORF 6) and nucleocapsid (N) protein 
(ORF 7) genes of five U.S. isolates of porcine reproductive and respiratory 
syndrome virus (PRRSV) with differing virulence were cloned and sequenced. To 
determine the genetic variation and the phylogenetic relationship of PRRSV, the 
deduced amino acid sequences of the putative M and N proteins from these 
isolates were aligned, to the extent known, with other PRRSV isolates, and also 
other members of the proposed arterivirus group including lactate dehydrogenase-
elevating virus (LDV) and equine arteritis virus (EAV). There was 96-100% amino 
acid sequence identity in the putative M and N genes among U.S. and Canadian 
PRRSV isolates with differing virulence. However, their amino acid sequences 
varied extensively from those of European PRRSV isolates, and displayed only 57-
59% and 78-81% identity, respectively. The phylogenetic trees constructed on the 
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basis of the putative l\/l and N genes of the proposed arterivirus group were similar 
and indicated that both U.S. and European PRRSV isolates were related to LDV 
and were distantly related to EAV. The U.S. and European PRRSV isolates fell into 
two distinct groups, suggesting that U.S. and European PRRSV isolates represent 
two distinct genotypes. 
Brief Report 
Porcine reproductive and respiratory syndrome (PRRS) has been 
devastating the swine industry in North America since 1987 and in Europe since 
1990 [9, 23, 32]. The causative agent of the syndrome, the porcine reproductive 
and respiratory syndrome virus (PRRSV), has been isolated and characterized [3, 
4, 30]. Both U.S. and European PRRSV isolates are tentatively classified as 
members of the newly proposed arterivirus group, which includes lactate 
dehydrogenase-elevating virus (LDV), equine arteritis virus (EAV) and simian 
hemorrhagic fever virus (SHFV) [5,18, 20, 24]. These positive-strand RNA viruses 
resemble togaviruses morphologically but are distantly related to coronaviruses 
and toroviruses on the basis of genome organization and gene expression [15, 24, 
25, 26, 28]. The members of this group infect macrophages and contain a nested 
set of 6 to 7 subgenomic mRNAs in infected cells [5,6, 8,13,14,18, 20, 21, 24]. 
However, no serological cross-reaction has been found among PRRSV, LDV and 
EAV [9]. The PRRSV is a positive-strand RNA vims with a genome of ^out 15 kb 
that contains eight open reading frames (ORFs) [20]. ORFs la and lb are 
predicted to encode viral RNA polymerase, whereas ORFs 2 to 6 probably encode 
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viral membrane-associated (envelope) proteins. The ORF 6 is predicted to encode 
the membrane (M) protein based on its similar characteristics with the ORF 6 of 
EAV and LDV, and the M protein of mouse hepatitis virus and infectious bronchitis 
virus [5,18, 20]. The product of ORF 7 is extremely basic and hydrophilic, and is 
predicted to be the viral nucleocapsid (N) protein [5,17,18, 20]. 
Although the syndrome caused by PRRSV appears to be similar in the 
U.S.A. and Europe, several recent studies have described phenotypic, antigenic, 
genetic and pathogenic variations among PRRSV isolates in the U.S. and in 
Europe [1, 2,18, 27, 31]. The European isolates grow preferentially in swine 
alveolar macrophage (SAM) cultures and replicate to a very low titer in other 
culture systems [30, 31, 32]. The U.S. isolates replicate well in SAM as well as in 
three continuous cell lines, CL2621, MARC-145 and CRL 11171 [3, 4,11, 18]. 
Phenotypic differences among U.S. isolates were also observed as not all PRRSV 
isolates isolated on SAM can replicate on CL2621 cell line [1] and some isolates 
show delayed onset of the cytopathic effect in infected cells [2, Meng and Paul, 
unpublished observation]. A high degree of antigenic variation among PRRSV 
isolates was also reported, four European isolates resembled each other closely, 
but differed from the U.S. isolates, whereas three U.S. isolates differed 
antigenically from each other [31]. Animals seropositive for European isolates 
were found to be seronegative for U.S. isolate VR 2332 [2]. The genetic differences 
between U.S. and European isolates are striking, especially as they are 
considered to be the same virus [18]. The amino acid sequence identity of ORFs 5, 
6 and 7 between U.S. isolate VR 2385 and the European isolate Leiystad virus 
(LV) is only 54%, 78% and 58%, respectively [18]. Similar observations were also 
reported when comparing the ORF 7 of a Canadian isolate IAF-exp91 and another 
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U.S. isolate VR 2332 with LV [17, 22]. However, tiie 3' terminal 5 kb nucleotide 
sequences of two European isolates [5, 20] and portion of the N genes from seven 
Spanish PRRSV isolates [29] are almost identical. The existence of apathogenic or 
low-pathogenic strains has been suggested among isolates [27]. The U.S. isolate 
VR 2385 is highly pathogenic compared to European LV, and differences in 
pathogenicity among U.S. isolates were also observed [Halbur, Paul, Meng and 
Lum, unpubl. obs.]. These studies suggest that the PRRSV isolates in North 
America and in Europe are antigenically and genetically heterogeneous, and that 
different genotypes or serotypes of PRRSV may exist. 
To further determine the genetic variation and the phylogenetic relationship 
of PRRSV, the putative M and N genes of five additional U.S. PRRSV isolates with 
differing virulence were cloned and sequenced. Phylogenetic trees based on the 
putative M and N genes of seven U.S. PRRSV isolates (six Iowa isolates and one 
Minnesota isolate), one Canadian PRRSV isolate, two European PRRSV isolates 
and other members of the proposed arterivirus group, including LDV and EAV, 
were constructed. The PRRSV isolates used in this study, designated as VR 2385 
[18], ISU-22, ISU-55, ISU-79, ISU-1894 and ISU-3927, were isolated from pig 
lungs obtained from different farms in Iowa during PRRS outbreaks. A continuous 
cell line, ATCC CRL 11171, was used to isolate and propagate these viruses. All 
viruses used in this study were biologically cloned by three rounds of plaque 
purification. Pathogenicity studies in caesarean-derived colostrum-deprived 
(CDCD) pigs showed that VR 2385, ISU-22 and ISU-79 were highly pathogenic 
and produced from 50 to 80% consolidation of the lung tissues in experimentally-
infected five-week-old CDCD pigs necropsied at 10 days post inoculation, whereas 
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ISU-55, ISU-1894 and ISU-3927 were low-pathogenic and produced only 10 to 
25% consolidation of lung tissues [Halbur, Paul, Meng and Lum, unpubl. obs.]. 
Monolayers of ATCC CRL 11171 cells were infected with different PRRSV 
isolates at the seventh passage at a m.o.i. of 0.1. Total intracellular RNA was 
isolated from infected cells by a guanidinium isothiocyanate method (Stratagene). 
The quality of RNA from each isolate was determined by Northern blot hybridization 
(data not shown) with a cDNA probe generated from the extreme 3' end of VR 2385 
isolate [18]. cDNA was synthesized from total intracellular RNA by reverse 
transcriptase using random primers and amplified by polymerase chain reaction 
(PGR) as described previously [19]. Primers for RT-PCR were designed on the 
basis of VR 2385 sequence which amplified the entire protein coding regions of the 
M and N genes (5' primer: 5' GGGGATCCAGAGTTTCAGCGG 3'; 3' primer: 5'GGG 
AATTCACCACGCATTC 3'). Unique restriction sites (EcoR 1 and BamH I) at the 
termini of the PGR products were introduced. A PGR product with the expected 
size of about 900 bp was obtained from all virus isolates (Fig. 1A). Southern blot 
hybridization was then used to confirm the specificity of the amplified products. The 
32p-iabeled cDNA probe from VR 2385 hybridized with the RT-PGR products from 
all virus isolates (Fig. IB). The PGR products of the M and N genes from all PRRSV 
isolates were then digested with EcoR I and BamH 1, purified and cloned into vector 
pSK+ [19]. Plasmids containing the full length M and N genes were sequenced 
with an automated DNA Sequencer (Applied Biosystem, Inc.). Three to four cDNA 
clones from each virus isolate were sequenced with universal and reverse primers 
as well as other virus-specific sequencing primers (PP288:5'GGGGTGTGGATTG 
AGGAG 3'; PP289: 5' GAGTGGTAGGGGTTGTGG 3'; DP968:5'AATGGGGGTTGTG 
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CGG 3'). The sequences were combined and analyzed by MacVector 
(International Biotechnologies, Inc) and GeneWorks (IntelliGenetics, Inc.) computer 
programs. Phylogenetic analyses were conducted with the aid of the PAUP 
software package version 3.1.1 (David L. Swofford, Illinois Natural History Survey, 
Champaign, IL). PAUP employs the maximum parsimony algorithm to construct 
phylogenetic trees. The nucleotide sequence data reported in this paper have 
been deposited with GenBank database under the accession numbers U18748 
(ISU-1894), U18749 (ISU-22), U18750 (ISU-3927), U18751 (ISU-55) and U18752 
(ISU-79). 
Analysis of the nucleotide sequences encoding the putative M and N 
proteins of the five U.S. PRRSV isolates indicated that, like LV [20] and VR 2385 
[18], the M and N genes of all the five U.S. isolates overlapped by 8 base pairs (bp) 
(Fig. 2). The AACC motif located 13 nucleotides upstream of the N gene is 
believed to be the leader-body junction site for subgenomic RNA 7 during PRRSV 
transcription [18, 21]. Numerous substitutions in the nucleotide sequence were 
distributed randomly throughout the M and N genes in all the five isolates when 
compared to VR 2385 (Fig. 2). There is no correlation between the virus virulence 
and the genetic variation in the M and N genes among these U.S. isolates 
analyzed. Most of the substitutions are third base silent mutations when converted 
to amino acid sequences (Fig. 3). Insertions and deletions were found in the 
nucleotide sequences of the M and N genes between the U.S. isolates and LV, but 
not among the U.S. isolates (Fig. 2). The deduced amino acid sequences of the M 
and N genes from the five U.S. PRRSV isolates were then aligned with the 
corresponding sequences of two other U.S. isolates, Minnesota isolate VR 2332 
[22, only N gene] and Iowa isolate VR 2385 [18], one Canadian PRRSV isolate lAF-
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exp91 [17, only N gene], two European PRRSV isolates, LV [20] and PRRSV 
isolate 10 (PRRSV-10) [5], two LDV strains, LDV-C [7] and LDV-P [14], and EAV [6] 
(Fig. 3). The amino acid sequence of the N gene among the eight North American 
PRRSV isolates were highly conserved (Fig. 3b), and displayed 96-100% amino 
acid sequence identity (Table 1). However, the N protein of ail North American 
PRRSV isolates shared only 57-59% amino acid sequence identity with that of the 
two European isolates when the inserted amino acids of the European isolates 
were included in the alignment (Table 1), suggesting that the North American and 
the European isolates may represent two different genotypes. The M protein of all 
the U.S. isolates with varying virulence was also highly conserved, and displayed 
higher sequence similarity with the M proteins of the two European isolates (Fig. 
3a), ranging from 78 to 81% amino acid identity (Table 1). The N gene of all the 
North American PRRSV isolates shared 49-50% amino acid sequence identity with 
that of the two LDV strains, whereas the two European PRRSV isolates shared only 
40-41% amino acid identity with that of the LDV strains when the inserted amino 
acids of the European PRRSV isolates were included (Table 1). Two regions of 
amino acid sequence insertions, "KKSTAPM" and "ASQG", were found in the N 
protein of the two European PRRSV isolates when compared to the eight North 
American PRRSV isolates as well as two LDV strains and EAV(Fig. 3b). These 
results indicated that the U.S. PRRSV isolates were more closely related to LDV 
than were the European PRRSV isolates, and that PRRSV may have undergone 
divergent evolution in the U.S. and in Europe before their association with PRRS 
was recognized in swine [22]. The M and N genes of the North American and 
European PRRSV isolates shared only 15-17% and 22-24% amino acid sequence 
identity with those of EAV, respectively. 
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The sequence homology of PRRSV with LDV and EAV suggests that these 
viruses are closely related and may have evolved from a common ancestor [22, 
24]. The evolutionary relationships of PRRSV with other members of the proposed 
arterivirus group were determined on the basis of the amino acid sequence of the 
M and N genes. Bootstrapped parsimony (1000 replicates) with branch-and-bound 
search option were performed to find the tree with shortest length (most 
parsimonious). The trees were rooted by assuming EAV as the outgroup for the N 
genes and LDV as the outgroup for the M genes. The phylogenetic tree drawn for 
the N gene is essentially the same as that drawn for the M gene (Fig. 4). The 
PRRSV isolates fall into two distinct groups. All the North American PRRSV 
isolates thus far sequenced are closely related and formed one group. The two 
European PRRSV isolates are closely related and comprised another group. 
Recently, portion of the N gene from seven Spanish PRRSV isolates has been 
determined, and displayed 96-97% sequence homology with the corresponding 
region of LV [29]. This again indicates that the European PRRSV isolates are 
highly conserved. Both the U.S. and European PRRSV isolates are related to LDV 
strains and distantly related to EAV (Fig. 4). The North American and European 
PRRSV isolates represent two distinct genotypes (Fig. 4). 
A striking feature of RNA viruses is their rapid evolution resulting in 
extensive sequence variation [12]. Direct evidence for recombination between 
different positive-strand RNA viruses has been obtained [16]. Western equine 
encephalitis virus appears to be an evolutionarily recent hybrid between Eastern 
equine encephalitis virus and another alphavirus closely related to Sindbis virus 
[10]. Thus, the emergence of PRRSV and its close relatedness to LDV and EAV is 
not surprising. Although the capsid or nucleocapsid protein has been used for 
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construction of evolutionary trees of many positive-strand RNA vinjses, proteins 
with conserved sequence motifs such as a RNA-dependent RNA polymerase or a 
RNA replicase, would be more suitable for phylogenetic studies [12]. Further 
sequence information of both North American and European PRRSV isolates 
would facilitate the evolutionary studies of PRRSV. 
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Figure 1. Reverse transcription-polymerase chain reaction (RT-PCR) amplification of the putative M and N 
genes of six U. S. isolates of PRRSV with differing pathogenicity (A). A PGR product with the 
expected size of about 900 bp was amplified from all six virus isolates, VR2385 (Lane 1), ISU22 
(Lane 2), ISU55 (Lane 3), ISLI79 (Lane 4), ISLI1894 (Lane 5) and ISU3927 (Lane 6). Southern 
blot hybridization with a 32p.|abeled cDNA probe generated from the extreme 3' end of VR2385 
viral genome was used to confirm the specificity of the amplified PGR products (B). 
B 
Figure 2. Comparison of the nucleotide sequences of the putative M (ORF 6) and N (ORF 7) genes of the LV 
and the six U.S. PRRSV isolates with varying virulence. The VR 2385 nucleotide sequence is 
showed on top, and only differences are indicated. The start codons are indicated by (+ 1>), and 
the termination codons are indicated by asterisks (*). Deletions are indicated by (-), and the two 
larger insertions in the N gene of LV are indicated by C^). The leader-body junction site motif, 
AACC, upstream of N gene is underlined. 
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Figure 2. (continued). 
Figure 3. Alignment of amino acid sequences of tlie M (a) and N (b) genes of the proposed arterivirus group. 
The EAV M gene sequence was omitted because the relatively low sequence identity with PRRSV 
and LDV requires gaps in the alignments. The M gene sequences of U.S. PRRSV isolate VR 2332 
and Canadian isolate IAF-exp91 are not available. VR 2385 sequences are shown on top, and 
only differences are indicated. Deletions are indicated by (-), and the two larger insertions in the N 
gene of the European PRRSV isolates are indicated by C^). The alignments were performed with a 
GeneWorks program (IntelliGenetics, Inc.). The following parameters (default value) were used. 
Cost to open a gap is 5, cost to lengthen a gap is 25, minimum diagonal length is 4, and the 
maximum diagonal offset is 10. 
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Figure 4. Phylogenetic trees based on the amino acid sequences of the M (a) 
and N (b) genes of the proposed arterivirus group. The trees were 
constructed by maximum parsimony methods with the aid of the PAUP 
software package version 3.1.1. The trees with the shortest length 
(most parsimonious) were found by implementing the bootstrap (1000 
replicates) with branch-and-bound search option. The trees were 
rooted by assuming EAV as the outgroup for the N genes and LDV as 
the outgroup for the M gene. The branch lengths (number of amino 
acid substitutions) are given above each branch. 
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MOLECULAR CHARACTERIZATION OF THE SUBGENOMIC RNAS OF PORCINE 
REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS (PRRSV) 
A paper submitted to the Journal of Virology 
Xiang-JIn Meng, Prem S. Paul, Igor Morozov and Patrick G. Halbur 
Abstract 
During the replication of porcine reproductive and respiratory syndrome 
virus (PRRSV), six subgenomic mRNAs (sg mRNA), in addition to the genomic 
RNA, are synthesized. These sg mRNAs were characterized in this study. The sg 
mRNAs of PRRSV were found to form a 3'-coterminal nested set in PRRSV-infected 
cells. Each of these sg mRNAs was polycistronic and contained multiple open 
reading frames (ORF) except for the smallest sg mRNA 7 as shown by Northern blot 
analysis using ORF-specific probes. The sg mRNAs were not packaged into the 
virions, and only the genomic RNA was detected in purified virions, suggesting that 
the encapsidatlon signal of PRRSV is likely localized in the ORF 1 region. The 
numbers of sg mRNAs in PRRSV-infected cells varied from six to seven among 
PRRSV isolates with differing vimlence. The additional species of sg mRNA in 
some isolates of PRRSV was shown to be derived from the sequence upstream of 
ORF 4, and was designated as sg mRNA 4-1. The leader-mRNA junction 
sequences of sg mRNAs 3 and 4 of isolates ISU79 and ISU1894 as well as sg 
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mRNA 4-1 of the isolate 1SU79 were determined to contain a common six 
nucleotide sequence motif, T(G)TA(G/C)ACC. ORFs 2 to 5 of two U.S. isolates, 
ISU79 and ISU1894 with and without the additional species of sg mRNA 4-1, 
respectively, were cloned and sequenced. Sequence analysis of the genomic 
RNA of the two U.S. isolates and their comparison with the European isolate 
Leiystad virus (LV) revealed heterogeneity of the leader-mRNA junction sequences 
among PRRSV isolates. The numbers, locations and sequences of the leader-
mRNA junction motifs varied between U.S. isolates and the European LV as well 
as among U.S. isolates. The last three nucleotides, ACC, of the leader-mRNA 
junction sequences were invariable, and variations were found in the first three 
nucleotides. By comparing the 5'-terminal sequence of sg mRNA 4-1 with the 
genomic sequence of ISU79 and ISU1894, it was found that a single nucleotide 
substitution, from T in isolate ISU1894to C in isolate ISU79, led to the acquisition 
of a new leader-mRNA junction sequence TTGACC in isolate ISU79, and therefore 
an additional species of sg mRNA 4-1. A small ORF (ORF 4-1) with a coding 
capacity of 45 amino acids was identified at the 5'-end of the additional species of 
sg mRNA 4-1. 
Introduction 
Porcine reproductive and respiratory syndrome virus (PRRSV) is a member 
of the newly proposed Arteriviridae family Including equine arteritis vinjs (EAV), 
lactate dehydrogenase-elevating virus (LDV) and simian hemorrhagic fever virus 
(SHFV) (5, 8, 22, 24, 25, 26, 27,31). This group of single plus-stranded RNA 
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viruses shares many properties such as morphology, macrophage cell tropism and 
genome organization (24, 26, 31). The genome organization of arteriviruses 
resembles coronaviruses and torovimses in that their replication involves the 
formation of a 3'-coterminal nested set of subgenomic mRNAs (sg mRNA) (6, 7,17, 
24, 31, 37, 39). Subclinical infections and persistent viremia with concurrent 
antibody production are also the characteristic properties of the arteriviruses (9, 
31). 
PRRSV was first isolated in Europe in 1991 (44) and then in the U.S. in 1992 
(4). As indicated by the name, PRRSV causes reproductive failure in female pigs 
and respiratory diseases in nursery pigs (3,19). Antigenic, genetic and pathogenic 
variations between U.S. PRRSV and European PRRSV as well as among U.S. 
PRRSV isolates have been demonstrated (10,11, 25, 26, 29,45). The U.S. 
PRRSV and European PRRSV represent two distinct genotypes (25). The 
complete nucleotide sequence of the LV genome and partial sequences of U.S. 
PRRSV isolates and other European PRRSV isolates have been determined (5, 22, 
24, 25, 26, 29, 40). The genome of PRRSV is polyadenylated and about 15 kb in 
length (24, 26.). Eight overlapping open reading frames (ORFs) were identified in 
LV (26). However, ORFs 4 and 5 of a U.S. PRRSV isolate VR2385 do not overlap 
and are separated by 10 nucleotides (29). ORFs la and 1b are predicted to 
translate into a single protein, which is the viral RNA polymerase by the mechanism 
of frameshifting (26). ORFs 2 to 4 might encode tor the viral membrane-associated 
proteins (5, 22, 24, 25,26, 29), and ORFs 5 to 7 encode for the major envelope 
protein (E), matrix protein (M) and nucleocapsid protein (N), respectively (28). 
In cells infected with PRRSV, seven species of virus-specific mRNAs 
representing a 3'-coterminal nested set are synthesized (5, 24, 26). These mRNAs 
105 
are named mRNAs 1 to 7, according to decreasing order of size, and tlie mRNA 1 
represents the genomic RNA. Each of the sg mRNAs contains a leader sequence, 
which is derived from the 5' end of the viral genome (26, 27, 30). Sequence 
analysis of the sg mRNAs of LDV and EAV indicates that the leader-mRNA junction 
motif is conserved (1, 7). Recently, the leader-mRNA junction sequences of the 
European LV were also shown to contain a common sequence motif, UCAACC, or 
a highly similar sequence (27). The sg mRNAs of LDV and EAV have been 
characterized in detail (1, 2, 7,15, 16, 31, 41). However, information regarding the 
sg mRNAs of PRRSV, especially the U.S. PRRSV, is very limited. In this paper, we 
report the molecular characterization of the sg mRNAs of U.S. PRRSV. 
Materials and Methods 
Viruses and cells 
The PRRSV isolates used in this study, designated as ISU22, ISU55, ISU79, 
ISU1894 and ISU3927, were isolated from pig lungs obtained from different farms 
in Iowa. A continuous cell line, ATCC CRL11171, was used for isolation and 
growth of viruses. These PRRSV isolates were biologically cloned by three rounds 
of plaque purification and grown on the CRL11171 cells. All of the vims isolates 
used in this study were at the seventh passage. Pathogenicity studies showed 
differences in virulence among these five isolates of PRRSV (10,11). The ISU22 
and ISU79 isolates were highly pathogenic and produced from 50 to 80% 
consolidation of the lung in experimentally-infected five-week-old caesarean-
derived colostrum-deprived pigs necropsied at 10 days post inoculation, whereas 
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the ISU55, ISU1894 and ISU3927 isolates were of low-pathogenicity and 
produced only 10 to 25% consolidation of lung in the same experiment (10, 11). 
Preparation of virus-specific total intracellular RNAs, poly (A)+ RNA and virion RNA 
Confluent monolayers of CRL11171 cells were infected with different 
isolates of PRRSV at the seventh passage at a multiplicity of infection (m. o. i.) of 
0.1. PRRSV-specific total intracellular RNAs were isolated from PRRSV-infected 
cells by a guanidinium isothiocyanate method (Stratagene) as described 
previously (24). The poly (A)+ RNA was enriched from the total intracellular RNAs 
by oligo (dT)-cellulose column chromatography (Invitrogen). For isolation of 
PRRSV virion RNA, confluent CRL11171 cells were infected with isolate ISU3927 
of PRRSV at a m. o. i. of 0.1. When more than 70% of the infected cells showed 
cytopathic effect, the cultures were frozen and thawed three times, and the culture 
medium was clarified at 1,200 X g for 20 min. at 4°C. The virus was then 
precipitated by polyethylene glycol and subsequently purified by cesium chloride 
gradient as described previously (24). The purified virus was treated with RNase A 
at a final concentration of 20 mg/ml for 90 min. at 37°C (36). The virus was then 
pelleted, and the virion RNA was isolated as described previously (24). 
cDNA synthesis and polymerase chain reaction 
cDNA was synthesized from total intracellular RNAs by reverse transcription 
using random primers and amplified by polymerase chain reaction (RT-PCR) as 
described previously (23). 
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Northern blot analyses 
Ten mg of total intracellular RNAs from virus-infected cells and mock-
infected cells were used per lane in a formaldehyde-agarose gel. For separation of 
poly (A)+ RNA and virion RNA, fifteen ng of virion RNA and 0.2 mg of poly (A)+ RNA 
were loaded per lane. The RNA was denatured with formaldehyde according to 
the method described elsewhere (33). Electrophoretic separation of RNA, RNA 
blotting and hybridization were performed as described previously (24). In some 
experiments, glyoxal-DMSO agarose gels were also performed as described 
previously (24). For preparation of probes, a specific cDNA fragment from each of 
ORFs lb to 7 was generated by RT-PCR with ORF-specific primers. The primers 
were designed in such a way that each primer pair will only amplify a specific 
fragment of a given ORF, and the overlapping regions between neighboring ORFs 
were not included in any given cDNA probe. The primer pairs for generating cDNA 
probes representing ORFs lb through 7 are 1M729 and IM782 for ORF lb, IM312 
and IM313 for ORF 2, XM1022 and IM258 for ORF 3, XM1024 and XM1023 for ORF 
4, PP287 and PP286 for ORF 5, PP289 and XM780 for ORF 6, and PP285 and 
PP284 for ORF 7 and the 3' noncoding region (Table 1). 
Cloning, sequencing and nucleotide sequence analyses 
Primers for RT-PCR were designed on the basis of PRRSV isolate VR2385 
sequences which amplified the protein coding regions of ORFs 2 to 5 of PRRSV 
isolates 1SU79 and 1SU1894 (24, 29). Primers JM259 and JM260 amplified ORFs 
4 and 5, and primers XM992 and XM993 amplified ORFs 2 and 3 (Table 1). 
Unique restriction sites (EcoR I and BamH I) at the 5'-termini of the primers were 
introduced. The PGR products of ORFs 2, 3 and ORFs 4,5 of ISU79 and ISU1894 
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were each digested witii EcoRI and BamHI, purified and cloned into vector pSK+ 
as described previously (23). Plasmids containing viral inserts were sequenced 
with an automated DNA Sequencer (Applied Biosystem, Inc.). At least three cDNA 
clones representing the entire sequence of ORFs 2 to 5 from each virus isolate 
were sequenced with universal and reverse primers as well as other virus-specific 
sequencing primers (XM969, XM970, XM1006, XM078 and XM077) (Table 1). 
To determine the leader-mRNA junction sequences of sg mRNAs 3, 4 and 4-
1, primer pair IM755 and DP586 (Table 1) was used for RT-PCR to amplify the 5'-
terminal sequences of these sg mRNAs. The resulting PGR products were purified 
and sequenced by direct PGR sequencing using virus-specific primers XM077 and 
XM141 (Table 1). The sequences were combined and analyzed by MacVector 
(International Biotechnologies Inc) and GeneWorks (IntelliGenetics, Inc) computer 
software programs. 
Oligonucleotides 
The synthetic oligonucleotides used in this study were summarized in Table 
1. These oligonucleotides were synthesized as single-stranded DNA using an 
automated DNA synthesizer (Applied Biosystem) and purified by high pressure 
liquid chromatography (HPLG). 
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Results 
Sg mRNAs are not packaged into PRRSV virion 
The sg mRNAs have been shown to be packaged into the virions in some 
coronaviruses, such as bovine coronavirus (BCV) (12) and transmissible 
gastroenteritis virus (TGEV) (36). However, only trace amounts of the sg mRNAs 
were detected in purified virions of mouse hepatitis virus (MHV), another 
coronavirus (17, 46). The sg mRNAs of LDV, a closely related member of PRRSV, 
are also not packaged in the virions, and only the genomic RNA was detected in 
the purified LDV virions (2). To determine whether the sg mRNAs of PRRSV are 
packaged, virions of PRRSV isolate ISU3927 were purified by CsCI gradient. The 
purified virions were treated with RNase A before pelleting virion and extraction of 
RNA to remove any RNA species which may adhere to the virion surface. RNAs 
from RNase A-treated virions along with the total intracellular RNAs from isolate 
ISU3927 of PRRSV-infected cells were separated in a formaldehyde gel and 
hybridized with a probe generated from the 3'-terminal sequence of the viral 
genome by PGR with primers PP284 and PP285 (Table 1). Only the genomic RNA 
was detected in the purified virions of PRRSV isolate ISU3927 (Fig. 1), and no 
detectable amounts of sg mRNAs were observed in the purified virions even after 3 
weeks exposure (data not shown). In contrast, seven species of sg mRNAs, in 
addition to the genomic RNA, were detected in the isolate ISU3927 of PRRSV-
infected cells (Fig. 1). Similar results were observed with two other U.S. isolates, 
ISU55 and ISU79 (data not shown). 
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Variation in the numbers of the sg mRNAs among U.S. PRRSV isolates with 
differing virulence 
All arteriviruses including U.S. PRRSV and European PRRSV liave been 
shown to produce six sg mRNAs (1, 5, 7, 24, 26, 31, 41), except for tlie tfiree LDV 
variants (LDV-P, LDV-a and LDV-v), which synthesize seven sg mRNAs (15,16, 
31). However, a nested set of six sg mRNAs is produced in the LDV-C strain (31). 
To compare if there are any variations in the sg mRNAs among U.S. PRRSV 
isolates, confluent monolayers of CRL11171 cells were infected with five different 
isolates of U.S. PRRSV with differing virulence (10,11) all at a m. o. i. of 0.1. Total 
intracellular RNAs were isolated from virus-infected cells at 24 hrs postinfection. A 
cDNA fragment was generated from the extreme 3' end of the viral genome by PGR 
with primers PP284 and PP285 (Table 1). The cDNA fragment was labeled with 
32p-clCTP by random primer extension method (24) and hybridized with the total 
intracellular RNAs separated on a formaldehyde gel. Analyses of RNAs showed 
that a nested set of six or seven sg mRNAs, in addition to the genomic RNA, was 
present in cells infected with these five isolates of U.S. PRRSV with differing 
virulence (Fig. 2). Similar results were obtained when the total intracellular RNAs 
were separated on a Glyoxal-DMSO agarose gel (data not shown). PRRSV 
isolates 1SU55, ISU79 and ISU3927 produced seven sg mRNAs, whereas isolates 
1SU22 and 1SU1894 only produced six sg mRNAs (Fig. 2). The U. S. isolate 
VR2385 of PRRSV was also shown to produce six sg mRNAs (24). The additional 
species of sg mRNA was located between sg mRNAs 3 and 4, and was designated 
as sg mRNA 4-1 because it was found to be generated from the sequence 
upstream of ORF 4 (see below). The sg mRNAs differed little, if any, in size among 
these five isolates of PRRSV (Fig. 2). Whether this observed difference in the 
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numbers of sg nnRNAs among U.S. isolates of PRRSV is related to any specific 
properties of these isolates is not known yet. There was no correlation, however, 
between the pneumovirulence and the numbers of the sg mRNAs observed in 
these five isolates. 
The sg mRNA 4-1 is neither a defective-interfering RNA nor is due to the 
nonspecific binding of the probes to the abundant ribosomai RNAs 
It has been shown that, in coronavinjses, a variety of defective-interfering 
RNA (Dl RNA) of different sizes were generated when MHV was serially passaged 
in tissue culture at a high m. o. i. (18,19, 20, 42). Dl RNAs were also observed in 
cells infected with torovirus during undiluted passage (38). Therefore, the 
possibility of sg mRNA 4-1 of PRRSV observed in this study being a Dl RNA 
needed serious consideration. To exclude this possibility, the original virus stock of 
PRRSV isolate ISU79, which produces the additional species of sg mRNA 4-1, was 
passaged four times in CRL11171 cells at different m. o. i. of 0.1, 0.01 and 0.001. 
In a control experiment, four undiluted passages of the original virus stock of ISU79 
were performed. After four passages, total intracellular RNAs were isolated from 
virus-infected cells and Northern blot analysis was repeated with the same probe 
generated from the extreme 3' end of the viral genome. Analysis of the sg mRNAs 
showed that the additional species of sg mRNA 4-1 was still present in all RNA 
preparations with different m. o. i. as well as in RNA preparation from undiluted 
passages (Fig. 3A). Moreover, there was no interference or reduction in the 
synthesis of all other sg mRNAs in the presence of sg mRNA 4-1 as is usually the 
case with Dl RNA. It has been demonstrated that the Dl RNAs of MHV disappeared 
after two high-dilution passages (13). Therefore, if the original virus stock of ISU79 
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contained Dl RNA, then tine Dl RNA sfiouid disappear after 4 higli-dilution 
passages performed in this study. These data suggested that, unlike the Dl RNA, 
the replication of sg mRNA 4-1 is independent of the amount of standard virus, thus 
the sg mRNA 4-1 is not a Dl RNA. 
In Northern blot analysis of total intracellular RNAs, the probes may 
nonspecifically bind to the 18S and 28S ribosomal RNAs which are abundant In 
total cytoplasmic RNA preparations. Alternatively, the abundant ribosomal RNAs 
may cause retardation of virus-specific sg mRNAs which would co-migrate with 
ribosomal RNAs in the gel. Two additional bands caused by nonspecific binding of 
probes to ribosomal RNAs have been observed in LV-infected cells (26) as well as 
in LDV-infected cells (16). Therefore, it is possible that the sg mRNA 4-1 of PRRSV 
observed in this study is due to the nonspecific binding of probes to the ribosomal 
RNAs. To rule out this possibility, polyadenylated RNA was isolated from total 
intracellular RNAs of CRL11171 cells infected with two PRRSV isolates, ISU55 and 
iSU79, respectively. Both ISU55 and ISU79 isolates were shown to produce the 
additional species of sg mRNA 4-1 (Fig. 2). Northern blot analysis of the 
polyadenylated RNA showed that the additional species of sg mRNA 4-1 in cells 
infected with these two isolates was still present (Fig. 3B), indicating that the sg 
mRNA 4-1 is not due to the nonspecific binding of probes to the ribosomal RNAs. 
The sg mRNAs represent a 3'-coterminal nested set and the sg mRNA 4-1 is 
derived from the sequence upstream of ORF 4 
We have demonstrated that six sg mRNAs, in addition to the genomic RNA, 
were detected in cells infected with the U.S. isolate VR2385 of PRRSV using a 
cDNA probe from the extreme 3' end of the viral genome (24). This finding 
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indicated that, like Berne virus (BEV), LDV, EAV, coronaviruses, and European LV, 
the replication of U.S. PRRSV also requires the synthesis of a 3'-coterminal nested 
set of sg mRNAs (5, 7,15,16,26, 37, 41). To analyze these sg mRNAs in more 
detail, seven cDNA fragments specific for each of ORFs 1 b through 7 were 
amplified by PGR. The design of primers for PGR was based on the published 
sequence of a U.S. PRRSV isolate VR2385 (24, 25, 29). The sequences and 
locations of the primers are shown in Table 1. The primers were designed in such 
a way that each set of primers will only amplify a fragment from a particular ORF, 
and the overlapping sequences between neighboring ORFs were not included in 
any given fragment. Therefore, each of these seven DNA fragments represents 
only one particular ORF except for fragment 7 which represents both ORF 7 and the 
3' NGR. These seven DNA fragments were labeled with ^Sp-dGTP and hybridized 
to Northern blots of total intracellular RNAs extracted from cells infected with two 
U.S. isolates of PRRSV, ISU1894 and ISU79, respectively. Total intracellular 
RNAs isolated from mock-infected GRL11171 cells were included as a control. 
Northern blot analyses showed that probe 1 which was generated from ORF lb 
hybridized only with the genomic RNA, and probes 2 through 7 each hybridized 
with one more additional RNA species besides the genomic RNA (Fig. 4). The 
results indicated that a 3'-coterminal nested set of six (ISU1894) or seven (ISU79) 
sg mRNAs is formed in PRRSV-infected cells (Fig. 4A and 4B), with the smallest 3' 
terminal RNA (sg mRNA 7) encoding ORF 7. The sg mRNAs of U.S. PRRSV all 
contain the 3' end of the genomic RNA, but extend for various distances towards 
the 5'-end depending on the size of the given sg mRNA. 
The sg mRNA 4-1 of PRRSV isolate 1SU79 hybridized with probes 4 through 
7, but not with probes 1, 2 and 3 (Fig. 4B), suggesting that the sg mRNA 4-1 
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contains ORFs 4 tlirough 7 as well as the 3' NCR. Therefore, the sg mRNA 4-1 is 
generated from the sequence upstream of ORF 4. 
A single nucleotide substitution leads to the acquisition of the additional species of 
sg mRNA 4-1 
Our Northern blot hybridization data showed that the sg mRNA 4-1 is derived 
from the sequence upstream of ORF 4 (Fig. 4B). To determine the exact location 
and the leader-mRNA junction sequence of sg mRNA 4-1, a set of primers, IM755 
and DP586, were designed (Table 1). The forward primer IM755 was based on the 
3' end of the leader sequence of a PRRSV isolate VR2385 (30), and the reverse 
primer DP586 is located in the ORF 4 (Table 1). RT-PCR with primers IM755 and 
DP586 was performed using total intracellular RNAs isolated from cells infected 
with two U.S. isolates of PRRSV, ISU1894 and ISU79. ISU79 was shown to 
produce the sg mRNA 4-1, and ISU1894 did not (Fig. 2). A short PGR extension 
time with 30 seconds was applied to preferentially amplify the short fragments 
which represent the 5'-terminal sequences of the sg mRNAs 3, 4 and 4-1. Analysis 
of the RT-PCR products showed that two fragments with sizes of about 1.1 kb and 
0.45 kb were amplified from the total RNAs of the ISU1894 virus-infected cells (Fig. 
5A). These two fragments represent 5'-portions of the sg mRNAs 3 and 4, 
respectively. In addition to the two fragments observed in the isolate of ISU1894, a 
third fragment of about 0.6 kb which represents the 5'-portion of sg mRNA 4-1 was 
also amplified from total RNAs of cells infected with the isolate ISU79 (Fig. 5A). 
To determine the leader-mRNA junction sequences of sg mRNAs 3, 4 and 4-
1, the RT-PCR products of ISU79 and ISU1894 were purified from agarose gel by 
using a GENECLEAN kit (Bio 101, Inc.), and sequenced directly with an automated 
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DNA Sequencer (Applied Biosystem). The primers used for sequencing the 5'-end 
of these RT-PCR products, XM141 and XM077 (Table 1), were designed on the 
basis of the genomic sequence of ISU79 and ISU1894 (Fig. 6). The leader-mRNA 
junction sequence, in which the leader joins the mRNA body during the synthesis 
of the sg mRNAs, of the sg mRNAs 3,4 and 4-1 of the two U.S. isolates of PRRSV 
were determined by comparing the sequences of the 5'-end of the sg mRNAs and 
the genomic RNA of the two isolates (Fig. 5B). The leader-mRNA junction 
sequences of sg mRNAs 3 and 4 of ISU1894 and ISU79 were GUAACC located at 
89 nucleotides upstream of ORF 3 for sg mRNA 3 and UUCACC located at 10 
nucleotides upstream of ORF 4 for sg mRNA 4 (Rg. SB and Fig. 6). The leader-
mRNA junction sequence of sg mRNA 4-1 of ISU79 was UUGACC which was 
located at 236 nucleotides upstream of ORF 4 (Fig. 5B and 6). Sequence 
alignment of the genomic sequence of ISU79 and 1SU1894 showed that a single 
nucleotide substitution, from T in isolate ISU1894 to C in isolate ISU79, led to the 
acquisition of an additional leader-mRNA junction sequence, UUGACC. in PRRSV 
isolate ISU79 (Fig. 5B and 6), and therefore an additional species of sg mRNA 4-1 
(Fig. 2). In addition to the ORFs 4 to 7 which are contained in the sg mRNA 4, the 
sg mRNA 4-1 contains an additional small ORF (ORF 4-1) with a coding capacity of 
45 amino acids at the 5'-end of the sg mRNA 4-1 (Rg. 6). This small ORF 4-1 
stopped just one nucleotide before the start codon of ORF 4. Whether this ORF 4-1 
encodes any protein or whether it has any biological function remains to be 
studied. 
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Sequence analyses of the ORFs 2 to 7 of two U.S. isolates reveal heterogeneity of 
the leader-mRNA junction sequences 
ORFs 2 to 5 of two U.S. PRRSV isolates, ISU79 and ISU1894, were cloned 
and sequenced. ISU79 was shown to produce seven sg mRNAs, whereas 
ISU1894 produced six sg mRNAs (Fig. 2 and 4). At least three cDNA clones at any 
given region of the ORFs 2 to 5 were sequenced for each virus isolate with 
universal and reverse primers as well as virus-specific primers XM969, XM970, 
XM1006, XM078 and XM077 (Table 1). The sequences of ORFs 6 and 7 of 
ISU1894 and ISU79 have been reported previously (25.). Sequence analysis of 
these two isolates showed that ORFs 2 to 7 of ISU79 and ISU1894 overlap each 
other except that there is a 10 nucleotide noncoding region between ORFs 4 and 5. 
The same observation has also been reported for the U.S. isolate VR2385 (29). 
This is very unusual since all members of the proposed Arteriviridae family, 
including the European LV, contain overlapping ORFs (6, 8, 26). However, the 
ORFs of coronaviruses are separated by intergenic noncoding sequences (17, 39). 
Therefore, the U.S. PRRSV is somewhat similar to the coronaviruses in terms of the 
genomic organization in the ORFs 4 and 5 junction region. ORF 2 of ISU1894 was 
one amino acid longer than that of ISU79 (Fig. 6). The stop codon of ORF 2, TAG, 
was changed to TGG in ISU1894 immediately followed by a new stop codon of 
TGA in ISU1894 (Fig. 6). The size of other ORFs between ISU79 and ISU1894 
was identical (Fig. 6). There were no deletions or insertions in ORFs 2 to 7 of these 
two isolates. However, substitutions were present throughout ORFs 2 to 7 of 
isolates ISU79 and ISU1894 (Fig. 6). 
The numbers and locations of the determined or predicted leader-mRNA 
junction sequences varied between isolate ISU1894 and isolate ISU79 (Fig. 6). In 
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addition to the regular leader-nnRNA 4 junction sequence, TTCACC. at 10 
nucleotides upstream of the ORF 4, there was an additional leader-mRNA 4-1 
junction sequence TTGACC located at 236 nucleotides upstream of ORF 4 in the 
isolate ISU79 of PRRSV (Fig. 6). A single nucleotide substitution, from T in 
ISU1894 to C in ISU79, resulted in this additional leader-mRNA junction sequence 
in ISU79, and subsequently a new species of sg mRNA (Fig. 2 and 4). The leader-
mRNA junction sequences of sg mRNAs 4 and 4-1 were separated by 226 
nucleotides which correlated with the estimated sizes of the sg mRNAs 4 and 4-1 
observed in the Northern blot analysis (Fig. 2) and RT-PCR amplification (Fig. 5A). 
The leader-mRNA 3 junction sequences of ISU1894 and ISU79 were determined 
to be identical; it is GTAACC located at 89 nucleotides upstream of ORF 3. The 
predicted leader-mRNA junction sequences of sg mRNAs 2 and 6 of ISU1894 and 
ISU79 were also the same (Fig. 6). However, the predicted leader-mRNA 5 
junction sequence of 1SU1894 and ISU79 were different (Fig. 6). There were 3 
potential leader-mRNA 5 junction sequences for 1SU79, GCAACC. GAGACC. and 
TCGACC at 55,70 and 105 nucleotides upstream of ORF 5, respectively. Two 
potential leader-mRNA 5 junction sequences were also found in ISU1894, 
GAAACC and TCGACC at 70 and 105 nucleotides upstream of ORF 5, respectively 
(Fig. 6). The differences were due to the two nucleotide substitutions in the 
predicted leader-mRNA 5 junction sequences of these two isolates (Fig. 6). In 
addition to the leader-mRNA 7 junction sequence at the 15 nucleotides upstream of 
ORF 7, an additional leader-mRNA 7 junction sequence was found to be ATAACC 
located at 129 nucleotides upstream of ORF 7 of these two isolates (Fig. 6). 
However, the sg mRNA corresponding to this additional leader-mRNA 7 junction 
sequence was indistinguishable from the abundant sg mRNA 7 which showed a 
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widely-diffused band in the Northern blot (Fig. 2, 3 and 4). Further experiments are 
needed to confirm these predicted leader-mRNA junction sequences. Variations in 
the numbers and locations of the leader-mRNA junction sequences between the 
two U.S. isolates analyzed in this study and the European LV were also found by 
comparing the leader-mRNA junction sequences of LV with those of the two U. S. 
isolates iSU1894 and ISU79 (27). Taken together, these data indicate that the sg 
mRNAs of PRRSV are polymorphic, and the numbers and the exact sizes of the sg 
mRNAs depend on the particular PRRSV isolate analyzed. However, a nested set 
of six sg mRNAs most likely reflects the standard arterivirus genome organization 
and transcription. 
Discussion 
In this study, we characterized the sg mRNAs in PRRSV-infected cells. Our 
data showed that a 3'-coterminai nested set of six or seven sg mRNAs is formed in 
cells infected with different isolates of PRRSV. However, unlike some of the 
coronaviruses and alphavirus, the sg mRNAs of PRRSV are not packaged into the 
virion, and only the genomic RNA of PRRSV was detected in purified virions. 
Variations in the numbers of the sg mRNAs among different PRRSV isolates with 
differing virulence were also observed. Further sequence analysis of ORFs 2 to 7 
of two U.S. isolates and their comparison with the European LV reveal the 
heterogenic nature of the leader-mRNA junction sequences of PRRSV. 
In addition to the genomic RNA, many animal viruses produce one or more 
sg mRNA species to allow expression of viral genes in a regulated fashion (17, 31, 
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32,37, 39,41,43). In this study, we demonstrated that a 3'-coterminal nested set of 
six or seven sg mRNAs is formed in cells infected with different isolates of PRRSV. 
Northern blot analysis with ORF-specific probes indicates that the structure of the 
PRRSV sg mRNAs is polycistronic, and each of the sg mRNAs except for the 
smallest sg mRNA 7 contains multiple ORFs. Therefore, the sequence of each sg 
mRNA is contained within the 3'-portion of the next larger sg mRNA, and the 5'-end 
of each sg mRNA does not overlap with the sequences of the smaller sg mRNAs. 
The presence of a nested set of sg mRNAs further indicates that U.S. PRRSV, like 
European LV, belongs to the newly proposed Arteriviridae family including LDV, 
EAV and SHFV (24, 26,31). However, the numbers of the sg mRNAs differed 
among arteriviruses and even among different isolates of the same virus. A nested 
set of 6 sg mRNAs was detected in EAV-infected cells (6,7, 41) and European 
PRRSV-infected cells (5, 26). However, a nested set of 6 (LDV-C) or 7 (LDV-P) sg 
mRNAs, in addition to the genomic RNA, was present in LDV-infected cells (1, 2, 
15,16). The additional sg mRNA 1-1 of LDV-P contains the 3'-end of ORF lb; this 
sg mRNA can potentially be translated to a protein which represents the C-terminal 
end of the viral polymerase (2). In the present study, we also detected a 3'-
coterminal nested set of six or seven sg mRNAs in cells infected with PRRSV 
isolates with differing virulence. There is no apparent correlation, however, 
between the numbers of sg mRNAs and viral pneumovirulence. The additional 
species of sg mRNA 4-1 was found to contain an additional small ORF 4-1 with a 
coding capacity of 45 amino acids at the 5'-end of the sg mRNA 4-1. However, 
whether this small ORF is actually translated or has any biological functions 
remains to be studied. 
120 
We also showed in this study that the sg mRNAs of PRRSV are not 
packaged into the virions. Whether sg mRNAs are packaged into virions may 
depend on whether they contain a packaging signal. The packaging signal of MHV 
is located in the 3'-end of ORF 1b (42), thus only the genomic RNA of MHV was 
packaged (17). The sg mRNAs of BCV (12) and TGEV (36), however, were found 
in the purified virions. The packaging signal of BCV and TGEV has not been 
determined. The Aura alphavirus sg mRNA is efficiently packaged into the virions 
presumably because the packaging signal is present in the sg mRNA (32). The 
Sindbis virus 26S sg mRNA is not packaged into virions because the packaging 
signal is located in the genome segment which is not present in the sg mRNA (43). 
The sg mRNAs of LDV, a closely related member of PRRSV, are also not packaged 
into the virions (2). Since the sg mRNAs of PRRSV are not packaged into virions 
as shown In this study, the encapsidation signal of PRRSV is likely localized 
somewhere in the ORF 1 region that is unique to the viral genome, but not present 
in the sg mRNAs. 
Many mechanisms are involved in the generation of the sg mRNAs (7,17). It 
has been proposed that coronaviruses utilize a unique leader RNA-primed 
transcription mechanism in which a leader RNA is transcribed from the 3' end of the 
genome-sized negative-stranded template RNA, dissociates from the template, and 
then rejoins the template RNA at downstream intergenic regions to prime the 
transcription of sg mRNAs (17). The model predicts that the 5'-leader contains a 
specific sequence at its 3'-end which is repeated further downstream in the 
genome, preceding each of the ORFs 2 to 7. The leader joins to the body of each 
of the sg mRNAs via the leader-mRNA junction segment. In this study, we have 
determined the junction segments or the leader-mRNA junction sequences of sg 
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mRNAs 3 and 4 of two U.S. isolates of PRRSV, ISU79 and ISU1894. The leader-
mRNA junction sequence of sg mRNAs 3 and 4 of the two isolates are different, 
TTGACC for mRNA 4-1 of isolate ISU79, GTAACC for mRNA 3, and TTCACC for 
mRNA 4. Most of the nucleotide differences were present in the first 3 nucleotides 
of the junctions and the last 3 nucleotides were invariable, suggesting that the 
joining of the leader sequence to the bodies of sg mRNAs occurs within the 5'-end 
of the leader-mRNA junction sequence (1). Similar observations have been 
reported for LV (27), EAV (7) and LDV (1, 2). The acquisition of the additional sg 
mRNA 4-1 in isolate ISU79 is due to a single nucleotide substitution which 
generates a new leader mRNA junction sequence. This substitution occurs in the 
last nucleotide of the junction segment, suggesting that the last nucleotide of the 
leader-mRNA junction motif may be critical for the binding of the leader and for the 
initiation of transcription. Although the sequence homology between the leader 
and the intergenic regions of coronaviruses led to the hypothesis that base-pairing 
might be essential in the leader-primed transcription, no experimental evidence 
has documented for the requirement of base-pairing in transcription of the sg 
mRNAs. The sequence at the 3'-end of the leader of both coronaviruses and 
arterivinjses that is involved in the fusion process remains unknown. Several lines 
of evidence support the leader-primed transcription mechanism for coronaviruses, 
but the presence of negative-stranded sg mRNAs and sg replicative intermediates 
(sg Rl) in coronavirus-infected cells suggests that the mechanism involved in the sg 
mRNA synthesis is more complex (34, 35). However, negative-stranded sg mRNAs 
have not been detected in arterivinjses except for LDV (2), and sg RIs have been 
detected only in EAV-infected cells. Therefore, whether arterivinjses and 
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coronaviruses utilize the same mechanism to synthesize the sg mRNAs is still not 
known. 
Sequence analysis of the ORFs 2 to 7 of two U.S. PRRSV isolates and their 
comparison with the European LV reveal the heterogeneity of the leader-mRNA 
junction sequences. The presence of the leader-mRNA junction motifs at positions 
which do not correspond to a sg mRNA raises a question whether the short stretch 
of only six nucleotides, which are conserved in the leader and junction sequences 
in the genomes of PRRSV and other arteriviruses, is sufficient for efficient binding 
of the leader to these specific junction sites upstream of the ORFs. This 
discrepancy, however, may be explained by the following two possibilities. First, 
additional structural elements, such as secondary structure or the sequences 
surrounding the leader-mRNA junction segment, are expected to be involved in the 
fusion of the leader to the specific sites. It has been shown that in MHV, the 
sequence flanking the consensus sequence (leader-mRNA junction sequence) of 
UCUAAAC affected the efficiency of sg Dl RNA transcription and that the 
consensus sequence was necessary but not sufficient for the synthesis of the sg Dl 
RNA (21). Secondly, the distance between two leader-mRNA junction regions may 
affect the transcription of sg mRNAs. It has been demonstrated that the 
downstream leader-mRNA junction region was suppressing sg Dl RNA synthesis of 
MHV from the upstream leader-mRNA junction region (14). The suppression was 
significant when the two leader-mRNA junction sequence separation was less than 
35 nucleotides. However, significant inhibition of larger sg Dl RNA synthesis (from 
the upstream leader-mRNA junction sequence) was not observed when the two 
leader-mRNA junction regions were separated by more than 100 nucleotides (14). 
These experimental results support our observations. In this study, we have 
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observed an additional species of sg mRNA 4-1, in addition to the sg mRNA 4, in 
some of the PRRSV isolates. The leader-mRNA junction sequences of sg mRNAs 
4 and 4-1 are found to be separated by 226 nucleotides. Therefore, the synthesis 
of the larger sg mRNA 4-1 from the upstream leader-mRNA junction sequence is 
not suppressed by the presence of the downstream leader-mRNA 4 junction 
sequence as evidenced by Northern blot analysis. In contrast, multiple potential 
leader-mRNA junction sequences were found at different positions upstream of 
ORFs 3, 5, 6 and 7, but there were no sg mRNAs corresponding to these leader-
mRNA junction motifs in the Northern blot analysis. Most of these leader-mRNA 
junction sequences are separated by less than 50 nucleotides from the 
downstream leader-mRNA junction region except for ORF 7 which the two potential 
leader-mRNA junction sequences are separated by 114 nucleotides. However, the 
sg mRNA 7 in Northern blot analysis showed a widely diffused band. Therefore, 
the transcription of larger sg mRNA 7 from the upstream leader-mRNA junction 
sequence may not be significantly suppressed by the downstream junction 
sequence, and it may not be distinguishable from the abundant sg mRNA 7 by 
Northern blot analysis. 
Acknowledgments 
The authors would like to thank Susan Carpenter and Richard Ross at the 
Department of Microbiology, Immunology and Preventive Medicine, John Andrews 
at the Veterinary Medical Research Institute (VMRI), and Donald Beitz at the 
Department of Animal Science, Iowa State University for their critical review of the 
124 
manuscript, Melissa A. Lum at the Solvay Animal Health, Inc., Mendota Heights, 
Minnesota for her many helpful discussion throughout this study, Beth Sagers at 
the Solvay Animal Health, Inc. and Marsha Morgan at VMRI for their technical 
assistance, and Harold Hills at the Nucleic Acid Facility, Iowa State University for 
his assistance in sequence analysis. This work was supported by the National 
Research Initiative Competitive Grant of US Department of Agriculture (USDA-NRI 
grant no. 94-02092). 
References 
1. Chen, Z., L. Kuo, R. R. R. Rowland, C. Even, K. 8. Faaberg, and P. 
G. W. Plagemann. 1993. Sequences of 3' end of genome and of 5' end of 
open reading frame 1a of lactate dehydrogenase-elevating virus and common 
junction motifs between 5' leader and bodies of seven subgenomic mRNAs. J. 
Gen. Virol. 74:643-660. 
2. Chen, Z., K. S. Faaberg, and P. G. W. Plagemann. 1994. Detection of 
negative-stranded subgenomic RNAs but not of free leader in LDV-infected 
macrophages. Virus Res. 34:167-177. 
3. Christianson, W. T., J. E. Collins, D. A. Benfield, L. Harris, D. E. 
Gorcyca, D. W. Chladek, R. B. Morrison, and H. S. Joo. 1992. 
Experimental reproduction of swine infertility and respiratory syndrome in 
pregnant sows. Am. J. Vet. Res. 53:485-488. 
125 
4. Collins, J. E., D. A. Benfield, W. J. Christianson, L. Harris, J. C. 
Hennings, D. P. Shaw, S. M. Goyal, S. McCullough, R. B. Morrison, 
H. S. Joo, D. E. Gorcyca, and D. W. Chladek. 1992. isolation of swine 
infertility and respiratory syndrome virus (isolate ATCC VR-2332) in North 
American and experimental reproduction of the disease in gnotobiotic pigs. J. 
Vet. Diagn. Invest. 4:117-126. 
5. Conzelmann, K-K., N. Visser, P. Van Woensel, and H-J. Thiel. 1993. 
Molecular characterization of porcine reproductive and respiratory syndrome 
virus, a member of the Arterivirus group. Virology. 193:329-339. 
6. Den Boon, J. A., E. J. Snijder, E. D. Chirnside, A. A. F. De Vries, M. 
C. Horzinek, and W. J. M. Spaan. 1991. Equine arteritis virus is not a 
Togavirus but belongs to the coronaviruslike superfamily. J. Virol. 65:2910-
2920. 
7. De Vries, A. A. F., E. D. Chirnside, P. J. Bredenbeek, L. A. 
Gravestein, M. C. Horzinek, and W. J. M. Spaan. 1990. All 
subgenomic mRNAs of equine arteritis virus contain a common leader 
sequence. Nucleic Acids Res. 18:3241-3247. 
8. Godeny, E. K., L. Chen, S. N. Kumar, S. L. Methven, E. V. Koonin, 
and M. A. Brinton. 1993. Complete genomic sequence and phylogenetic 
analysis of the lactate dehydrogenase-elevating virus (LDV). Virology. 
194:585-596. 
9. Goyal, S. M. 1993. Porcine reproductive and respiratory syndrome. J. Vet. 
Diagn. Invest. 5: 656-664. 
10. Halbur, P. G., P. S. Paul, M. L. Frey, J. Landgraf, K. Eernisse, X.-J. 
Meng, M. A. Lum, and J. A. Rathje. 1995. Comparison of the 
pathogenicity of two U. S. porcine reproductive and respiratory syndrome virus 
isolates with the LeIystad virus. Vet. Pathol. 32(4):000-000. 
126 
11. Halbur, P. G., P. S. Paul, X.-J. Meng, M. A. Lum., and J. A. Rathje. 
unpublished data 
12. Hofmann, M. A., P. B. Sethna, and D. A. Brian. 1990. Bovine 
coronavirus mRNA replication continues throughout persistent infection in cell 
culture. J.Virol. 64:4108-4114. 
13. Jeong, Y. S. and S. Makino. 1994. Evidence for coronavirus 
discontinuous transcription. J.Virol. 68:2615-2623. 
14. Joo, iVI. and S. Maicino. 1995. The effect of two closely inserted 
transcription consensus sequences on coronavirus transcription. J. Virol. 
69:272-280. 
15. Kuo, L., J. T. Harty, L. Erickson, G. A. Palmer, P. G. W. Plagemann. 
1991. A nested set of eight RNAs is formed in macrophages infected with 
lactate dehydrogenase-elevating virus. J.Virol. 65:5118-5123. 
16. Kuo, L., Z. Chen, R. R. R. Rowland, K. S. Faaberg, and P. G. W. 
Plagemann. 1992. Lactate dehydrogenase-elevating virus (LDV): 
subgenomic mRNAs, mRNA leader and comparison of 3'-terminal sequences of 
two LDV isolates. Virus Res. 23:55-72. 
17. Lai, M. M. C. 1990. Coronavirus: organization, replication and expression of 
genome. Annu. Rev. Microbiol. 44:303-333. 
18. Makino, S., F. Taguchi, and K. Fujiwara. 1984. Defective interfering 
particles of mouse hepatitis virus. Virology. 133:9-17. 
19. Makino, S., N. Fujioka, and K. Fujiwara. 1985. Structure of the 
intracellular defective viral RNAs of defective interfering particles of mouse 
hepatitis virus. J. Virol. 54:329-336. 
127 
20. Makino, S., C.-K. Shieh, J. G. Keck, and M. M. C. Lai. 1988. Defective 
interfering particles of murine coronavirus: mechanism of synthesis of defective 
viral RNAs. Virology. 163:104-111. 
21. Makino, S., M. Joo, and J. K. Makino. 1991. A system for study 
coronavirus mRNA synthesis: a regulated, expressed subgenomic defective 
interfering RNA results from intergenic site insertion. J. Virol. 65:6031-6041, 
22. Mardassi, H., S. Mounir, and S. Dea. 1994. Identification of major 
differences in the nucleocapsid protein genes of a Quebec strain and European 
strains of porcine reproductive and respiratory syndrome virus. J. Gen. Virol. 
75:681-685. 
23. Meng, X.-J., P. S. Paul, E. V. Vauglin, and J. J. Zimmerman. 1993. 
Development of a radiolabeled nucleic acid probe for the detection of 
encephalomyocarditis virus of swine. J. Vet. Diagn. Invest. 5:254-258. 
24. Meng, X.-J., P. S. Paul, and P.G. Halbur. 1994. Molecular cloning and 
nucleotide sequencing of the 3'-terminal genomic RNA of the porcine 
reproductive and respiratory syndrome virus. J. Gen. Virol. 75:1795-1801. 
25. Meng, X.-J., P. S. Paul, P. G. Halbur, and M. A. Lum. 1995. 
Phylogenetic analysis of the putative M (0RF6) and N (0RF7) genes of porcine 
reproductive and respiratory syndrome virus (PRRSV): implication for the 
existence of two genotypes of PRRSV in the U. S. and Europe. Arch. Virol. 
140:745-755. 
26. Meulenberg, J. J. M., M. M. Hulst, E. J. De Meijer, P. L. J. M. 
Moonen, A. Den Besten, E. P. De Kiuyver, G. Wensvoort, and R. J. 
M. Moormann. 1993. Leiystad virus, the causative agent of porcine epidemic 
abortion and respiratory syndrome (PEARS), is related to LDV and EAV. 
Virology. 192:62-72. 
128 
27. Meulenberg, J. J. M., E. J. De Meijer, and R. J. M. Moormann. 1993. 
Subgenomic RNAs of Lelystad virus contain a conserved leader-body junction 
sequence. J. Gen. Virol. 74:1697-1701. 
28. Meulenberg, J. J. M., A. Petersen-Den Besten, E. P. De Kluyver, R. 
J. M. Moormann, W. M. M. Schaaper, and G. Wensvoort. 1995. 
Characterization of proteins encoded by ORFs 2 to 7 of Lelystad virus. Virology. 
206:155-163. 
29. Morozov, I., X.-J. Meng, and P. S. Paul. 1995. Sequence analysis of the 
open reading frames (ORF) 2 to 4 of a U. S. isolate of porcine reproductive and 
respiratory syndrome virus (PRRSV). Arch. Virol. 141:000-000. 
30. Morozov, I., X.-J. Meng, and P. S. Paul, unpublished data. 
31. Plagemann, P. G. W., and V. Moennlg. 1992. Lactate dehydrogenase-
elevating virus, equine arteritis virus and simian hemorrhagic fever virus, a new 
group of positive strand RNA virus. Adv. Virus. Res. 41:99-192. 
32. Rumenapf, T., E. G. Strauss, and J. H. Strauss. 1994. Subgenomic 
mRNA of Aura alphavirus is packaged into virions. J. Virol. 68:56-62. 
33. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. "Molecular Cloning: 
A Laboratory Manual", second ed.. Cold Spring Harbor Laboratory, Cold Spring 
Harbor, New York. 
34. Sawicki, S. G., and D. L. Sawlcki. 1990. Coronavirus transcription: 
subgenomic mouse hepatitis virus replicative intermediates function in RNA 
synthesis. J.Virol. 64:1050-1056. 
35. Sethna, P. B., S.-L. Hung, and D. A. Brian. 1989. Coronavirus 
subgenomic minus-strand RNAs and the potential for mRNA replicons. Proc. 
Natl. Acad. Sci. USA. 86:5626-5630. 
129 
36. Sethna, P. B., M. A. Hofmann, and D. A. Brian. 1991. Minus-strand 
copies of replicating coronavirus mRNAs contain antileaders. J. Virol. 65:320-
325. 
37. Snijder, E. J., M. C. Horzinek, and W. J. I\1. Spaan. 1990. A 3'-
coterminal nested set of independently transcribed messenger RNAs is 
generated during Berne virus replication. J. Virol. 64:331-338. 
38. Snijder, E. J., J. A. Den Boon, M. C. Horzinek, and W. J. M. Spaan. 
1991. Characterization of defective interfering RNAs of Berne virus. J. Gen. 
Virol. 72:1635-1643. 
39. Spaan, W. J. IVI., D. Cavanagh, M. C. Horzinek. 1988. Coronaviruses: 
structure and genome expression. J. Gen. Virol. 69:2939-2952. 
40. Suarez, P., R. Zardoya, C. Prieto, A. Solana, E. Tabares, J. IVI. 
Bautista, J. M. Castro. 1994. Direct detection of the porcine reproductive 
and respiratory syndrome (PRRS) virus by reverse polymerase chain reaction 
(RT-PCR). Arch. Virol. 135:89-99. 
41. Van Berlo, M. F., P. J. M. Rottier, h/l. C. Horzinek, and B. A. M. Van 
der Zeijst. 1986. Intracellular equine arteritis virus (EAV)-specific RNAs 
contain common sequences. Virology. 152:492-496. 
42. Van der Most, R. G., P. J. Bredenbeek, and W. J. M. Spaan. 1991. A 
domain at the 3' end of the polymerase gene is essential for encapsidation of 
coronavirus defective interfering RNAs. J. Virol. 65:3219-3226. 
43. Weiss, B., H. Nitsciiko, I. Ghattas, R. Wright, and S. Schiesinger. 
1989. Evidence for specificity in the encapsidation of Sindbis virus RNAs. J. 
Virol. 63:5310-5318. 
130 
44. Wensvoort, G., C. Terpstra, J. M. Pol, E. A. Ter Laak, M. Bloemraad, 
E. P. De Kluyver, C. Kragten, L. Van Butten, A. Den Besten, F. 
Wagenaar, J. M. Broekhuijsen, P. L. J. M. Moonen, T. Zetstra, E. A. 
De Boer, H. J. Tibben, M. F. De Jong, P. Van't Veld, G. J. R. 
Groenland, J. A. Van Gennep, M. T. Voets, J. H. M. Verheljden, J. 
Braamskamp. 1991. Mystery swine disease in the Netherlands: The isolation 
of Leiystad virus. Vet. Q. 13:121-130. 
45. Wensvoort, G., E. P. De Kluyver, E. A. Luijtze, A. Den Besten, L. 
Harris, J. E. Collins, W. T. Christianson, D. Chladek. 1992. Antigenic 
comparison of Leiystad virus and swine infertility and respiratory syndrome virus. 
J. Vet. Diagn. Invest. 4:134-138. 
46. Yokomori, K., L. R. Banner, and M. M. C. Lai. 1992. Coronavirus mRNA 
transcription: UV light transcriptional mapping studies suggest an early 
requirement for a genomic-length template. J.Virol. 66:4671-4678. 
131 
Table 1. Synthetic oligonucleotides used in this study 
Oligo 
Name 
Sequence Location (nucleotides)^ Polarity' 
IM729 5-GACTGATGGTGTGGAAAG-3' 
IM782 5"-CTGTATCCGATTCAAACC-3' 
IM312 5'-AGGTTGGGTGGTGGTCTT-3' 
IM313 5-TCGCTCACTACCTGTTTC-3' 
XM1022 5-TGTGCCCGCCTrGCCTCA-3' 
IM258 5--AAACCAATTGCCCCCGTC-3' 
XM1024 5'-TATATCACTGTCACAGCC-3' 
XM1023 5'-CAAATTGCCAACAGAATG-3' 
PP287 5'-CAACTTGACGCTATGTGAGC '^ 
PP286 5"-GCCGCGGAACCATCAAGCAC-3' 
PP289 5'-GACTGCTAGGGCTTCTGCAC-3' 
XM780 5-CGTTGACCGTAGTGGAGC-3' 
PP285 5'-CCCCATTTCCCTCTAGCGACTG-3' 
PP284 5'-CGGCCGTGTGGTTCTCGCCAAT-3' 
JM260 5'-GGGGAATTCGGGATAGGGAATGTG-3' 
JM259 S'-GGGGATCCTTTTGTGGAGCCGT-S' 
XM993 5--GGTGAATTCGTnTATnrCCCTCCGGGC-3' 
XM992 5'-GGGGGATCCTGTTGGTAATAG/AGTCTG-3' 
XM970 5'-GGTTTCACGTAGAATGGC-3' 
XM969 5'-GATAGAGTCTGCCCTTAG-3' 
XM1006 5-GCTTCTGAGATGAGTGA-3' 
XM078 5-GTGAGCAATTACAGAAG-3' 
XM077 5'-CAAGGAGGCGTAAACACT-3' 
IM755 5'-GAGTGGTTTACGGTGTGTC^-
DP586 5"-GATGGCTGACACATTGCG-3' 
XM141 5-CTGGAAGAGTCGAAGTGAA-3' 
ORF1 b, -507 to -490 upstream of 0RF2 + 
ORF1 b, -180 to -163 upstream of 0RF2 
0RF2,131 to 148 downstream of 0RF2 + 
ORF2,381 to 398 downstream of GRF2 
ORF3,158 to 175 downstream of 0RF3 + 
ORF3,520 to 537 downstream of 0RF3 
0RF4,232 to 249 downstream of 0RF4 + 
0RF4, 519 to 536 downstream of 0RF4 
ORF5,129 to 148 downstream of 0RF5 + 
ORF5,538 to 557 downstream of 0RF5 
ORF6,119 to 138 downstream of 0RF6 + 
0RF6, 416 to 433 downstream of 0RF6 
0RF7,157 to 178 downstream of 0RF7 + 
3' NCR, -27 to -6 upstream of poly (A) 
ORF3,338 to 356 downstream of 0RF3 + 
0RF6,34 to 52 downstream of 0RF6 
ORF1 b. -53 to -35 upstream of 0RF2 + 
ORF3, -50 to -34 upstream of 0RF4 
0RF2,533 to 550 downstream of 0RF2 + 
ORF5,443 to 460 downstream of 0RF5 
0RF4,316 to 332 downstream of 0RF4 + 
ORF2,202 to 218 downstream of 0RF2 + 
0RF3,316 to 333 downstream of 0RF3 
Leader, 3' end of the leader sequence + 
ORF4,355 to 372 downstream of 0RF4 
0RF4, 78 to 97 downstream of 0RF4 -
a. The oligonucleotides were designed on the basis of published data (25, 26, 29) 
as well as sequence data presented in this paper (Fig. 8). 
b. Oligonucleotides complementary to the genomic RNA have negative (-) 
polarities. 
Figure 1. Northern blot analysis of RNAs isolated from isolate ISU3927 of 
PRRSV-infected CRL11171 cells (lane 1) and from purified virions 
of 1SU3927 (lane 2). The RNAs were separated on a denaturing 
formaldehyde agarose gel. The blot was hybridized with a probe 
generated from the 3' terminal sequence of the viral genome (24). 
The mRNA numbered 1 represents the viral genome and the other 
subgenomic mRNAs were numbered from 2 to 7 according to their 
sizes. The additional species of sg mRNA detected in this isolate 
was designated as mRNA 4-1 (lane 1). 
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Figure 2. Northern blot analysis of total intracellular RNAs isolated from 
CRL11171 cells infected with different isolates of PRRSV, ISU22 
(lane 1), ISU55 (lane 2), ISU79 (lane 3), ISU1894 (lane 4) and 
ISU3927 (lane 5), respectively. The CRL11171 cells were infected 
with different isolates of PRRSV at the same multiplicity of infection 
of 0.1, and the total RNAs were isolated from the infected cells at 
24 hrs postinfection. The RNAs were separated on a denaturing 
formaldehyde gel, transferred to nylon membranes and hybridized 
with a S'-terminal probe(24). The PRRSV specific mRNA species 
are numbered 1 to 7, and mRNA 1 represents the genomic RNA. 
An additional subgenomic mRNA species, designated as sg 
mRNA 4-1, was detected in some isolates of PRRSV. PRRSV 
specific mRNA species were not detected from mock-infected 
CRL11171 cells (data not shown). 
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Figure 3. Northern hybridization of total RNAs isolated from CRL11171 cells infected with isolate ISU79 of 
PRRSV at different multiplicity of infection (m. o. i.) (A), and polyadenylated RNA from cells infected 
with PRRSV Isolates ISU55 and ISU79 (B). The Isolate ISU79 was passaged four times either 
undiluted (panel A, lane 1) or at different m. o. i. of 0.1 (panel A, lane 2), 0.01 (panel A, lane 3) and 
0.001 (panel A, lane 4). The total RNAs were isolated at the fourth passage, separated on a 
denaturing formaldehyde gel and hybridized with a 3'-terminal probe (24). The polyadenylated 
RNA of ISU55 (panel B, lane 1) and ISU79 (panel B, lane 2) was enriched from total RNAs by oligo 
(dT)-cellulose column chromatography, and hybridized with the same 3'-terminal probe. Numbers 
1 to 7 represents the PRRSV specific mRNA species, and the mRNA 1 represents the genome. The 
additional species of sg mRNA was designated as mRNA 4-1. 
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Figure 4. Northern blot analysis of total intracellular RNAs isolated from 
CRL11171 cells infected with ISU1894 (A) and iSU79 (B). The 
RNAs were separated on a denaturing formaldehyde gel. The 
blots were hybridized with seven different ORF-specific probes, 
respectively. The probes 1 to 7 were generated from ORFs 1 b to 7, 
respectively. Each of the seven probes is specific for only one 
ORF, and the overlapping sequences between neighboring ORFs 
were not included in any given probe (see text for detail). Lanes 1 
to 7 of both panels A and B represent the Northern blot results with 
probes 1 to 7, respectively. The mRNA numbered 1 represents 
viral genome, and other sg mRNAs are numbered 2 to 7 according 
to their sizes. The additional mRNA species in isolate ISU79 is 
designated as mRNA 4-1 (panel B). PRRSV specific mRNA 
species were not detected in RNAs from mock-infected cells (data 
not shown). 
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Figure 5. Determination of the leader-mRNA junction sequences of sg 
mRNAs 3, 4, and 4-1. (A) RT-PCR amplification of the 5'-terminal 
sequences of the sg mRNAs 3 and 4 of ISU1894 (lane 1), and sg 
mRNAs 3, 4 and 4-1 of ISU79 (lane 2). The locations of primers 
used for RT-PCR are indicated in Table 1. Lane L is the 1-kb 
marker. (B) Leader-mRNA junction sequences of sg mRNAs 3 and 
4 of ISU79 and ISU1894, and sg mRNA 4-1 of ISLI79. The 3'-end 
of the RT-PCR products shown in panel A were sequenced to 
determine the leader-mRNA junction sequences. The locations of 
the leader-mRNA junction sequences in the genome relative to the 
start codon of each ORF were indicated by minus (-) numbers of 
nucleotides upstream of ORFs. The leader-mRNA 4-1 junction 
sequence of ISU79 was compared with the corresponding region 
in the genome of ISLI1894. 
A 
B 
ISn-1894-mRNA3 
ISU-7 9-mRNA3 
ISU-1894 
ISU-79-mRNA4-l 
-89 +1>0RF3 
GUAACC...AUG 
GUAACC AUG 
-236 +1>0RF4 
UUGACu••.AUG 
UUfi&C£...AUG 
ISU-1894-mRNA4 
ISU-7 9-mRNA4 
-10 +1>0RF4 
UUCACC AUG 
UUCACC AUG 
Figure 6. Sequence alignment of ORFs 2 to 7 of PRRSV Isolates ISU1894 and ISU79. The nucleotide 
sequences of ORFs 6 and 7 of ISU79 and ISU1894 have been reported previously (25). The 
sequence of ISU79 was shown on top, and only differences were indicated in isolate ISU1894. 
The start codon of each ORF was indicated by +>, and the termination codon of each ORF was 
indicated by asterisks (*). The small ORF in the additional species of sg mRNA 4-1 of ISU79 is 
designated as ORF 4-1. The determined or predicted leader-mRNA junction sequences were 
underlined. The locations of the leader-mRNA junction sequences relative to the start codon of 
each ORF are indicated by minus (-) numbers of nucleotides upstream of each ORF. 
-26(IDI^2> •l^ORPa 
ISU79 GTTn'ATTTCCCTV:CGGa-2CCT3TrATU2&A^MCTTrAG3CCT>3AArD3AAAT0A;xATO3G5TCCATCCAAAa-CC'rPm\3ACAAAA'PT>3G-2C/<ACTrTlT>3'P5GnT3-::'nT:ACGGn 120 
ISU1894 C G 120 
ISU79 GTT>:TTO3TCPCCATTGTmATAT:ATrATAri>:TTCacCATTIT3TTTGG-:ri>rACCAT\:GCCG3TTXy3CPJGTCG1VmTOCAT>:AGATTCGTrK;C'r:-:3:GATACTV:C-3TACGCG 240 
ISU1894 C C T 240 
ISU7 9 CCCT>3CCArrCACT<n^AGCAATTACAGAAGAT:TTAT3AGGCCTTrcTTTCCCAGTCCCAAG'I\3GACA'rrCCCACCTCGG3AACTAAACAT>:CTT?3G3GA'I>3rmGGCACCATAAG3 3 60 
ISU1894 T.A 360 
ISu79 T3T:AACCCTGAn>3A'P3AGA'rcGT3'I>rGCGTrGAAT3TACC3CA'I>:A'n3GAAAAAGCACJ3ACAGGC'rcCC'rcGAAACAGG'n3GT>3AGCGAGGCTACGCT3'PCT:GCATTAGTAG'm>33 400 
ISU1894 A C G C 480 
•*89 (IBRN^3) 
ISU79 ATGTCGy3GCT\:AnTTCAGCATCTT3:CGCCATCGAAGCCGAGACC'P3TAAATATrroGCCTCCCQ3CTCCCCA'P3CTACACAACCTCCGrATCACAG33TCAAi\TCTAACCATAGTCT 600 
ISU1894 T T T A 600 
ISU79 ATAATAGTACTTrGAATCGGGT>3TTr3-2TATTTTrCCAACCCC'P3GTTCCCGGCCAAAGC'IT'CAT3ACTTrrAGCAAT03CTAATAGC'I>3TCCA'rrrCT-CATATrTTJC'PCT3TT>3'rAG 720 
ISU1894 C.G.G.A T T A 720 
***<0RF2(Iff079) 
ISU79 CTTCTTCTACTCTCrrTGTTGTG'ri>3T>3GTP3CG3GTT"rCAATACTACGTACTGriTn03TTrrCGCT>3Gm03GGCAATTTmnTTCGAAC'PrATA3'P3AATTACACG3'n3'IV3CCC 840 
ISU1894 T C G G C G T. . 840 
***<ORP2(ISU1094) 
ISU79 ACCTTG'r0'rcACCCGGCAAGCAGCCGCAGAGGCCTACGAACCCGGTAGGTCTC'ITTGGTG-rAG3ATAGG3TACGATCaA1>31\3GAGAGGACGACCA1>3ACGAG'::TA3G3TTrATCATACC 960 
ISU1894 T T..C G T 960 
-236(18079 BRNA4-1) 
ISU79 GTVri\y3':C'rcTCCAG'CGAAGGCCAC13SAiiAGT3TTTACGCCT03TrcGCG'riV:rrcT>:CTOA3CTACACGGCCCAGTT\:CACCCCGAGATATT:GG3ATA3G3AA'r3P3AGTCGAGT 1080 
ISU1894 .C T T T 1080 
+1>0RF4-1 
ISU79 TTATOn>3ACA'rcAAACA'K:AACTrATCT3CGCCGAACATGACGG3CAGAACACCACCTrccCT'CG'I\:ATGACAACATTTrGGCCG'I\3'nTCAGACOTATTA:CAACA'I\:AAGT::GACG3 1200 
ISU1894 T A G T A T.. 1200 
-10(nRMA4)4-l>ORF4 
ISU7 9 CGGrAATTGGTIE£^££TAGAAT03CT3CGTCCCTT\:TTITCCT\:AT3GTTGGTTITAAAT3T\:TCTT>3'3TT^:T>:AG3CG'rrcGCCT>3CA;iACCAT3TTI\:AGTTCGAGTCTT\3CAGAC 1320 
1SU1894 T A C T 1320 
#*#<0RF4-1 
** 
ISU79 ATTAAGACCAACACCACCGCAGCGGCAAGC'ITrcC'n3'IvrCTCCAAGACA'rcAG'rr3CClTAGGrA'IV:GCA/vCT3G3CC'I\:TCAGGCG;\'nV:GCAAAATCC:TrA3T3:CGTACGGCGATA 1440 
ISU1894 T 1440 
*<0RP3 
ISU79 GGGACACCTATGTATATTACCATCACAGCCAAT3T>3ACAGATGAAAATrA'nTACATTC'ITCTCATr'r:c'r7A'I>3:TC'rcTTC'rrcCC'nTTCTA'P3ClTCT>3AGA'PjAGTCAAAAGGGA 1560 
ISU1894 CG G T C A... 1560 
-lOS 
ISU*;9 TITCAC>3TGGTITnQGCAAT>3T>3TCAG3CATCGTGG3T>3TGTCTGTCAATmACCAGCTACGTTN:/tACAT3TCAGGGAGTrTACCCAACGCT>:CTI>3AT3GJN:5^^::^A'n3T>3CG3CT>3 1680 
ISU1894 . .CA A C C. .3 T. . 1680 
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SEQUENCE COMPARISON OF OPEN READING FRAMES 2 TO 5 OF LOW AND 
HIGH VIRULENCE U. S. ISOLATES OF PORCINE REPRODUCTIVE AND 
RESPIRATORY SYNDROME VIRUS (PRRSV) 
A paper submitted to the Journal of General Virology 
Xiang-Jin Meng, Prem S. Paul, Patrick G. Halbur and Igor Morozov 
Abstract 
The sequences of ORFs 2 to 5 of one low virulence, one moderate virulence 
and one high virulence U. S. PRRSV isolates were determined. The nucleotide 
and deduced amino acid sequences of these three U. S. isolates were compared 
with other known PRRSV isolates with differing vimlence. The results indicated 
that considerable genetic variations exist not only between the European and the 
U. S. PRRSV isolates but among the U. S. isolates as well. The amino acid 
sequence identity between seven U. S. PRRSV isolates was 91-99% in ORF 2, 86-
98% in ORF 3, 92-99% in ORF 4, and 88-97% in ORF 5. The low virulence U. S. 
isolate had highest sequence variation in ORFs 2 to 4, and little variation in ORFs 5 
to 7 compared to the other U. S. isolates. A hypervariable region with antigenic 
potential was identified within the major envelope glycoprotein encoded by ORF 5. 
Painwise comparison of the sequence of ORFs 2 to 7 and phylogenetic tree 
analysis implied the existence of at least three groups of PRRSV variants (or minor 
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genotypes) within the major genotype of U. S. PRRSV. The low virulence U. S. 
isolate formed a branch distinct from the other U. S. isolates. The results of this 
study have implications for the taxonomy of PRRSV and vaccine development. 
Introduction 
Porcine reproductive and respiratory syndrom"^ (PRRS), a new and severe 
disease in swine, was first reported in the U. S. A. in 1987 and was rapidly 
recognized in many Western European countries (reviewed by Goyal et al., 1993 
and Paul et al., 1993). The disease is characterized by reproductive failure in sows 
and gilts, pneumonia in nursery and young growing pigs, and an increase in 
preweaning mortality (Terpstra et al., 1991; Wensvoort et al., 1991; Benfield et al., 
1992; Christiansen et al., 1992; Loula, 1992; Halbur et al., 1995b, 1995c). 
The causative agent of this disease, porcine reproductive and respiratory 
syndrome vims (PRRSV), was identified first in Europe (Wensvoort et al., 1991) and 
then in the U. S. A. (Benfield et al., 1992; Collins et al., 1992). The European strain 
of PRRSV, designated Lelystad virus (LV), has been cloned and sequenced 
(Conzelmann et al., 1993; Meulenberg et al., 1993a). Partial sequences of several 
North American isolates were also determined (Mardassi et al., 1994; Meng et al., 
1994,1995a, 1995b; Morozov et al., 1995; Murtaugh et al., 1995). The genome of 
PRRSV is about 15 kb and contains eight open reading frames (ORF) 
(Conzelmann et al., 1993; Meulenberg et al., 1993a; Meng et al., 1994). ORFs la 
and lb probably encode viral RNA polymerase (Meulenberg et al., 1993a). ORFs 
5, 6 and 7 were found to encode a glycosylated membrane protein (E), an 
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unglycosylated membrane protein (M) and a nucleocapsid protein (N), respectively 
(Meulenberg et al., 1995). ORFs 2 to 4 have the characteristics of membrane-
associated proteins (Conzelmann et a!., 1993; Meulenberg et al., 1993a: Morozov 
et al., 1995), however, the translation products of ORFs 2 to 4 were not detected in 
virus-infected cell lysates or virions (Meulenberg et al., 1995). 
PRRSV was provisionally classified in the newly proposed virus family 
Arteriviridae which includes equine arteritis virus (EAV), lactate dehydrogenase-
elevating virus (LDV) and simian hemorrhagic fever virus (SHFV) (Den Boon et al., 
1991; Plagemann and Moennig, 1992; Conzelmann et al., 1993; Godeny et al., 
1993; Meulenberg et al., 1993a; Meng et al., 1994,1995a; Godeny et al., 1995). 
This group of single plus-stranded RNA viruses shares many characteristics such 
as genome organization, replication strategy, morphology, and macrophage cell 
tropism (Conzelmann et al., 1993; Meulenberg et al., 1993a; Meng et al., 1994; 
Halbur et al., 1994,1995a). The replication of arteriviruses requires the formation 
of a 3'-coterminal nested set of subgenomic mRNAs (Den Boon et al., 1991; De 
Vries et al., 1990; Kuo et al., 1991,1992; Chen et al., 1993; Conzelmann et al., 
1993; Meulenberg et al., 1993a, 1993b: Meng et al., 1994, 1995b). 
Antigenic, genetic and pathogenic variations have been reported among 
PRRSV isolates (Wensvoort et al., 1992; Mardassi et al., 1994; Meng et al., 1994, 
1995a; Halbur et al., 1995b, 1995c). The U. S. PRRSV and European PRRSV 
represent two distinct genotypes (Meng et al., 1994,1995a). Antigenic variability 
exists not only between North American and European isolates but among North 
American isolates as well (Wensvoort et al., 1992). Marked differences in 
pathogenicity were demonstrated between U. S. and European isolates, and 
among U. S. isolates (Halbur et al., 1995b, 1995c). In this study, we have 
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determined and compared the nucleotide sequences of ORFs 2 to 5 of a low 
virulence PRRSV isolate and two other PRRSV isolates with moderate and high 
virulence, respectively. 
Materials and Methods 
Cells and viruses 
The ATCC CRL 11171 cell line was used to propagate the PRRSV. The 
cells were grown in Dulbecco's minimal essential medium (DMEM) supplemented 
with 10% fetal bovine serum (FBS) and 1 X antibiotics (10,000 unit/ml penicillin G, 
10,000 mg/ml streptomycin and 25 mg/ml amphotericin B). 
Three U. S. isolates of PRRSV used in this study, designated ISU22, ISU55 
and ISU3927, were isolated from pig lungs obtained from different farms in Iowa 
during PRRS outbreaks. All three isolates were plaque-purified three times in CRL 
11171 cells before further experimentation. Comparative pathogenicity studies in 
our laboratory showed that isolate ISU3927 is the least virulence isolate among 
nine different U. S. PRRSV isolates (Halbur et al., 1995b, 1995c). Isolate ISU22 is 
one of the high virulence isolates and isolate 1SU55 is of moderate-pathogenicity 
(Halbur et al., 1995b, 1995c). All of the three virus isolates used in this study, as 
well as in pathogenicity studies, were at seventh cell culture passage. 
Isolation of PRRSV intracellular RNAs 
Confluent monolayers of CRL 11171 cells were infected with the three U. S. 
isolates of PRRSV, 1SU22, ISU55 and ISU3927, respectively, at a multiplicity of 
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infection (m. o. i.) of 0.1. At 24 firs, postinfection, the infected cells were washed 
three times with cold PBS buffer. The total intracellular RNAs were then isolated by 
guanidinium isothiocyanate and phenol-chloroform extraction (Stratagene). The 
presence of virus-specific RNA species in the RNA preparation was confirmed by 
Northern blot hybridization (data not shown). The total intracellular RNAs were 
quantitated spectrophotometrically. 
Reverse transcription and polymerase chain reaction (RT-PCR) 
First strand complementary (c) DNA was synthesized from the total 
intracellular RNAs by reverse transcription using random primers as described 
previously (Meng et ai., 1993). For amplification of the entire protein coding 
regions of ORFs 2 to 5 of the three isolates of PRRSV, two sets of primers were 
designed on the basis of the published sequences of isolate VR2385 (Meng et al., 
1994; Morozov et al., 1995) and LV (Meulenberg et al., 1993a). Primers JM259 (5'-
GGGGATCCTTTTGTGGAGCCGT-3"> and JM260 fS'GGGGAATTCGGGATAGG 
GAATGTG-3') amplified the sequence of ORFs 4 and 5, and primers XM992 [5'-
GGGGGATCCTGrrGGTAATAGfA^GTCTG-SI and XM993 rS'-GGTGAATTCGTT 
TTATTTCCCTCCGGGC-3') amplified the sequence of ORFs 2 and 3. Unique 
restriction sites (EcoR I or BamH I) at the 5' end of these primers were introduced to 
facilitate cloning. A degenerate base, G (A), was synthesized in primer XM992 
based on the sequence comparison of VR2385 and LV (Meulenberg et al., 1993a: 
Morozov et al., 1995). PGR was performed as described previously (Meng et al., 
1993). 
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Cloning and nucleotide sequencing 
The RT-PCR products were analyzed by a 0.8% agarose gel 
electrophoresis. The two PGR fragments representing ORFs 2 and 3 as well as 
ORFs 4 and 5, respectively, were purified by the glassmilk procedure 
(GENECLEAN kit, BIO 101, Inc.). The purified fragments were each digested with 
BamH I and EcoR I, and cloned into the vector pSK+ as described previously 
(Meng et al., 1993). The E coll DH 5a cells were used for transformation of 
recombinant plasmids. White colonies were selected and grown in LB broth 
containing 100 |ig/ml ampicillin. The E. coli cells containing recombinant plasmid 
were lysed with lysozyme, and the plasmids were then isolated by using the 
QIAGEN column chromatography (QIAGEN, Inc.). 
Plasmids containing viral inserts were sequenced with an automated DNA 
Sequencer (Applied Biosystem, Inc.). Three or more independent cDNA clones 
representing the entire sequence of ORFs 2 to 5 from each of the three PRRSV 
isolates were sequenced with universal and reverse primers. Several virus-
specific primers, XM969 (5'-GATAGAGTCTGCCCTTAG-3'), XM970 (5'-GGTTTCA 
CCTAGAATGGC-3'), XM1006 (5'-GCTTCTGAGATGAGTGA-3'), XM077 (5'-CAACC 
AGGCGTAAACACT-3'), and XM078 (5'-CTGAGCAATTACAGAAG-3'), were also 
used to determine the sequence of ORFs 2 to 5. 
Sequence and phylogenetic analyses 
Sequence data were combined and analyzed by using MacVector 
(International Biotechnologies, Inc.) and GeneWorks (IntelliGenetics, Inc.) computer 
software programs. Phylogenetic analyses were performed using the PAUP 
software package version 3.1.1 (David L. Swofford, Illinois Natural History Survey, 
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Champaign, IL). PAUP employs the maximum parsimony algorithm to construct 
phylogenetic trees. 
Results 
Nucleotide sequence analyses of ORFs 2 to 5 
The sequences of ORFs 2 to 5 of the three PRRSV isolates, ISU22, ISU55 
and ISU3927, were determined and compared with other known PRRSV isolates 
including VR2385 (Meng et al., 1994; Morozov et al., 1995), ISU79 and ISU1894 
(Meng et al., 1995b), VR2332 (Murtaugh et al., 1995) and the European LV 
(Meulenberg et al., 1993a). It has been shown that isolates VR2385 and ISU79 
were highly pneumopathogenic, and isolates 1SU1894 and the European LV were 
of Icw-pneumopathogenicity (Halbur et al., 1995b, 1995c). Like other U. S. PRRSV 
isolates, ORFs 2 to 4 of these three U. S. isolates ISU22,1SU55 and ISLI3927 
overlapped each other (Rg. 1). However, unlike the European LV (Meulenberg et 
al., 1993a), ORFs 4 and 5 of all the U. S. isolates sequenced so far do not overlap 
and are separated by 10 nucleotides (Fig. 1). ORFs 4 and 5 of the LV overlapped 
by one nucleotide, the junction region between ORFs 4 and 5 in LV is ATATGA 
(Meulenberg et al., 1993a). The single nucleotide substitution from A in the start 
codon of ORF 5 of LV to T in all U. S. isolates makes the start codon of ORF 5 of the 
U. S. isolates 10 nucleotides downstream of the ORF 4 stop codon. Therefore, a 10 
nucleotide noncoding sequence appeared between ORFs 4 and 5 of all the U. S. 
isolates (Fig. 1). The size of ORFs 2 to 5 of all the U. S. isolates are identical except 
for the ORF 2 of ISLI79 and ORF 5 of 1SU3927 which are both 3 nucleotides shorter 
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(Fig. 1). The single nucleotide substitution from TGG to TAG just before the stop 
codon of ORF 2 creates a new stop codon in the isolate ISU79 (Fig. 1). A three 
nucleotide deletion was also found in ORF 5 of the isolate ISU3927 (Fig. 1). 
Sequence comparison of ORFs 2 to 5 of seven U. S. PRRSV isolates 
indicates that there are considerable nucleotide sequence variations in ORFs 2 to 5 
(Fig. 1). The nucleotide sequence identity was 96-98% in ORF 2, 92-98% in ORF 3, 
92-99% in ORF 4, and 90-98% in ORF 5 between VR2385, VR2332, ISU22, ISU55, 
1SU79, and ISU1894 (Table 1). The least virulence U. S. isolate 1SU3927 has the 
most variation compared to the other six U. S. isolates (Rg. 1 and Table 1). The 
nucleotide sequence identity between ISU3927 and the other U. S. isolates was 
93-94% in ORF 2, 89-90% in ORF 3, and 91 -93% in ORF 4 (Table 1). ORF 5 of 
ISU3927 had a three nucleotide deletion compared to other U. S. isolates (Fig. 1); 
it shares 91-93% nucleotide sequence identity with ORF 5 of other U. S. isolates 
(Table 1). These results indicate that U. S. isolates VR2385, VR2332,1SU22, 
1SU55,1SU79, and ISU1894 are more closely related to each other than they are to 
the least virulence U. S. isolate ISU3927. Extensive sequence variation was found 
in ORFs 2 to 5 between the European LV and the U. S. isolates (Fig. 1 and Table 
1). The nucleotide sequence identity between LV and the U. S. isolates was 65-
67% in ORF 2, 61-64% in ORF 3, 63-66% in ORF 4, and 61-63% in ORF 5 (Table 
1). Extensive genetic variation in ORFs 6 and 7 between LV and U. S. PRRSV has 
also been reported previously (Meng et al., 1994,1995a). 
We have previously shown that, in addition to the genomic RNA, a nested 
set of six or seven subgenomic mRNAs is formed in cells infected with different 
PRRSV isolates including VR2385 (Meng et al., 1994), ISU22, ISU55, ISU79, 
1SU1894 and 1SU3927 (Meng et al., 1995b). The isolates VR2385, ISU22 and 
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ISU1894 produced six sg mRNAs, whereas isolates ISU55, ISU79 and ISU3927 
synthesized seven sg mRNAs (Meng et al., 1994,1995b). The additional species 
of sg mRNA, designated as sg mRNA 4-1, in isolate ISU79 was found to be 
generated from the sequence upstream of ORF 4 (Meng et al., 1995b). It has been 
shown that a single nucleotide substitution, from T in ISU1894 to C in ISU79, led to 
the acquisition of an additional leader-mRNA junction sequence TTGACC in 
ISU79, and therefore an additional species of sg mRNA 4-1 in ISU79 virus-infected 
cells (Meng et al., 1995b). In this study, the sequences of three more U. S. isolates, 
ISU22, ISU55 and ISU3927, were analyzed (Fig. 1). The single nucleotide 
substitution observed in the isolate ISU79 was also present in isolates ISU55 and 
ISU3927 (Fig. 1) which both produced seven sg mRNAs (Meng et al., 1995b), but 
not in isolates ISU22 and ISU1894 (Fig. 1) which synthesized only six sg mRNAs 
(Meng et al., 1995b). The results indicate that the leader-mRNA 4-1 junction 
sequence of ISU55 and ISU3927 is very likely to be the same as the isolate ISU79 
(Fig. 1). The leader-mRNA junction sequences for sg mRNAs 3 and 4 of 1SU79 and 
ISU1894 were determined to be GTAACC at 89 nucleotides upstream of ORF 3 for 
sg mRNA 3 and TTCACC at 10 nucleotides upstream of ORF 4 for sg mRNA 4 
(Meng et al., 1995b). Sequence comparison of isolates ISU22, ISU55 and 
ISU3927 with isolates VR2385 (Morozov et al., 1995), ISU79, ISU1894 (Meng et 
al., 1995b) indicates that the leader-mRNA junction sequences for sg mRNAs 3 and 
4 are conserved among all the U. S. isolates (Fig. 1). However, the locations of the 
leader-mRNA junction sequences for subgenomic mRNAs 3 and 4 of the U. S. 
isolates are different from those of LV (Meulenberg et al., 1993b). 
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Analysis of the deduced amino acid sequences encoded by ORFs 2 to 5 
On the basis of its high content of basic amino acids and its hydrophiiic 
nature, the translation product of ORF 7 was predicted to be the nucleocapsid 
protein (Conzelmann et al., 1993; Meulenberg et al., 1993; Mardassi et al., 1994; 
Meng et al., 1994). The ORF 6 gene product lacks a potential amino-terminal 
signal sequence and contains several hydrophobic regions which may represent 
the potential transmembrane fragments. Therefore, the ORF 6 gene product was 
predicted to be the M protein (Conzelmann et al., 1993; Meulenberg et al., 1993; 
Meng et al., 1994). Computer analysis of ORFs 2 to 5 showed that the products 
encoded by ORFs 2 to 5 of the U. S. isolates all have hydropathy characteristics 
reminiscent of the membrane-associated proteins. The translation products of 
ORFs 2 to 5 each contain a hydrophobic amino terminus (data not shown). The N-
terminal hydrophobic sequences may function as a signal sequence for each of 
these ORFs and they may be involved in the transport of ORFs 2 to 5 to the 
endoplasmic reticulum. At least one additional hydrophobic domain in each of 
ORFs 2 to 5 was found at the carboxy termini which may function as a membrane 
anchor (data not shown). 
The deduced amino acid sequences of ORFs 2 to 5 of the seven U. S. 
isolates also varied considerably (Rg. 2), indicating that most of the nucleotide 
differences observed in Fig. 1 are not just silent mutations. The amino acid 
sequence identity between VR2385, VR2332, ISU22, ISU55, ISU79, and ISLI1894 
was 95-99% in ORF 2, 90-98% in ORF 3, 94-98% in ORF 4, and 88-97% in ORF 5 
(Table 1). Again, the least virulence isolate, ISU3927, displayed higher sequence 
variations compared to other U. S. isolates in ORFs 2 to 4 (Fig. 2 and Table 1), and 
only little variation in ORFs 5 to 7 (Meng et al., 1995a and Table 1). The amino acid 
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sequence identity between the isolate ISU3927 and other U. S. isolates is 91-93% 
in ORF 2, 86-88% in ORF 3, and 92-93% in ORF 4. The ORFs 2 to 5 of the 
European LV share only 57-61%, 55-56%, 65-67%, and 51-55% amino acid 
sequence identity with those of the U. S. isolates, respectively {Table 1). The size 
of ORFs 2 to 5 of all U. S. isolates are identical except that there is one amino acid 
deletion in the N-terminal hypervariable region of ORF 5 of the isolate ISU3927 
and in the C-terminus of ORF 2 of the isolate ISU79 (Fig. 2A, 2D). However, 
deletions or Insertions between the European LV and the U. S. isolates were found 
throughout ORFs 2 to 5 (Fig. 2). 
Sequence comparison of ORF 5 gene product showed that the hydrophobic 
N-terminal region of ORF 5 is extremely variable, not only between the U. S. 
isolates and the European LV but among the U. S. isolates as well (Fig. 2D). It has 
been predicted that the first 32-33 amino acid residues of ORF 5 is the signal 
sequence of ORF 5 in LV (Meulenberg et al., 1995; Fig. 2D). Therefore, the 
potential signal sequence of ORF 5 in all the PRRSV isolates is very 
heterogeneous. An additional hypen/ariable region immediately following the 
signal sequence (positions 34-40 amino acid residues) was also identified by 
comparing the amino acid sequences of ORF 5 of all the PRRSV isolates available 
(Fig. 2D). Amino acid variations in this hypervariable region are significant, and 
are not structurally conserved (Fig. 2D). Computer analysis indicates that this 
hypen^ariable region is very hydrophilic and antigenic (data not shown). Thus, it is 
likely that this hypervariable region is exposed on the viral membrane and is under 
the host immune selection pressure. However, many other non-conserved amino 
acid substitutions were also found within the ORF 5 protein (Fig. 2D), especially at 
positions 60-68 and 122-130 amino acid residues (Fig. 2D). 
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Phylogenetic relationship among U. S. isolates of PRRSV 
It has been shown previously that the U. S. PRRSV and the European 
PRRSV represent two distinct genotypes based on the M and N genes (Meng et al., 
1995a). To determine the phylogenetic relationships of U. S. PRRSV isolates, 
ORFs 2 to 7 of seven U. S. PRRSV isolates were first aligned with the GeneWorks 
program (IntelliGenetics, Inc.). The PAUP program (David L Swofford, Illinois 
Natural History Survey, Champaign, IL) was then used to construct a phylogenetic 
tree illustrating relationships among U. S. isolates of PRRSV. The phylogenetic 
tree based on ORFs 2 to 7 sequences indicates that at least three groups of PRRSV 
variants (or minor genotypes) exist within the major U. S. PRRSV genotype (Fig. 3). 
The least virulence U. S. PRRSV isolate ISU3927 forms a branch distinct from 
other U. S. isolates (Fig. 3). Isolates ISU22, ISU79, ISU1894, and VR2332 form 
another branch which represent a minor genotype. The third minor genotype was 
represented by isolates ISU79 and VR2385 (Rg. 3). A very similar tree was also 
obtained by analyzing the last 60 nucleotides of ORF 1b of seven U. S. isolates 
presented in Fig. 1 (data not shown). Identical tree topology was also produced by 
the unweighted pair-group method with arithmetic mean (LIPOMA) using the 
GeneWorks program (data not shown). 
Discussion 
We present here the sequence analysis of ORFs 2 to 5 of a low virulence U. 
S. PRRSV isolate and two other U. S. isolates with moderate and high 
pathogenicity, respectively. Sequence comparison with other published PRRSV 
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isolates showed considerable variations at both nucleotide and amino acid 
sequence level in ORFs 2 to 5 of seven U. S. isolates with differing virulence. 
However, ORFs 6 and 7 of these seven U. S. isolates are highly conserved (Meng 
et al., 1995a). Extensive sequence variations were also found in ORFs 2 to 7 
between the European LV and the U. S. isolates. The least virulence U. S. PRRSV 
isolate, ISU3927, displayed more sequence variation than other U. S. isolates. 
It has been reported that two major genotypes of PRRSV exist in the U. S. 
and Europe (Meng et al., 1995a). Phylogenetic analysis of ORFs 2 to 7 of the U. S. 
isolates indicated that there are at least three groups of PRRSV variants (or minor 
genotypes) within the major genotype of U. S. PRRSV. So, it is highly likely that a 
number of additional major or minor genotypes will be identified as more virus 
isolates from different geographic regions are examined. Interestingly, the least 
virulence U. S. isolate, ISU3927, forms a branch distinct from other U. S. isolates. 
Analysis of the nucleotide and amino acid sequences also showed that the least 
virulence isolate, ISU3927, exhibited the most variations in ORFs 2 to 4, and only 
little variations in ORFs 5 to 7, as compared to other U. S. isolates. Many of these 
variations in the isolate ISU3927 resulted in non-conserved amino acid 
substitutions. However, these non-conserved changes in isolate ISU3927 as 
compared to other U. S. isolates are not limited to a particular region or ORF and 
they are present throughout ORFs 2 to 4. Therefore, it is difficult to speculate 
regarding any correlation between sequence variation and viral virulence. 
Recent study has shown that the virions of the European LV contain three 
structural proteins, a nucleocapsid protein (N) encoded by ORF 7, an 
unglycosylated membrane protein (M) encoded by ORF 6, and a glycosylated 
envelope protein (E) encoded by ORF 5 (Meulenberg et al., 1995). The major 
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envelope glycoprotein of EAV encoded by ORF 5 may be the virus attachment 
protein, and neutralizing monoclonal antibodies (MAbs) are directed to this protein 
(De Vries et al., 1992; Faaberg et al., 1995). The primary envelope glycoprotein of 
LDV is also encoded by ORF 5, and several different neutralizing MAbs were found 
to specifically immunoprecipitate the ORF 5 protein of LDV (Cafruny et al., 1986; 
Faaberg et al., 1995). Therefore, it is likely that the major envelope protein of 
PRRSV encoded by ORF 5 may induce neutralizing antibodies against PRRSV. 
Sequence analysis of the ORF 5 protein of different PRRSV isolates revealed a 
hypervariable region which contained non-conserved amino acid substitutions. 
This region is hydrophilic and also antigenic as predicted by computer analysis. It 
has been proposed that antigenic variation of viruses is the result of direct selection 
of variants by host immune responses, although new observations suggest that this 
may not be true for all viruses (reviewed by Domingo et al., 1993). This 
hypervariable region is likely evolved because of selection pressure by host 
immune system; thus providing a possible explanation for the observed antigenic 
diversity among PRRSV isolates (Wensvoort et al., 1992). However, at least two 
other variable regions in ORF 5 were also identified (Fig. 2D, positions 60-68 and 
122-130 amino acid residues), the significance of these variations needs to be 
further studied. The M and N proteins of U. S. PRRSV isolates including the isolate 
ISU3927 are very conserved (Meng et al., 1995a). The M and N proteins are 
integral to preserving the structure of PRRSV virions and the N protein may be 
under strict functional constraints. Therefore, it is unlikely that the M and N proteins 
are subjected to major antibody selection pressure. Interestingly, higher sequence 
variation of the M protein of LDV was observed between LDV isolates with differing 
neurovirulence (Kuo et al., 1992). 
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In summary, we have confirmed and extended our previous report of 
different genotypes of PRRSV and have identified at least three minor genotypes 
within the major genotype of U. S. PRRSV, based on an analysis of the sequence 
of ORFs 2 to 7. We have also further confirmed that genetic variations exist not only 
between European PRRSV and U. S. PRRSV but among the U. S. PRRSV isolates 
as well, indicating the heterogeneous nature of PRRSV. The least virulence U. S. 
PRRSV isolate has higher sequence variation in ORFs 2 to 4 compared to other U. 
S. isolates. Further experiments are warranted to study the virulence determinant 
(s) of PRRSV. 
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Table 1 Nucleotide sequence (lower left half) and deduced amino acid 
sequence (upper right half) identities (%) of ORFs 2 to 5 of PRRSV 
ORF 2 VR2385 ISU22 ISU55 ISU79 ISU1894 ISU3927 VR2332 LV 
VR2385 ** 97 96 96 95 91 98 58 
ISU22 97 96 98 96 93 99 59 
ISU55 98 97 ** 96 95 91 97 61 
ISU79 96 97 97 *it 96 91 98 60 
ISU1894 96 97 96 96 • • 93 96 57 
ISU3927 94 94 94 93 93 ** 93 58 
VR2332 97 98 97 98 97 94 ** 59 
LV 65 66 66 67 66 65 66 • • 
ORF 3 
VR2385 ** 91 94 92 90 87 91 55 
ISU22 92 ** 93 96 96 88 98 56 
ISU55 94 93 *• 94 93 87 94 56 
ISU79 94 96 94 ** 95 87 96 56 
ISU1894 92 97 93 96 ** 86 96 55 
ISU3927 90 90 89 90 90 87 55 
VR2332 93 98 94 97 97 90 •kit 56 
LV 64 63 62 63 63 61 63 • • 
ORF 4 
VR2385 ** 94 96 94 95 93 94 66 
ISU22 93 94 97 99 93 98 66 
iSU55 96 94 ** 96 96 93 95 67 
ISU79 93 97 94 ic* 98 92 96 66 
1SU1894 92 98 94 96 tr-k 93 98 66 
ISU3927 91 93 92 91 91 92 67 
VR2332 94 99 95 97 98 92 ** 65 
LV 66 66 63 65 66 65 65 
ORF 5 
VR2385 • * 90 91 88 89 91 89 54 
ISU22 93 90 94 96 92 97 52 
1SU55 94 92 ** 89 89 90 89 51 
ISU79 91 95 91 95 89 94 53 
ISU1894 92 97 90 94 ** 91 96 53 
ISU3927 91 93 91 91 91 ** 91 55 
VR2332 93 98 91 95 97 92 • * 53 
LV 63 63 63 61 62 63 63 
Figure 1 Nucleotide sequence comparison of ORFs 2 to 5 of U. S. isolates ISU3927, ISU22 and ISU55 
sequenced in this study with other known PRRSV isolates. The nucleotide sequence of the 
VR2385 was shown on top, and only differences were indicated. The start codon of each ORF was 
indicated by +>, and the termination codon of each ORF was indicated by asterisks (*). Deletions 
were indicated by (-). The leader-mRNA junction sequences for subgenomic mRNAs 3, 4 and 4-1 
were underlined, and the locations of the junction sequences relative to the start codon of each 
ORF are indicated by minus (-) numbers of nucleotides upstream of each ORF. The sequences of 
VR2385 (Meng et al., 1994; Morozov et al., 1995), VR2332 (Murtaugh et al., 1995), and ISU79 and 
ISU1894 (Meng et al., 1995b) used in this alignment were previously reported. 
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-e9(liJUA3) 
GCA'rc'rrcCCGCCATI>3AAGCCGAGACCTGTAAATA'IV:T3GCCTC'rcGGCT3':C rATSCTACACCACCTCCGCATCACAGGGTrAAATCTAACCATAGTCTATAATAGTA-^TTTC/iATVA 
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GCAGC03CAGAG3CCTACGAACCCGGCAGGTCCC'm>3GT3CA<:K5ATA0:>3CATGATCGAT3TGG3GA3GACGATCATGATGAACTAGGGTTrGTGGTGCCGTCT3GCCT:'n::CAG:GAA 960 C. .AT AA T C. . .A T C. .C A. . .ACA. .A. . .C AA. .. 960 
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-236(nANX4-l} G3CCACJ!I5£^££AGTGC'PrACGCCT3G'rP33CGTCC':T3TCCTTCAGCTATAC03CCCAGITrCATCCCGAGATATTCGGGATAGGGAAT3TCAGTC3AGT:TATCTP3ACA'P:AAGCAC 1080 
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Figure 1. (continued). 
***<0RF3 
VP.2385 CAGCGGCA03C'rrrGCTCTr'rrrCAAGACATN:AG'rn3CCTTAGGCA'I\:G2AACTeGGCCTC'I>3A(J3CGATrCGCAAAG'I\:cCTVrAGTCCCGCACGGCGATA033ACACCCG'I\;TATATCA 1440 
ISU3927 .G. .A.. .AAT. .C G G.C G A. .A T A 1440 
ISU55 T T A ....T..T A T. 1440 
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VR2332 A G A T G.T. 1440 
ISU1894 A A T T. 1440 
ISU79 A A T TA T. 1440 
VR238S CT\3TCACAG"CAATGTTACCGATCAGAArrATTIGCATTC(rrcTCATV:rrcTCA1X;CTTI^TOTT>3CCriTrcTATCCTrcTCAGATCAGTCAAAAQ3GA'nTAAGGT03TATTTCaCA 1S60 
ISU3927 ..A A..A C T C C G G 1560 
ISUS5 . .G A C C A 1560 
ISU22 ,CA G..A A T C G 1560 
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ISU1894 .CA G. .A A T C C A C 1560 
ISU79 .CA G. .A A A T C C G T 1560 
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TGGTGTA'I\:?3TGCCGTCTT3TTIT3TT3CG::TCGTCAGCGCCAACGGGAACAGCGGCTCAAATTTACAGC'rcATrTACAAC'nGACGCTAT3T>3AGC'P3AA'r33':ACAGATT3GCTAGCT 1920 
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G. . 
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C A.C.G. .A.A.. . 
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C. .T C. .A G. .CC A. . . 
•C. .T C.GA.. . .C. .A.C A.. . 
TC. 
. . .T T. . .C C G. .. 1917 
. . .T T T 1920 
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CC..C 1920 
TV:. .C.G. .AT 1920 
VR2385 ISU3927 
ISU55 
ISU22 
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AATAAATTrcACTGG3CAGT33AGT>3TITrcTCATriTn:CTGTCTTCACTCACA'rP3T:TCTTA'I\3GTCCCCT:ACTACTAGCCATrK:criGACACAG'I\:GGTCTCG'I\:ACTCTC'I\:T 2040 
T A C C T. .C A C..C T 2037 
.......C. 2040 
T A C C..T C C C.T.A 20-10 
,.C T A C C..T C C C.T.A 2040 
G T A C C..T C C CCT.A 2040 
G. . .0 T A.C C T C C C. .C A.T.C.T.A 2040 
Figure 1. (continued). 
VR2385 AC'CGCTCGGTTTCTT^rACGGGCGGTAT3TTCT>3AGTAGCAT3T/v::GCG'3TV:TGTGCCCTGGCTCCG'ITGATTrcC'rrCGTrA'ITAG3C'rrcCGAAGAATT3--ATU'I\:C'r53CGCTAC'rrA 2160 
ISU3927 C CA C T T C T 2157 
ISU55 C..C...TCC C T..A 2160 
ISU22 C  C  C  C  A C . . . T  A G2160 
VR2332 C C.,A C C T A G.G2160 
ISU1894 C C..A C AGC T A T. .G 2160 
ISU79 C C..A C C T...T 2160 
VR2385 TGTACCAGATATACCAACrrrc'rrcTGGACACTAAG3GCAGACT:TAT'CGTTGGCGG'I\:GCCTG'K:A'K:ATAGAGAAAAGGGGCAAAG'nX3AGG1\:GAAGGTCACC'IGAT2GACCTrAAA 2280 
ISU3927 C A G T. .G T A... 2277 
ISU55 T T G 2280 
ISU22 C T 2280 
VR2332 T 2280 
ISU1894 AT T 2280 
ISU79 T T G  T T 2280 
***<0Rr5 
VR2385 AGAGTTCTC-^TTCATCGTTCCGCGGCTACCCCTCTAACCAGAGmvrAGCGGAACAATCGAGTOGTCCTrAO 2 352 
Figure 1. (continued). 
Figure 2 Aiignment of the deduced amino acid sequences of ORF 2 (A), ORF 3 (B), ORF 4 (C), and ORF 5 
(D) of U. S. isolates ISU22, ISU55 and ISU3927 sequenced in this study with other PRRSV 
isolates. The sequence of the isolate VR2385 is shown on top, and only differences were 
indicated. Deletions were indicated by (-). The proposed signal sequence in the ORF 5 of LV (D) 
is underlined (Meulenberg et al., 1995). The hypervariable region with antigenic potential in the 
ORF 5 (D) was indicated by asterisks (*). The other two variable regions are indicated by C^). The 
published sequences used in this alignment were LV (Meulenberg et al., 1993), VR 2385 (Meng et 
al., 1994; Morozov et al., 1995), VR 2332 (Murtaugh et al., 1995), ISU79 and ISU1894 (Meng et 
a!., 1995b). 
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ISU1894 I SE....I G..P...W 256 
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VR2332 I I V 256 
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VR2385 RAl-IS'CTFLVIFLCCSFLVSFOCAWAGSHATYCFVJFPLVRGMFSFELTViri'P/CPPCLTRQAAAEAVEFGRSLWCRIGHDRCGEDDHDEL 90 
ISU55 T Y 90 
IS(.79 A..H L T I Y 90 
ISU1894 .V H A H V Y 90 
ISU22 .V H T.F I Y 90 
ISL:3927 H.L V..TDA...F M QI...M II 90 
VR2332 .V H T T.I Y 90 
LV . .HQ.ARFHF. . .GFIC.LVHS.L.ASH.SS.L AH. .T I. . . I .H. .S.S. . .RQRL IHI. .K E.R 90 
VR2385 GFWPSGLSSEGHLTSAYAV.'LASLSFSYTTOFHPEIFGIGUVSRVA'DIKHQFrCAVHDGQHTTLPHHDniS.AVLQTYYQHOVDGGlMFH 180 
ISU55 V F A Q R A...R F 180 
ISU79 ..MI V F A L...E R F 180 
ISU1894 ..HI.P V F A L...E A...R F 180 
ISU22 ..M..P.F V F A L...E R F 180 
ISU3927 ..T..P...K.Y V F A K M. .L R F 180 
VR2332 ..MI.P G^.' F A L...E R F 180 
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ISU3927 ...L RO.IS. . .R. .A--. . .M 254 
VR2332 ...L H L.IL -- ..--...V.. 254 
LV . . .L. .L I V.P. .R. lY. XL. . .R. RLPVSW. FR. . IVSD.TGSOaPK • K . PSESRPITA'. PSV. PSTS . 265 
Figure 2. (continued). 
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VR2332 - A.. 175 
ISU55 - A.. 175 
ISU139.4 R - A.. 175 
ISU22 R - A.. 175 
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LV ..S..YUA A I V.SA D. .A. .TiH. .QHHL. IDHI L..SA TI A.. 180 
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ISU55 ... 178 
ISU1894 ... 178 
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Figure 2. (continued). 
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VR2385 MLGKCLTAGCCSQLLFLV.'CIVPSCFVA--LVSAI-lGIISGSULQLIYnLTLCELIIGTD'.';LAllKFD'.-/AVECF'.'IFPYLTHIVSVG.ZiLTTSHFL 
VP.2332 . .E P.. .S F. .AV-- .All.SMD.S.H S 
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ISU3927 P.S F.UA.-- -..S.H S 
LV .RCSHKLGRFr.TPHSCF.WLFLL.TGLSWSF.D. .GDS.TY.V I SSH.G T. .LY. .A. . .L.L.F F 
(60-60) 
VR2385 DTVGLVTVSTAGP/HGRT/LSSI.|YAVCALAALICF\aRUAKJia-ISWRYSCrRYTIIFLLDTKGRLYRVJRSPVIIEK.RGh?.'P/EGHLIDLKP. 
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LV .AL. .GA G C.V.GA. .F. .FV A AC . . AR. . F . . . IV .DR. . VH . .K . . IW . .L. .A. .D.II.VTI.H 
" (122-130) 
yR2385 VVLD3SAATPVTP.VSAE;WSRP 200 
VP.2332 V...I G.. 200 
ISU55 1.K G.. 200 
ISU1894 V...I G.. 200 
ISU79 V...I G.. 200 
ISU22 V...I G.. 200 
ISU3927 L G.. 199 
LV . . .E.VK..Q.L. .T EA- 201 
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Figure 2. (continued). 
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Figure 3 Piiylogenetic tree based on the nucleotide sequences of ORFs 2 to 7 
of seven U. S. PRRSV isolates with differing virulence. The tree was 
constructed by maximum parsimony methods with the aid of the PAUP 
software package version 3.1.1. The tree with the shortest length (most 
parsimonious) was found by implementing the exhaustive search option. The 
branch lengths (numbers of nucleotide substitutions) are given above each 
branch. The sequences used in the analysis are LV (Meulenberg et al., 
1993), VR 2385 (Meng et al., 1994; Morozov et al., 1995), VR 2332 (Murtaugh 
et al., 1995), ISU 79 and ISU 1894 (Meng et al., 1995b). 
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GENERAL CONCLUSION 
My colleagues and I have proved our original hypothesis that the respiratory 
disease in nursery and growing pigs was caused by a virus, PRRSV. PRRSV was 
then propagated and characterized in a continuous cell line designated as ATCC 
CRL11171. My colleagues and I also showed that PRRSV is evolutionarily related 
to LDV, EAV and SHFV and belongs to the newly proposed Arteriviridae family. 
The data obtained from this dissertation research also supported the hypothesis 
that there is a genetic basis for the observed difference in virulence among PRRSV 
isolates. Genetic variation was found not only between U.S. and European 
PRRSV isolates but among U.S. isolates as well, and a low virulence U.S. isolate 
had highest sequence variation compared to other U.S. isolates. However, more 
work is needed to identify the virulence determinant (s) of PRRSV. 
In the first study, twenty-four different cell lines or primary cells from various 
species of animals and different tissues of origin were tested for susceptibility to 
PRRSV. In addition to the primary swine alveolar macrophages (SAM), a 
continuous cell line, ATCC CRL11171, was found to support the replication of 
PRRSV. A PRRSV, ATCC VR2385, was isolated from the lung homogenate of a 
four-week-old pig with severe interstitial pneumonia, myocarditis, and encephalitis, 
and subsequently characterized in CRL11171 cells. The VR2385 virus produced 
cytopathic effects in SAM cultures and in CRL11171 cells. Evidence for virus 
replication was not observed in twenty-two additional cell lines or primary cell 
cultures that were tested. The high virulence VR2385 virus was shown to be a 
PRRSV by immunofluorescence assay (IFA) and radioimmunoprecipitation (RIP) 
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using polyclonal and monoclonal antibodies against PRRSV. The VR2385 virus 
was an enveloped, nonhemagglutinating, spherical RNA virus with a size of 50-70 
nm in diameter. The VR2385 virus can replicate to a high titer (10® to 10^ 
TCIDso/ml) in CRL11171 cells and had a buoyant density of 1.15-1.18 g/ml in 
cesium chloride gradient. Fifteen additional isolates of PRRSV were isolated using 
CRL11171 cells, and these isolates have been shown to differ in virulence (Halbur 
et al., 1995c, 1995d). Up to the present, PRRSV has been shown to replicate in 
SAM cultures and two other continuous cell lines, CL2621 and MARC-145 
(Wensvoort etal., 1991; Benfield etal., 1992; Collins etal., 1992; Kim etal., 1993). 
However, the CRL11171 cells found in this study supports growth of PRRSV 
isolates that did not replicate in CI-2621 cell line at the National Veterinary 
Services Laboratory. Differences in the susceptibility of CL2621 to different 
isolates of PRRSV were also reported as not all virus growing on SAM replicated 
on CL2621 (Bautista etal., 1993). Considerable antigenic and genetic variations 
were found among PRRSV isolates with differing virulence (Wensvoort et al., 1992; 
Meng et al., 1994,1995a, 1995d). It is likely that the observed differences in the 
ability to replicate in various cell cultures and the differences in virulence among 
PRRSV isolates are caused by antigenic and genetic variations. The ATCC 
CRL11171 cells will be a useful cell line in PRRSV research and diagnosis. 
Once PRRSV was propagated in this continuous cell line, CRL11171, my 
colleagues and 1 cloned and sequenced the 3'-terminal genomic RNA of a U.S. 
PRRSV isolate ATCC VR2385. The genomic RNA of the VR2385 was copied into 
cDNA after priming with oligo (dT) and cloned into lambda phage. By using 
differential hybridization technique, the first positive clone representing PRRSV 
cDNA was identified. The cDNA clones representing the 3'-termlnal genomic RNA 
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of VR2385 were isolated and sequenced. The PRRSV VR2385 genome was found 
to be a positive-stranded, polyadenylated RNA with an estimated size of 15 Kb. 
Three complete open reading frames (ORFs), with the potential to encode 
polypeptides with predicted molecular mass of 22.2 (ORF 5), 19.1 (ORF 6) and 13.6 
(ORF 7) kDa, were identified in the resulting 3'-terminal sequence. ORF 7, which is 
closest to the 3' end, is predicted to encode a highly basic nucleocapsid protein, 
displaying 58% amino acid identity to the corresponding protein of the Leiystad 
virus (LV), a European PRRSV isolate. ORFs 6 and 5, preceding the ORF 7, are 
each predicted to encode proteins containing several hydrophobic domains that are 
thought to be membrane-associated. The VR2385 ORF 6 protein is the most 
conserved structural protein, it shares 78% amino acid identity to the equivalent LV 
protein, and ORF 5 shares only 54% of its amino acid sequence. Northern blot 
analysis revealed a 3'-coterminal nested set of 6 subgenomic RNAs in VR2385 
virus-infected ATCC CRL11171 cells. These results suggest that both the U.S. 
PRRSV and the European PRRSV are all members of the newly proposed 
Arteriviridae family which include LDV, EAV and SHFV{Den Boon et al., 1991; 
Plagemann and Moennig, 1992; Conzelmann et al., 1993; Meulenberg et al., 1993; 
Meng et al., 1994; Godeny et al., 1995). However, striking genetic variation exists 
between the U.S. PRRSV (VR2385) and the European PRRSV, indicating that the 
viruses causing PRRS, PEARS or SIRS are, if they are the same virus, highly 
variable. 
To determine the extent of genetic variation and the phylogenetic 
relationship of PRRSV, the putative membrane (M) protein (ORF 6) and 
nucleocapsid (N) protein (ORF 7) genes of five U.S. isolates of PRRSV with 
differing virulence were then cloned and sequenced. The deduced amino acid 
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sequences of the putative M and N proteins from these isolates were aligned, to the 
extent known, with other PRRSV isolates, and also other members of the proposed 
Arteriviridae family including LDV and EAV. There was 96-100% amino acid 
sequence identity in the putative M and N genes among U.S. and Canadian 
PRRSV isolates with differing virulence. However, their amino acid sequences 
varied extensively from those of European PRRSV isolates, and displayed only 57-
59% and 78-81% identity, respectively. The phylogenetic trees constructed on the 
basis of the putative M and N genes of the members of the proposed Arteriviridae 
family were similar and indicated that both U.S. and European PRRSV isolates 
were related to LDV and were distantly related to EAV. The U.S. and European 
PRRSV isolates fell into two distinct groups, suggesting that U.S. and European 
PRRSV isolates represent two distinct genotypes. A striking feature of RNA viruses 
is their rapid evolution resulting in extensive sequence variation (Koonin and Doija, 
1993). Genetic recombination between different positive-strand RNA viruses has 
been reported (Hahn et al., 1988; Lai, 1992). Therefore, the emergence of PRRSV 
and its close relatedness to LDV and EAV is not surprising. 
Since the ORF 6 (M gene) and ORF 7 (N gene) of six U. S. isolates of 
PRRSV with differing virulence were highly conserved, then the question was what 
is the genetic basis for the observed differences in virulence (Halbur et al., 1995c, 
1995d). To answer this question, the sequences of ORFs 2 to 5 of five U. S. 
isolates of PRRSV with differing virulence were then determined. The nucleotide 
and deduced amino acid sequences of these five U. S. isolates were compared 
with other known PRRSV isolates. The results indicated that considerable genetic 
variations exist not only between European PRRSV and U. S. PRRSV but among 
the U. S. isolates as well. The amino acid sequence identity between seven U. S. 
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PRRSV isolates was 91-99% in ORF 2, 86-98% in ORF 3, 92-99% in ORF 4, and 
88-97% in ORF 5. The low virulence U. S. isolate, ISU3927, had highest sequence 
variation in ORFs 2 to 4, and little variation in ORFs 5 to 7 compared to the other U. 
S. isolates. Many of these variations in the isolate ISU3927 resulted in non-
conserved amino acid substitutions. However, these non-conserved changes in 
isolate ISU3927 as compared to other U. S. isolates are not limited to a particular 
region or ORF and they are present throughout ORFs 2 to 4. Therefore, it is too 
early to speculate regarding any correlation between sequence variation and viral 
vioilence. A hypervariable region with antigenic potential was identified within the 
N-terminus of the major envelope glycoprotein encoded by ORF 5. This 
hypervariable region is likely evolved because of selection pressure by host 
immune system; thus providing a possible explanation for the observed antigenic 
diversity among PRRSV isolates (Wensvoort et al., 1992). Pairwise comparison of 
the sequence of ORFs 2 to 7 and phylogenetic tree analysis implied the existence 
of at least three groups of PRRSV variants (or minor genotypes) within the major 
genotype of U. S. PRRSV. The low virulence U. S. isolate formed a branch distinct 
from the other U. S. isolates. The results from this study further confirmed that 
genetic variations exist not only between European PRRSV and U. S. PRRSV but 
among the U. S. PRRSV isolates as well, indicating the heterogeneous nature of 
PRRSV. 
During the replication of PRRSV, six subgenomic mRNAs (sg mRNA), in 
addition to the genomic RNA, are synthesized (Conzelmann et al., 1993; 
Meulenberg et al., 1993; Meng et al., 1994). These sg mRNAs were characterized 
in more detail in this study. The sg mRNAs of PRRSV were found to form a 3'-
coterminal nested set in PRRSV-infected cells. Each of these sg mRNAs was 
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poiycistronic and contained multiple open reading frames (ORF) except for the 
smallest sg mRNA 7 as shown by Northern blot analysis using ORF-specific 
probes. The sg mRNAs were not packaged into the virions, and only the genomic 
RNA was detected in purified virions, suggesting that the encapsidation signal of 
PRRSV is likely localized in the ORF 1 region which is unique to the viral genome, 
but not present in the sg mRNAs. The numbers of sg mRNAs in PRRSV-infected 
cells varied from six to seven among PRRSV isolates with differing virulence. The 
additional species of sg mRNA in some isolates of PRRSV was shown to be 
derived from the sequence upstream of ORF 4, and was designated as sg mRNA 4-
1. The leader-mRNA junction sequences of sg mRNAs 3 and 4 of isolates ISU79 
and ISU1894 as well as sg mRNA 4-1 of the isolate ISU79 were determined to 
contain a common six nucleotide sequence motif, T(G)TA(G/C)ACC. Sequence 
analysis of the genomic RNA of the two U.S. isolates ISU79 (with sg mRNA 4-1-1) 
and ISU1894 (without sg mRNA 4-1-1) and their comparison with the European 
isolate Leiystad virus (LV) revealed heterogeneity of the leader-mRNA junction 
sequences. The numbers, locations and sequences of the leader-mRNA junction 
motifs varied between U.S. isolates and the European LV as well as among U.S. 
Isolates. The last three nucleotides, ACC, of the leader-mRNA junction sequences 
were invariable, and variations were found in the first three nucleotides. By 
comparing the 5'-terminal sequence of sg mRNA 4-1 with the genomic sequence of 
ISU79 and 1SU1894, it was found that a single nucleotide substitution, from T in 
isolate ISU1894 to C in isolate ISU79, led to the acquisition of a new leader-mRNA 
junction sequence, TTGACC, in isolate ISU79, and therefore an additional species 
of sg mRNA 4-1. This indicates that the last nucleotide of the leader-mRNA junction 
motif may be critical for the leader binding and for the initiation of transcription. A 
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small ORF (ORF 4-1) with a coding capacity of 45 amino acids was identified at the 
5'-end of the additional species of sg mRNA 4-1. This small ORF 4-1 stopped just 
one nucleotide before the start codon of ORF 4. Whether this ORF 4-1 encodes any 
protein or has any biological function remains to be studied. These data indicate 
that the sg mRNAs of PRRSV are polymorphic, and the number and the exact size 
of the sg mRNAs depend on the particular PRRSV isolate analyzed. However, a 
nested set of six sg mRNAs most likely reflects the standard arterivirus genome 
organization and transcription. 
Since PRRSV is a previously unrecognized virus and has been isolated only 
for about four years, there are many unanswered questions which need to be 
addressed. The role of the additional sg mRNA 4-1-1 in some isolates of PRRSV 
found in this study and the potential bicistronic function of sg mRNA 4-1 need to be 
clarified. The significance of the sequence variation found in the ORFs 2 to 4 
between the low virulence isolate ISU3927 and other U. S. isolates also need to be 
studied. Trans-complementation in ORFs 2 to 4 between low and high vinjience 
isolates of PRRSV would definitely provide some useful information about the 
virulence determinant (s) of PRRSV. However, an infectious molecular clone of 
PRRSV is needed to ultimately determine the viral virulence determinant (s). The 
extensive genetic variation among PRRSV isolates found in this study indicated the 
heterogenetic nature of this virus. The effect of the observed strain variation on 
vaccine development and diagnosis needs to be seriously considered. A common 
antigen must be identified to develop a reliable diagnostic test. Further antigenic 
and genetic characterizations of other PRRSV isolates in the world are needed 
before an effective vaccine can be developed. The pathogenesis of PRRSV in 
reproductive and respiratory diseases and the role of PRRSV in 
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immunosuppression and immunomodulation are poorly understood and require 
further study. Intensive basic research about PRRSV replication and gene 
expression strategies will also be beneficial from the future point of view because 
we don't know if PRRSV can cause diseases in humans and other animals. 
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APPENDIX: 
DEVELOPMENT OF A RADIOLABELED NUCLEIC ACID PROBE FOR THE 
DETECTION OF ENCEPHALOMYOCARDITIS VIRUS OF SWINE 
A paper published in the Journal of Veterinary Diagnostic Investigation' 1993, 
5:254-258. 
Xiang-Jin Meng, Prem S. Paul, Eric M. Vaughn and 
Jeff J. Zimmerman 
Short Communication 
Encephalomyocarditis virus (EMCV) is a member of the genus Cardiovirus 
of the family Picornaviridae and infects a number of species including mice, 
elephants, squirrels, swine and humans.20 EMCV infections in swine are usually 
sporadic in nature throughout the world. EMCV has been shown to cause 
encephalitis and myocarditis in young piglets with high mortality^-and has 
also been associated with maternal reproductive disease in swine.'*' 
Transplacental infection in pregnant sows has been demonstrated,but the role of 
EMCV in clinical reproductive disease in the U.S. swine herds is unclear. 
Serologic evidence of EMCV infection in swine without clinical problem has been 
reported.22 Serological data suggest that EMCV infections are widespread in the 
U.S. swine herds,2® but EMCV has been isolated from only a limited number of 
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cases.^1-^^' 26 Whether the poor success in EI\/ICV isolation from aborted fetuses is 
due to the lability of EMCV or the lack of any role of EMCV in swine reproductive 
disease has not been resolved. The presence of blocking antibodies may also 
interfere with the isolation of EMCV from clinical specimens. The recent isolation of 
porcine reproductive and respiratory syndrome (PRRS) virus from herds with 
reproductive failure has further confused what role EMCV has in swine 
reproductive failure in the U.S. swine herds.^' is, is 
It is generally believed that EMCV isolates are closely related antigenically 
and there is only one serotype of EMCV.20 Variants of EMCV have been isolated 
that differ in organ tropism and pathogenicity.^ Antigenic and genomic variability 
among various EMCV strains has also been reported and may be associated with 
the diversity in pathogenicity.^- 7.12.24.25 VP1 is the major polypeptide of EMCV 
against which virus neutralizing antibodies are directed. The VP1 gene is also the 
least-conserved capsid gene among different members of picornavirus. In contrast, 
the VPS and VP4 genes and the 5' nontranslated region of EMCV are more 
conserved."- ^3.20,26 j^e major objective of the present study was to determine 
whether a nucleic acid probe specific for EMCV infection in swine could be 
developed. Availability of such a probe should be useful in determining the 
prevalence and role of EMCV, if any, in swine reproductive failure. 
The EMCV strains used for this study were NVSL-FL,i^ MN-25,II-12 ATCC 
VR-1Georgia,^ OVL-5/90 ^ and Mengo.® The NVSL-FL strain was isolated 
initially from pigs in Florida. The MN-25 strain was isolated from an aborted swine 
fetus obtained from a Minnesota farm that had a history of acute reproductive 
failure and neonatal losses. The ATCC VR-129B was originally isolated from a 
chimpanzee and has been passaged in suckling mice or other hosts since 1944. 
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The Mengo virus was isolated from the cerebrospinal fluid and CNS tissue from a 
paralyzed rhesus monkey. The EMCV isolates were propagated in Vero cells, a 
continuous monkey kidney cell line (ATCC CCL 81). When more than 90% of the 
infected cells showed cytopathic changes, the cultures were frozen and thawed 
three times, and the culture medium was clarified by low-speed centrifugation for 
20 min. at 2,000 X g. Total RNA from cell lysates of EMCV-infected Vero cells and 
uninfected cells was extracted by phenol-chloroform extraction and ethanol 
precipitation. The RNA concentration was determined spectrophotometrically. First 
strand cDNA synthesis was accomplished by a "cDNA cycle kit for RT-PCR".'' The 
single-stranded cDNA was then extracted with phenol-chloroform, ethanol 
precipitated and resuspended in DEPC-treated sterile water. The design of the 
primers for reverse transcription-polymerase chain reaction (RT-PCR) amplification 
in this study were based on the published mouse VP1 gene sequence of the 
EMCV-D strain.3-17 26-mer oligonucleotides with BamHI restriction sites at the 
5' end of each primer corresponding to the positions 2716-2733 (5'-GGGGATC 
CGAGTTGAGAATGCTGAGA-3') and 3505-3522 (5'-GGGGATCCTCGGGGTCATG 
TCTATCT-3') of the VP1 gene of the mouse EMCV-D sequence were chosen as 
primers. The primers were synthesized as single-stranded DNA using an 
automated DNA synthesizer.^ PCR was performed in a total volume of 50 ^il 
containing 1X amplification buffer,^ 1 mM of each dNTP, 50 pmoles of each primer, 
0.1 |ig of sample cDNA, 2.5 units of Taq polymerase.*^ The samples were 
subjected to three programs in a programmable Thermocycler e as follows: 
program 1 (2 cycles of 2-min denaturation at 940C, 2-min annealing at 520C and 4-
min extension at 72oC), program 2 (25 cycles of 1-min denaturation at 94 oC, 1-min 
annealing at 52oC and 2-min extension at 720C) and program 3 (1 cycle of 1.5-min 
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denaturation at 940C, 1.5-min annealing at 52°C and 5-min extension at 72°C). A 
cDNA clone which contained the full length of mouse EMCV-D cDNA sequence, 
designated Plasmid PDlI^. 17 vvas used as a positive control for PGR. The PGR 
products were analyzed by 1% agarose gel electrophoresis prepared in 1 X TAE 
buffer. A major product of 806 bp which was the expected size of EMGV VP1 gene 
was obtained from all 6 isolates of EMGV and from the cloned mouse EMGV 
plasmid PDL, but not from uninfected Vero cells (Fig. 1). This indicates that the 
regions flanking the VP1 gene among different EMGV isolates are highly 
conserved. A computer analysis of the published sequences of the EMGV ATGG 
129B and EMGV-D revealed high sequence homology for the regions from which 
the PGR primers were selected.®-is 
To further confirm the specificity of the product of the first generation PGR, 
we designed two internal primers of 20-mer oligonucleotides corresponding to the 
positions 2861-2880 (5'-GTGTGGAAGGGTGGAATGTG-3') and 3316-3335 (5-
GGGGTTGTGAGGATTATAGG-3') of the VP1 gene of the mouse EMGV-D 
sequence. Nested-PGR was performed according to the procedure described 
above using the product of the first generation PGR as a template. A major nested-
PGR product of 474 bp fragment was obtained from all 6 EMGV isolates and the 
PDL plasmid cDNA which is the expected size to be generated from these internal 
primers (Fig. 2). 
The NVSL-FL VP1 cDNA of 806 bp generated by RT-PGR was excised from 
ethidium bromide-stained agarose gel, and purifled.9 The purified cDNA was then 
cloned into the pKS+ plasmid ^  by the process of directional cloning.21 The E. coli 
strain DH 5a cells was used for the transformation of recombinant plasmids. 
Gharacterization of recombinant plasmids was performed according to the 
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described metiiod.^i White colonies were selected and grown in LB broth 
containing 100|j.g/ml of ampicillin. The E. coli cells containing recombinant plasmid 
were lysed with lysozyme, and the plasmids were then isolated by the alkali lysis 
method-^i The VP1 gene probe from NVSL-FL strain of EMCV was obtained by 
digesting the recombinant VP1 gene clone, designated as pPSP913, with BamHI 
restriction endonuclease (Fig. 3). The pPSP913 clone was further confirmed by 
partial DNA sequencing using universal and reversal primers (data not shown). 
The released 806 bp VP1 gene fragment was then separated on a 0.8% agarose 
gel, purified and labeled with ^^p-dCTP by the random primer extension method.' 
The probe had a specific activity of 1 x 10^ c.p.m per |xg of DNA. 
Lysates prepared from uninfected Vero cells, and Vero cells infected with the 
6 EMCV isolates, swine enterovirus (groups 1, 2 and 8c) and TGEV (Miller strain) 
propagated on the swine testis cell line were incubated with proteinase K 
(lOOjig/ml) for 1 hr at 37°C. Samples of different concentrations were then directly 
applied onto a pretreated nylon membrane J using a 96-well hybridot manifold 
apparatus ^  according to the method described by Cova et al.^ Denatured full 
length cDNA of rotavirus NCDV strain was also dotted onto the membranes along 
with other controls. The membranes were air dried, and baked at 80oC for 2 hrs. 
Prehybridization and hybridization were carried out at 42^0 with 50% formamide 
as described previously® except these procedures were performed in roller bottles 
in a hybridization oven.e Membranes were washed at room temperature once in 2 
X SSC, 0.5% SDS for 15 min, once in 2 X SSC, 0.1% SDS for 30 min and three 
times at 65°C in 0.1 X SSC, 0.5% SDS for up to 3 hrs. The membranes were air 
dried and the X-ray film was exposed to the membranes for 16-72 hrs at -70°C 
before development. The results showed that the VP1 gene probe hybridized with 
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RNAs from all 4 swine EMCV isolates (NVSL-FL, MN-25, OVL and Georgia), but 
didn't hybridize with RNAs from the ATCC 129B and Mengo isolates which were 
originally isolated from a chimpanzee and a rhesus monkey, respectively (Fig. 4). 
No hybridization signal was demonstrated with the EMCV VP1 molecular probe 
toward the nucleic acids from uninfected cells or other viruses tested. To test the 
sensitivity of the VP1 probe, successive dilutions of MN-25 strain of EMCV infected 
Vero cell lysates ranging from lO"" to 10^ TCIDso per spot were dotted in duplicates 
and hybridized with the labeled VP1 gene probe.® The probe detected at least 
103TCIDso of EMCV, and it also showed that the limited detectability is less than 
0.3 ng of VP1 DNA (Fig. 5). Specificity and detection threshold tests of the probe 
were repeated three times with the similar results (data not shown). 
Results obtained from the hybridization indicate that genetic differences exist 
between the recent swine EMCV isolates analyzed in this study and the prototype 
EMCV isolates ATCC 129B and Mengo. Differences in pathogenicity of EMCV 
isolates have been also reported. The ATCC 1298 isolate was not pathogenic, but 
MN-25, MN-30 and NVSL-PR were highly pathogenic and NVSL-MDV was 
moderately pathogenic to swine fetuses.12 it was also reported that Quebec EMCV 
isolate Q.890 and ATCC 1298 isolate had some antigenic differences. The virus 
neutralization titer of antiserum to ATCC 1298 was four fold lower for Q.890 than 
ATCC 1298.7 Our data suggest that there may be correlation between the 
pathogenicity of EMCV in swine and its genetic makeup. To answer this question, 
we sequenced the VP1 region of EMCV NVSL-FL strain by a method for direct 
automated sequencing of PCR fragments^s. The VP1 probe sequence obtained 
was then compared with the published mouse EMCV-D and ATCC 1298 
sequences by a computer sequence alignment program.^"' 3- I8 jhe results 
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showed that the nucleotide sequence of the VP1 gene probe of EMCV NVSL-FL 
used in this study shared about 97% homology with the corresponding region of 
mouse ElVICV-D strain, but only shared 82% nucleotide sequences homology with 
the corresponding region of EMCV ATCC 129B strain. Also the nucleotide 
sequences homology of the VP1 regions between mouse EMCV-D strain and 
EMCV ATCC 129B strain was about 81%. These sequence differences may 
explain the diversity in pathogenicity among various EMCV isolates, and also could 
explain our hybridization results. Under the hybridization stringency used in this 
study, the VP1 gene probe from EMCV NVSL-FL strain is unlikely to hybridize with 
the prototype EMCV isolate ATCC 129B due to the genetic differences. 
The probe developed in this study was specific for EMCV of swine, also it 
was sensitive enough to detect the presence of EMCV genome in infected cell 
lysates without complicated RNA extraction and purification procedures. Therefore, 
this probe offers a rapid, specific and sensitive method for the detection of swine 
EMCV infection. Availability of this probe should make it feasible to better 
understand the pathogenesis of EMCV infection in swine, and possibly detect 
EMCV in dead and mummified fetuses where live virus cannot be isolated. 
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Figure 1. RT-PCR products amplified from RNAs extracted from EMCV-infected and uninfected Vero cells. 
Lane L, 1-kb ladder: Lane A, plasmid PDL containing mouse EMCV cDNA; Lane B, uninfected Vero 
cells; Lanes C-H, EMCV isolates MN-25, Georgia, NVSL-FL, Mengo, OVL-5/90 and ATCC 129B, 
respectively. 
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Figure 2. Results of nested-PCR using product of first generation PGR as a template. An expected 474 bp 
fragment was amplified from all isolates of EMCV and plasmid PDL CDNA, but not from uninfected 
Vero cells. Lane L, 1-kb ladder; Lane A, plasmid PDL containing mouse EMCV cDNA; Lane B, 
uninfected Vero cells; Lanes C-H, EMCV isolates MN-25, Georgia, NVSL-FL, Mengo, OVL-5/90 
and ATCC 129B, respectively. 
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Figure 3. Restriction endonuciease analysis of swine EMCV NVSL-FL VP1 
gene clone (pPSP913). Lane L, 1-kb ladder; Lane A, pPSP913 
clone digested with BamH I restriction endonuciease: Lane B, VP1 
gene cDNA probe isolated from recombinant clone pPSP913 and 
purified. 
bp 
1018 
506 
Figure 4. Detection of EMCV RNA in infected cell lysates by dot blot liybridization using swine EMCV NVSL-
FL VP1 gene radiolabeled probe. Rows A and H contain different concentrations of VP1 cDNA 
positive controls (2 ng, 1 ng, 0.8 ng, 0.4 ng, and 0.1 ng, respectively). Rows B-G have different 
EMCV isolates (row B, Georgia: row C, Mengo; row D, OVL-5/90: row E, ATCC 129B: row F, MN-25 
and row G, NVSL-FL) with different amount of virus from lanes 1 to 5 (lane 1, 200|nl: lane 2, 100|il; 
lane 3, 50|il: lane 4, 25|al: lane 5, 5|il). Rows L-N have swine enterovirus groups 8c, 1 and 2-
infected cell lysates, respectively. Row K has TGEV-infected cell lysate and row I has uninfected 
Vero cell lysate. The same amount of virus (200^1,100|al, 50|il, 25nl and 5|il in lanes 6 to 10, 
respectively) was applied to rows K-N and row I. Row J contains rotavirus cDNA of different 
concentrations (50 ng, 25 ng, 5 ng, 1 ng and 0.5 ng in lanes 6 to 10, respectively). 
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Figure 5 Sensitivity of VP1 gene probe for Eiy/ICV RNA detection. 
Successive dilutions of EMCV l\/IN-25 infected cell lysate ranging 
from 10"^ to 10® TCID50 per spot were dotted in duplicates (B) and 
hybridized with VP1 gene probe. Different amount of VP1 DNA (A) 
was used for positive control (2 ng, 1 ng, 0.6 ng, 0.3 ng and 0.1 
ng)-
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